
<html lang="en"     class="pb-page"  data-request-id="7cb7425b-f3ef-49e1-9295-79b8a3f737d3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2008.51.issue-5;wgroup:string:ACHS website Group;article:article:10.1021/jm701056x;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and in Vitro Evaluation of a Rhenium-Cyclized Somatostatin Derivative Series" /></meta><meta name="dc.Creator" content="Heather M.  Bigott-Hennkens" /></meta><meta name="dc.Creator" content="Sulochana  Junnotula" /></meta><meta name="dc.Creator" content="Lixin  Ma" /></meta><meta name="dc.Creator" content="Fabio  Gallazzi" /></meta><meta name="dc.Creator" content="Michael R.  Lewis" /></meta><meta name="dc.Creator" content="Silvia S.  Jurisson" /></meta><meta name="dc.Description" content="The structure–activity relationships of a series of rhenium (Re)-cyclized octreotide derivatives are described. The effects of changes in the peptide sequence, N-terminus, and C-terminus on metal c..." /></meta><meta name="Description" content="The structure–activity relationships of a series of rhenium (Re)-cyclized octreotide derivatives are described. The effects of changes in the peptide sequence, N-terminus, and C-terminus on metal c..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 13, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm701056x" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm701056x" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm701056x" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm701056x" /></link>
        
    
    

<title>Synthesis and in Vitro Evaluation of a Rhenium-Cyclized Somatostatin Derivative Series | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm701056x" /></meta><meta property="og:title" content="Synthesis and in Vitro Evaluation of a Rhenium-Cyclized Somatostatin Derivative Series" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/large/jm-2007-01056x_0003.jpeg" /></meta><meta property="og:description" content=" The structure–activity relationships of a series of rhenium (Re)-cyclized octreotide derivatives are described. The effects of changes in the peptide sequence, N-terminus, and C-terminus on metal cyclization, as well as binding to the somatostatin receptor, were investigated. Each peptide complex was found to have an integrated Re(V) core with a single metal oxo group, two coordination sites filled by the cysteine sulfhydryls, and another by the amide nitrogen of Phe3/Tyr3. The final coordination site was determined by the peptide N-terminus: the N-terminal amine coordinated for N-NH2 peptides and the amide nitrogen of Thr6 for peptides with acetylated N-termini. Re-cyclization of the octreotide derivatives led to structural perturbations of the somatostatin receptor-binding sequence relative to the Re−free disulfide analogues, resulting in reduced binding affinities. The findings presented herein demonstrate the importance of understanding the consequences of structural modifications when designing metal−peptide complexes for somatostatin receptor targeting." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm701056x"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm701056x">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm701056x&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm701056x&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm701056x&amp;href=/doi/10.1021/jm701056x" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1223-1230</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm701021b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm701096v" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and in Vitro Evaluation of a Rhenium-Cyclized Somatostatin Derivative Series</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heather+M.++Bigott-Hennkens">Heather M. Bigott-Hennkens</a></span><span class="author-xref-symbol "><sup>†</sup></span><span class="author-xref-symbol "><sup>‡</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sulochana++Junnotula">Sulochana Junnotula</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lixin++Ma">Lixin Ma</a></span><span class="author-xref-symbol "><sup>△</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span><span class="author-xref-symbol "><sup>#</sup></span><span class="author-xref-symbol "><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabio++Gallazzi">Fabio Gallazzi</a></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+R.++Lewis">Michael R. Lewis</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>‡</sup></span><span class="author-xref-symbol "><sup>△</sup></span><span class="author-xref-symbol "><sup>#</sup></span><span class="author-xref-symbol "><sup>○</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia+S.++Jurisson">Silvia S. Jurisson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>§</sup></span><span class="author-xref-symbol "><sup>△</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Life Sciences Fellowships Program, Department of Veterinary Medicine and Surgery, Department of Chemistry, Department of Radiology, International Institute of Nano and Molecular Medicine, Nuclear Science and Engineering Institute, and Structural Biology Core, University of Missouri—Columbia, Columbia, Missouri 65211, and Research Service, Harry S. Truman Memorial Veterans’ Hospital, Columbia, Missouri 65201</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. (S.S.J.) Phone: (573) 882-2107 . Fax: (573) 882-2754. E-mail: <a href="/cdn-cgi/l/email-protection#ee849b9c879d9d8180bdae83879d9d819b9c87c08b8a9b"><span class="__cf_email__" data-cfemail="5b312e293228283435081b36322828342e2932753e3f2e">[email protected]</span></a>. (M.R.L.) Phone: (573) 814-6000  ext 53703. Fax: (573) 814-6551. E-mail: <a href="/cdn-cgi/l/email-protection#e78b82908e948a8e84a78a8e94948892958ec9828392"><span class="__cf_email__" data-cfemail="cba7aebca2b8a6a2a88ba6a2b8b8a4beb9a2e5aeafbe">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Life Sciences Fellowships Program, University of Missouri—Columbia.</div><div class="corresp-fn" id="afn2">‡Department of Veterinary Medicine and Surgery, University of Missouri—Columbia.</div><div class="corresp-fn" id="afn3">§Department of Chemistry, University of Missouri—Columbia.</div><div class="corresp-fn" id="afn4">△Department of Radiology, University of Missouri—Columbia.</div><div class="corresp-fn" id="afn5">⊥International Institute of Nano and Molecular Medicine, University of Missouri—Columbia.</div><div class="corresp-fn" id="afn6">#Nuclear Science and Engineering Institute, University of Missouri—Columbia.</div><div class="corresp-fn" id="afn8">○Research Service, Harry S. Truman Memorial Veterans’ Hospital.</div><div class="corresp-fn" id="afn7">∇Structural Biology Core, University of Missouri—Columbia.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm701056x&amp;href=/doi/10.1021%2Fjm701056x" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1223–1230</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 13, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 August 2007</li><li><span class="item_label"><b>Published</b> online</span>13 February 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 March 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm701056x" title="DOI URL">https://doi.org/10.1021/jm701056x</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1223%26pageCount%3D8%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHeather%2BM.%2BBigott-Hennkens%252C%2BSulochana%2BJunnotula%252C%2BLixin%2BMa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D5%26contentID%3Djm701056x%26title%3DSynthesis%2Band%2Bin%2BVitro%2BEvaluation%2Bof%2Ba%2BRhenium-Cyclized%2BSomatostatin%2BDerivative%2BSeries%26numPages%3D8%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1230%26publicationDate%3DMarch%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm701056x"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">646</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm701056x" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and in Vitro Evaluation of a Rhenium-Cyclized Somatostatin Derivative Series&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;M. Bigott-Hennkens&quot;},{&quot;first_name&quot;:&quot;Sulochana&quot;,&quot;last_name&quot;:&quot;Junnotula&quot;},{&quot;first_name&quot;:&quot;Lixin&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Fabio&quot;,&quot;last_name&quot;:&quot;Gallazzi&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;R. Lewis&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;S. Jurisson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;1223-1230&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm701056x&quot;},&quot;abstract&quot;:&quot;The structure–activity relationships of a series of rhenium (Re)-cyclized octreotide derivatives are described. The effects of changes in the peptide sequence, N-terminus, and C-terminus on metal cyclization, as well as binding to the somatostatin receptor, were investigated. Each peptide complex was found to have an integrated Re(V) core with a single metal oxo group, two coordination sites filled by the cysteine sulfhydryls, and another by the amide nitrogen of Phe3/Tyr3. The final coordination site was determined by the peptide N-terminus: the N-terminal amine coordinated for N-NH2 peptides and the amide nitrogen of Thr6 for peptides with acetylated N-termini. Re-cyclization of the octreotide derivatives led to structural perturbations of the somatostatin receptor-binding sequence relative to the Re−free disulfide analogues, resulting in reduced binding affinities. The findings presented herein demonstrate the importance of understanding the consequences of structural modifications when designing metal−pep&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701056x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701056x" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701056x&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701056x" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701056x&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701056x" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm701056x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701056x&amp;href=/doi/10.1021/jm701056x" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm701056x" /></input><a href="/doi/pdf/10.1021/jm701056x" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (298 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm701056x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm701056x%26sid%3Dliteratum%253Aachs%26pmid%3D18269231%26genre%3Darticle%26aulast%3DBigott-Hennkens%26date%3D2008%26atitle%3DSynthesis%2Band%2Bin%2BVitro%2BEvaluation%2Bof%2Ba%2BRhenium-Cyclized%2BSomatostatin%2BDerivative%2BSeries%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D5%26spage%3D1223%26epage%3D1230%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290797" title="Metals">Metals</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/medium/jm-2007-01056x_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/large/jm-2007-01056x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701056x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The structure–activity relationships of a series of rhenium (Re)-cyclized octreotide derivatives are described. The effects of changes in the peptide sequence, <i>N</i>-terminus, and <i>C</i>-terminus on metal cyclization, as well as binding to the somatostatin receptor, were investigated. Each peptide complex was found to have an integrated Re(V) core with a single metal oxo group, two coordination sites filled by the cysteine sulfhydryls, and another by the amide nitrogen of Phe<sup>3</sup>/Tyr<sup>3</sup>. The final coordination site was determined by the peptide <i>N</i>-terminus: the <i>N</i>-terminal amine coordinated for <i>N</i>-NH<sub>2</sub> peptides and the amide nitrogen of Thr<sup>6</sup> for peptides with acetylated <i>N</i>-termini. Re-cyclization of the octreotide derivatives led to structural perturbations of the somatostatin receptor-binding sequence relative to the Re−free disulfide analogues, resulting in reduced binding affinities. The findings presented herein demonstrate the importance of understanding the consequences of structural modifications when designing metal−peptide complexes for somatostatin receptor targeting.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Radiolabeled antibodies, peptides, and small molecules can be used for selective targeting of antigens and receptors on tumor cells, enabling highly specific molecular imaging and radiotherapy of cancer. For example, somatostatin (somatotropin release-inhibiting factor or SRIF) receptor-expressing tumors have received considerable attention following the FDA approval of an <sup>111</sup>In-labeled somatostatin derivative (<sup>111</sup>In-DTPA-<span class="smallcaps smallerCapital">d</span>-Phe-c(Cys-Phe-<span class="smallcaps smallerCapital">d</span>-Trp-Lys-Thr-Cys)-Thr(ol), <sup>111</sup>In-DTPA-octreotide) for the diagnosis of pancreatic, carcinoid, lung, and other cancers that express somatostatin receptors (SSTR) on their cell surfaces. Like <sup>111</sup>In-DTPA-octreotide, most of the work reported to date with radiolabeled SRIF analogues has employed a bifunctional chelate (BFC) approach, in which a radiometal chelating moiety (e.g., DTPA for <sup>111</sup>In, DOTA for <sup>90</sup>Y/<sup>177</sup>Lu, EDDA/HYNIC for <sup>99m</sup>Tc) is appended to the receptor-targeting peptide.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11">(1-11)</a> Octreotide, an eight amino acid peptide cyclized by a disulfide bond between the two Cys residues (<span class="smallcaps smallerCapital">d</span>-Phe-c(Cys-<b>Phe-<span class="smallcaps smallerCapital">d</span>-Trp-Lys-Thr</b>-Cys)-Thr(ol); SSTR binding sequence in bold), and its derivatives are frequently radiolabeled with this approach, due to their stability in vivo and high SSTR<a class="ref internalNav" href="#fn1" aria-label="a">a</a> affinity.</div><div class="NLM_p">The lead compounds arising from such studies have demonstrated excellent imaging characteristics and/or promise for peptide receptor radionuclide therapy (PRRT), albeit with certain drawbacks. Van Essen et al. give a comprehensive summary of the efficacies and limitations of three radiolabeled SRIF analogues used in PRRT: <sup>111</sup>In-DTPA-octreotide (negligible toxicity, but low incidence of objective responses), <sup>90</sup>Y-DOTA-Tyr<sup>3</sup>-octreotide (substantial response rates, yet caused nephrotoxicity), and <sup>177</sup>Lu-DOTA-Tyr<sup>3</sup>-octreotate (significant response rates and lower toxicity, but may not be effective in large tumors).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> With another promising radiolabeled SRIF analogue, <sup>99m</sup>Tc-EDDA/HYNIC-Tyr<sup>3</sup>-octreotide, nonspecific uptake in the bowel and inflammatory lesions led to false-positive results, requiring additional scanning after injection and creating potential patient compliance complications.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> While these agents have shown promise for use in clinical imaging and targeted radiotherapy, the development of superior radiolabeled SRIF analogues, with higher response rates, lower nontarget tissue uptake and toxicity, and rapid clearance from excretion organs, is still warranted.</div><div class="NLM_p">Introducing a radiometal into a somatostatin analogue as an integral part of the peptide molecule is an alternative to the BFC-radiolabeling approach. Developing Tc agents for imaging somatostatin receptors with single photon emission computed tomography (SPECT) is attractive due to the advantage of potential translation to <sup>186</sup>Re/<sup>188</sup>Re (rhenium-186/188) analogues with decay properties appropriate for targeted radiotherapy. Taking advantage of their affinity for sulfur and nitrogen ligands, Re and Tc radiometals can be added directly into the disulfide bond of SRIF derivatives, using a Cys-S-Re/Tc-S-Cys structure to form the cyclic peptide. Previously, the potential of this integrated radiolabeling approach was demonstrated in studies comparing both BFC and metal cyclization methods to Tc-/Re-labeling of α-melanocyte-stimulating hormone (α-MSH) peptides.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Successful integration of the radiometal into the disulfide bond of the α-MSH derivative (Cys<sup>3,4,10</sup>,<span class="smallcaps smallerCapital">d</span>-Phe<sup>7</sup>)-α-MSH<sub>3–13</sub> (Ac-Cys-Cys-Glu-His-<span class="smallcaps smallerCapital">d</span>-Phe-Arg-Trp-Cys-Lys-Pro-Val-NH<sub>2</sub>) resulted in highly stable radiometal−peptide conjugates with the greatest tumor uptake observed for the α-MSH complexes studied.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Metal cyclization (Re or Tc, whether radiometal or nonradiometal) was shown to result in higher tumor uptake and retention, even for radioiodinated α-MSH analogues.<a onclick="showRef(event, 'ref12 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref14 ref15">(12, 14, 15)</a> Increased retention of radioactivity in tumors should translate to improved tumor imaging contrast, as well as more effective therapy at lower doses, sparing the nontarget tissues. Applying this design strategy to SRIF analogues, and potentially improving the status of diagnostic imaging and targeted radiotherapy with SRIF peptide-based radiopharmaceuticals, is therefore attractive.</div><div class="NLM_p">A limited number of studies have been reported on the Re-/Tc-cyclization of SRIF analogues, describing modest success in receptor binding and tumor uptake. Zamora et al., for example, directly labeled the octreotide analogue RC-160 (<span class="smallcaps smallerCapital">d</span>-Phe-Cys-Tyr-<span class="smallcaps smallerCapital">d</span>-Trp-Lys-Val-Cys-Trp-NH<sub>2</sub>) with <sup>188</sup>Re and observed growth inhibition and partial regressions of human prostate tumor xenografts in mice.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Octreotide cyclized with <sup>188</sup>Re selectively localized in small-cell lung cancer lesions of mice, albeit with somewhat lower tumor-to-normal tissue ratios compared to the BFC-radiolabeled octreotide peptide, were also examined.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> While <sup>188</sup>Re-octreotide and <sup>188</sup>Re-RC-160 have shown some promise as radiopharmaceutical agents, they have fared no better to date than their iodinated counterparts and have suffered from prolonged retention in the liver, with subsequent slow clearance through the intestines (more renal uptake was observed for <sup>188</sup>Re-octreotide).<a onclick="showRef(event, 'ref16 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref18 ref19">(16, 18, 19)</a> These disadvantages would likely lead to sizable nontarget tissue doses in addition to causing difficulties in clinical applications for certain tumors (e.g., pancreatic cancer).</div><div class="NLM_p">The modest performance of the Re-/Tc-cyclized octreotide analogues previously reported may be due to suboptimal peptide sequences rather than to the method of radiometal incorporation; their lipophilic nature is consistent with their tendency to exhibit high hepatobiliary clearance. In several studies employing the BFC-radiolabeling approach, alterations made to the basic octreotide peptide structure yielded complexes with greater hydrophilicities and tumor-targeting properties.<a onclick="showRef(event, 'ref2 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref2 ref8 ref9">(2, 8, 9)</a> To the best of our knowledge, radiometal cyclization has not been investigated with such “optimized” octreotide peptide derivatives. Therefore, we investigated the structure–activity relationship in a series of octreotide peptides modified at the peptide <i>N</i>-terminus, the peptide <i>C</i>-terminus, and/or the third amino acid of the peptide sequence. These subtle changes in peptide structure had dramatic effects on the Re(V) coordination sphere, overall Re−peptide complex structure, and SSTR binding affinity. The findings presented herein demonstrate the importance of understanding the consequences of structural modifications when developing metal-peptide complexes for SSTR targeting and offer new insights for future designs.</div><div class="NLM_p last"><div class="NLM_fn" id="fn1"><i>a</i><p class="last">Abbreviations: SRIF, somatostatin; DTPA, diethylenetriaminepentaacetic acid; octreotide, <span class="smallcaps smallerCapital">d</span>-Phe-Cys-Phe-<span class="smallcaps smallerCapital">d</span>-Trp-Lys-Thr-Cys-Thr(ol); SSTR, somatostatin receptor; BFC, bifunctional chelate; DOTA, 1,4,7,10-tetraazacyclododecanetetraacetic acid; EDDA/HYNIC, ethylenediamine <i>N</i>,<i>N</i>′-diacetic acid/hydrazinonicotinic acid; PRRT, peptide receptor radionuclide therapy; SPECT, single photon emission computed tomography; α-MSH, α-melanocyte-stimulating hormone; RC-160, <span class="smallcaps smallerCapital">d</span>-Phe-Cys-Tyr-<span class="smallcaps smallerCapital">d</span>-Trp-Lys-Val-Cys-Trp-NH<sub>2</sub>; Ac-Tyr<sup>3</sup>-octreotate, CH<sub>3</sub>C(O)NH-<span class="smallcaps smallerCapital">d</span>-Phe-Cys-Tyr-<span class="smallcaps smallerCapital">d</span>-Trp-Lys-Thr-Cys-Thr; LC-ESI-MS, liquid chromatography-electrospray ionization-mass spectrometry; RP-HPLC, reversed-phase HPLC; TOCSY, total correlated spectroscopy; HSQC, heteronuclear single quantum coherence; (Cys<sup>4,10</sup>,<span class="smallcaps smallerCapital">d</span>-Phe<sup>7</sup>)-α-MSH<sub>4–13</sub>, Ac-Cys-Glu-His-<span class="smallcaps smallerCapital">d</span>-Phe-Arg-Trp-Cys-Lys-Pro-Val-NH<sub>2</sub>; hsst2, human somatostatin receptor subtype 2; Fmoc, 9-fluorenylmethoxycarbonyl; DSS, 2,2-dimethylsilapentane-5-sulfonic acid; SSTR2, somatostatin receptor subtype 2.</p></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Four reduced linear peptide sequences (octreotide, Ac-octreotide, Tyr<sup>3</sup>-octreotate, and Ac-Tyr<sup>3</sup>-octreotate, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were cyclized with nonradioactive Re via transchelation reactions with [ReOCl<sub>3</sub>(OPPh<sub>3</sub>)(SMe<sub>2</sub>)] in aqueous methanol solutions (see the Experimental Section). Analysis of the crude product solutions by liquid chromatography−electrospray ionization−mass spectrometry (LC−ESI−MS) confirmed the expected Re−peptide complex mass for the main product of each reaction. Some of the linear peptide starting material was converted to a Re−free disulfide-bridged peptide that gave rise to a small peak in each of the chromatograms (10–22%, confirmed by both LC−ESI−MS and reversed-phase HPLC (RP−HPLC) coinjection with a synthesized standard). Generation of this side product is not surprising given the basic starting conditions and the single phase nature of this intramolecular reaction (versus the biphasic and intermolecular Re cyclization reaction), both of which can facilitate disulfide formation. Also noteworthy was the observance of another, smaller peak (minor product; 6–12%) with the predicted Re−product mass, yet with a significantly different retention time from the major Re product.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Octreotide Analogue Sequences and Their Calculated and Observed Molecular Weights by ESI-MS</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle" char=".">linear peptide</th><th colspan="2" align="center" valign="middle" char=".">disulfide peptide</th><th colspan="2" align="center" valign="middle">Re-peptide complex<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="bottom">peptide</th><th class="rowsep1" align="center" valign="bottom">peptide sequence<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th class="rowsep1" align="center" valign="bottom" char=".">(M + H)<sup>+</sup> calcd</th><th class="rowsep1" align="center" valign="bottom" char=".">(M + H)<sup>+</sup> obsd</th><th class="rowsep1" align="center" valign="bottom" char=".">(M + H)<sup>+</sup> calcd</th><th class="rowsep1" align="center" valign="bottom">(M + H)<sup>+</sup> obsd (purity, %)</th><th class="rowsep1" align="center" valign="bottom">(M + H)<sup>+</sup> calcd</th><th class="rowsep1" align="center" valign="bottom">(M + H)<sup>+</sup> obsd (purity, %)</th></tr></thead><tbody><tr valign="top"><td align="left">octreotide</td><td align="left">NH<sub>2</sub>-<span class="smallcaps smallerCapital">d</span>FCF<span class="smallcaps smallerCapital">d</span>WKTCT(ol)</td><td align="char" char=".">1021.5</td><td align="char" char=".">1021.4</td><td align="char" char=".">1019.4</td><td align="left">1019.5 (99.0)</td><td align="left">1220.4</td><td align="left">1221.7 (97.7)</td></tr><tr valign="top"><td align="left">Ac-octreotide</td><td align="left">Ac-<span class="smallcaps smallerCapital">d</span>FCF<span class="smallcaps smallerCapital">d</span>WKTCT(ol)</td><td align="char" char=".">1063.5</td><td align="char" char=".">1063.3</td><td align="char" char=".">1061.5</td><td align="left">1061.6 (98.8)</td><td align="left">1262.4</td><td align="left">1263.9 (96.3)</td></tr><tr valign="top"><td align="left">Tyr<sup>3</sup>-octreotate</td><td align="left">NH<sub>2</sub>-<span class="smallcaps smallerCapital">d</span>FCY<span class="smallcaps smallerCapital">d</span>WKTCTOH</td><td align="char" char=".">1051.4</td><td align="char" char=".">1051.5</td><td align="char" char=".">1049.4</td><td align="left">1049.5 (98.6)</td><td align="left">1250.4</td><td align="left">1251.9 (98.7)</td></tr><tr valign="top"><td align="left">Ac-Tyr<sup>3</sup>-octreotate</td><td align="left">Ac-<span class="smallcaps smallerCapital">d</span>FCY<span class="smallcaps smallerCapital">d</span>WKTCTOH</td><td align="char" char=".">1093.4</td><td align="char" char=".">1093.4</td><td align="char" char=".">1091.4</td><td align="left">1091.5 (98.4)</td><td align="left">1292.4</td><td align="left">1293.8 (97.8)</td></tr><tr valign="top"><td align="left">DOTA-Tyr<sup>3</sup>-octreotide<a class="ref internalNav" href="#tbl1-fn3" aria-label="c">c</a></td><td align="left">DOTA-<span class="smallcaps smallerCapital">d</span>FCY<span class="smallcaps smallerCapital">d</span>WKTCT(ol)</td><td align="char" char=".">1423.6</td><td align="char" char=".">1424.0</td><td align="char" char=".">1421.6</td><td align="left">1421.8 (99.2)</td><td align="left">NA<a class="ref internalNav" href="#tbl1-fn4" aria-label="d">d</a></td><td align="left">NA<a class="ref internalNav" href="#tbl1-fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">NH<sub>2</sub> and Ac represent <i>N</i>-terminal NH<sub>2</sub> and NHC(O)CH<sub>3</sub>, respectively; (ol) and OH represent <i>C</i>-terminal CH<sub>2</sub>OH and COOH, respectively.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Both <sup>185</sup>Re and <sup>187</sup>Re peaks were observed. For clarity, values are reported for <sup>187</sup>Re, the more abundant isotope.</p></div><div class="footnote" id="tbl1-fn3"><sup>c</sup><p class="last">Used as the competitive binding assay standard when radiolabeled with <sup>111</sup>In.</p></div><div class="footnote" id="tbl1-fn4"><sup>d</sup><p class="last">NA, not applicable.</p></div></div></div><div class="NLM_p">Interestingly, the RP-HPLC elution pattern of the three peptide products formed from each sequence was affected by the <i>N</i>-terminus of the linear peptide used in the reaction. For example, Re cyclization with octreotide (<i>N</i>-NH<sub>2</sub>) resulted in an elution order of minor, disulfide, and major products, whereas a major, disulfide, minor product order was observed under the same RP-HPLC conditions following Re integration into Ac-octreotide. A retention time comparison of the crude product solutions (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) showed that acetylation of the <i>N</i>-termini resulted in the preferred formation of products with retention times that were significantly closer to their respective disulfide-bridged peptides, and which always eluted between the two Re−peptide products. These results suggested the involvement of the <i>N</i>-terminus in Re complexation and the formation of isomers with different metal coordination spheres. Formation of syn and anti isomers would be expected to give products with similar retention times, but such products were not observed. With several amides and, for the nonacetylated peptides, an unprotected <i>N</i>-terminal amine near the metal center, formation of more than one configuration for Re coordination was certainly reasonable.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparison of RP-HPLC Retention Times of the Re Cyclization Products<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">retention time (min)</th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="middle">linear peptide</th><th class="rowsep1" align="center" valign="middle" char=".">disulfide product</th><th class="rowsep1" align="center" valign="middle" char=".">major Re product</th><th class="rowsep1" align="center" valign="middle" char=".">minor Re product</th></tr></thead><tbody><tr valign="top"><td align="left">octreotide</td><td align="char" char=".">19.6</td><td align="char" char=".">30.0</td><td align="char" char=".">17.4</td></tr><tr valign="top"><td align="left">Ac-octreotide</td><td align="char" char=".">27.6</td><td align="char" char=".">25.5</td><td align="char" char=".">30.4</td></tr><tr valign="top"><td align="left">Tyr<sup>3</sup>-octreotate</td><td align="char" char=".">16.1</td><td align="char" char=".">23.9</td><td align="char" char=".">14.6</td></tr><tr valign="top"><td align="left">Ac-Tyr<sup>3</sup>-octreotate</td><td align="char" char=".">20.4</td><td align="char" char=".">19.0</td><td align="char" char=".">22.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Values were obtained from analytical RP-HPLC runs using a 35-min linear gradient from 15 to 40% solvent B in solvent A, a 1 mL/min flow rate, and UV detection at 280 nm (<i>A</i> = 0.1% TFA in H<sub>2</sub>O; <i>B</i> = 0.1% TFA in CH<sub>3</sub>CN).</p></div></div></div><div class="NLM_p">Therefore, to investigate the role of the peptide <i>N</i>-terminus in Re complexation, each of the four nonradioactive Re-cyclized major products was purified by semipreparative RP-HPLC and subsequently lyophilized. The purified major products were characterized by LC−ESI−MS (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), and their solution-phase structures were examined by two-dimensional nuclear magnetic resonance (2D NMR) spectroscopy. The four disulfide-cyclized “parent” peptides (Re−free) were also synthesized, purified by RP-HPLC, confirmed by LC−ESI−MS (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), and analyzed by 2D NMR spectroscopy. Purification was not carried out for the minor Re-cyclized products due to insufficient amounts of material formed during the reactions.</div><div class="NLM_p">In order to identify the Re(V) coordination spheres, complete <sup>1</sup>H and <sup>13</sup>C chemical shift assignments (Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and S1−S6 (Supporting Information)) for the Re−peptide complexes and their parent disulfide-bridged peptides were obtained from 2D <sup>1</sup>H−<sup>1</sup>H total correlated spectroscopy (TOCSY) and <sup>1</sup>H−<sup>13</sup>C heteronuclear single quantum coherence (HSQC) NMR spectra. Natural abundance <sup>1</sup>H−<sup>13</sup>C HSQC NMR experiments were used to detect the backbone carbon chemical shift changes in the Re−peptides versus the parent peptides. Overlays of the spectra for each Re−peptide and its parent peptide showed that most peaks aligned well in the HSQC spectra. However, significant downfield shifts were observed for both the C<sub>α</sub> and C<sub>β</sub> (e.g., 10.4–15.6 ppm) and the H<sub>α</sub> and H<sub>β</sub> (e.g., 0.58–1.43 ppm) of Phe<sup>3</sup>/Tyr<sup>3</sup> for all four metal-cyclized peptides. In addition, downfield shifts of 10.8–12.4 ppm for the C<sub>α</sub> and 1.05–1.08 ppm for the H<sub>α</sub> of Thr<sup>6</sup> were observed for the acetylated metal-cyclized peptides, whereas a 9.8–10.5 ppm downfield shift occurred for the C<sub>α</sub> of <span class="smallcaps smallerCapital">d</span>-Phe<sup>1</sup> for the nonacetylated metal-cyclized peptides. The results indicate that these residues were likely involved in the Re coordination. Chemical shift alterations of Cys<sup>2</sup>-βCH<sub>2</sub> and Cys<sup>7</sup>-βCH<sub>2</sub> showed that the thiolate sulfurs of Cys<sup>2</sup> and Cys<sup>7</sup> were coordinated to the Re metal center. For example, significant upfield shifts of 4.7–6.5 ppm were observed for C<sub>β</sub> of Cys<sup>2</sup> for all four Re-cyclized peptides. Upfield shifts of 2.7–3.8 ppm and downfield shifts of 1.5–2.9 ppm were observed for C<sub>β</sub> of Cys<sup>7</sup> for nonacetylated and acetylated metal-cyclized peptides, respectively. In addition, downfield shifts up to 1.12 ppm were observed for H<sub>β</sub> for both Cys residues for all four Re-cyclized peptides.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <sup>1</sup>H and <sup>13</sup>C NMR Chemical Shift Assignments<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a> of Re−Ac-octreotide</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="middle">residue</th><th class="rowsep1" align="center" valign="middle">NH</th><th class="rowsep1" align="center" valign="middle">αCH</th><th class="rowsep1" align="center" valign="middle">βCH</th><th class="rowsep1" align="center" valign="middle">others</th></tr></thead><tbody><tr valign="top"><td align="left"><i>N</i>-terminus</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">CH<sub>3</sub>: 2.08 (17.7)</td></tr><tr valign="top"><td align="left"><span class="smallcaps smallerCapital">d</span>-Phe<sup>1</sup></td><td align="left">8.09</td><td align="left">4.50 (50.5)</td><td align="left">3.00 (33.9)</td><td align="left">δ: 7.27 (126.9); ϵ: 7.37 (126.1); ζ: 7.32 (124.5)</td></tr><tr valign="top"><td align="left">Cys<sup>2</sup></td><td align="left">8.08</td><td align="left">4.76<a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a></td><td align="left">2.83, 3.28 (32.2)</td><td align="left"> </td></tr><tr valign="top"><td align="left">Phe<sup>3</sup></td><td align="left"> </td><td align="left">5.13 (65.0)</td><td align="left">3.68, 4.33 (46.5)</td><td align="left">δ: 7.15 (126.4); ϵ: 7.24 (125.8); ζ: 7.20 (124.1)</td></tr><tr valign="top"><td align="left"><span class="smallcaps smallerCapital">d</span>-Trp<sup>4</sup></td><td align="left">7.53</td><td align="left">4.63 (50.1)</td><td align="left">3.18, 3.28 (24.1)</td><td align="left">δ1: 7.20 (122.2); ϵ1: 10.14; ϵ3: 7.60 (115.7); ζ2: 7.48 (109.3); ζ3: 7.23 (119.1); η2: 7.19 (116.5)</td></tr><tr valign="top"><td align="left">Lys<sup>5</sup></td><td align="left">8.34</td><td align="left">3.78 (50.2)</td><td align="left">1.46, 1.64 (24.7)</td><td align="left">γ: 1.03 (17.4); δ: 1.55 (22.1); ϵ: 2.90 (35.1); ζ: 7.54</td></tr><tr valign="top"><td align="left">Thr<sup>6</sup></td><td align="left"> </td><td align="left">5.39 (66.6)</td><td align="left">4.44 (62.1)</td><td align="left">γ2: 1.45 (12.3)</td></tr><tr valign="top"><td align="left">Cys<sup>7</sup></td><td align="left">8.21</td><td align="left">4.63 (51.5)</td><td align="left">3.49, 3.64 (31.5)</td><td align="left"> </td></tr><tr valign="top"><td align="left">Thr<sup>8</sup></td><td align="left">7.75</td><td align="left">3.82 (52.1)</td><td align="left">4.01 (62.0)</td><td align="left">γ2: 1.12 (14.8)</td></tr><tr valign="top"><td align="left"><i>C</i>-terminus</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">CH<sub>2</sub>: 3.61, 3.70 (57.1)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Chemical shifts (ppm) were referenced relative to DSS and were measured at 25 °C. <sup>1</sup>H chemical shift values are listed with <sup>13</sup>C values in parentheses. The chemical shifts are generally accurate to 0.02 ppm for <sup>1</sup>H and 0.1 ppm for <sup>13</sup>C.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">The chemical shift of <sup>13</sup>C<sub>α</sub> could not be assigned due to overlapping resonance with H<sub>2</sub>O in the <sup>1</sup>H−<sup>13</sup>C HSQC spectrum.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <sup>1</sup>H and <sup>13</sup>C NMR Chemical Shift Assignments<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a> of Disulfide-Cyclized Ac-octreotide</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="middle">residue</th><th class="rowsep1" align="center" valign="middle">NH</th><th class="rowsep1" align="center" valign="middle">αCH</th><th class="rowsep1" align="center" valign="middle">βCH</th><th class="rowsep1" align="center" valign="middle">others</th></tr></thead><tbody><tr valign="top"><td align="left"><i>N</i>-terminus</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">CH<sub>3</sub>: 2.00 (17.6)</td></tr><tr valign="top"><td align="left"><span class="smallcaps smallerCapital">d</span>-Phe<sup>1</sup></td><td align="left">8.24</td><td align="left">4.59 (51.1)</td><td align="left">3.04 (33.2)</td><td align="left">δ: 7.27 (126.6); ϵ: 7.38 (126.1); ζ: 7.34 (124.6)</td></tr><tr valign="top"><td align="left">Cys<sup>2</sup></td><td align="left">8.16</td><td align="left">4.69<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td><td align="left">2.86, 2.72 (37.2)</td><td align="left"> </td></tr><tr valign="top"><td align="left">Phe<sup>3</sup></td><td align="left">8.20</td><td align="left">4.66 (50.8)</td><td align="left">2.93, 3.04 (34.1)</td><td align="left">δ: 7.24 (126.7); ϵ: 7.36 (126.1); ζ: 7.37 (124.6)</td></tr><tr valign="top"><td align="left"><span class="smallcaps smallerCapital">d</span>-Trp<sup>4</sup></td><td align="left">8.63</td><td align="left">4.32 (51.7)</td><td align="left">2.92, 3.04 (22.0)</td><td align="left">δ1: 7.14 (121.9); ϵ1: 10.20; ϵ3: 7.58 (115.7); ζ2: 7.51 (109.3); ζ3: 7.26 (119.3); η2: 7.20 (116.7)</td></tr><tr valign="top"><td align="left">Lys<sup>5</sup></td><td align="left">8.33</td><td align="left">3.89 (50.2)</td><td align="left">1.29, 1.58 (25.4)</td><td align="left">γ: 0.39, 0.56 (17.3); δ: 1.32 (22.0); ϵ: 2.70 (35.0); ζ: 7.48</td></tr><tr valign="top"><td align="left">Thr<sup>6</sup></td><td align="left">7.99</td><td align="left">4.31 (55.8)</td><td align="left">4.37 (62.5)</td><td align="left">γ2: 1.24 (15.0)</td></tr><tr valign="top"><td align="left">Cys<sup>7</sup></td><td align="left">8.02</td><td align="left">4.80<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td><td align="left">2.94, 3.19 (35.3)</td><td align="left"> </td></tr><tr valign="top"><td align="left">Thr<sup>8</sup></td><td align="left">7.72</td><td align="left">3.86 (52.4)</td><td align="left">4.02 (62.0)</td><td align="left">γ2: 1.16 (14.8)</td></tr><tr valign="top"><td align="left"><i>C</i>-terminus</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">CH<sub>2</sub>: 3.63, 3.72 (57.1)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Chemical shifts (ppm) were referenced relative to DSS and were measured at 25 °C. <sup>1</sup>H chemical shift values are listed with <sup>13</sup>C values in parentheses. The chemical shifts are generally accurate to 0.01 ppm for <sup>1</sup>H and 0.1 ppm for <sup>13</sup>C.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">Chemical shifts of <sup>13</sup>C<sub>α</sub> could not be assigned due to overlapping resonances with H<sub>2</sub>O in the <sup>1</sup>H−<sup>13</sup>C HSQC spectrum.</p></div></div></div><div class="NLM_p">Further analyses were carried out on the 2D TOCSY spectra, which show cross peaks between the backbone amide protons and the side chain protons of each residue. Cross peaks from two backbone amide protons, Phe<sup>3</sup>/Tyr<sup>3</sup> and Thr<sup>6</sup>, were absent from the TOSCY spectra of the acetylated metal-cyclized peptides (e.g., Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), suggesting these two amide protons had been lost during complexation. Thus, each Re(V) center of the acetylated complexes was coordinated to the two cysteine sulfhydryls (Cys<sup>2</sup> and Cys<sup>7</sup>) and the amide nitrogens from both Phe<sup>3</sup>/Tyr<sup>3</sup> and Thr<sup>6</sup>. In the case of the nonacetylated metal-cyclized peptides, only one amide proton resonance, namely Phe<sup>3</sup>/Tyr<sup>3</sup>, was absent from the TOCSY spectra. As expected, the <i>N</i>-terminal amine was not found on the TOCSY spectra for the parent nonacetylated peptides, due to the fast exchange with bulk water resonance. Interestingly, a single <i>N</i>-terminus amine resonance was observed with cross peaks to the side chain protons of <span class="smallcaps smallerCapital">d</span>-Phe<sup>1</sup> in the TOCSY spectra of the nonacetylated metal-cyclized peptides. Therefore, in the nonacetylated Re−peptides, each Re(V) center was again coordinated to the two cysteine sulfhydryls and the amide nitrogen from Phe<sup>3</sup>/Tyr<sup>3</sup>. However, unlike the acetylated Re−peptides, the final coordination site was filled by the <i>N</i>-terminal amine (<span class="smallcaps smallerCapital">d</span>-Phe<sup>1</sup>) rather than a second amide nitrogen. The derived Re(V) coordination spheres are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/medium/jm-2007-01056x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/large/jm-2007-01056x_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overlay of 2D <sup>1</sup>H−<sup>1</sup>H TOCSY NMR spectra of Re−Ac-octreotide (red) and disulfide-cyclized Ac-octreotide (blue). As indicated by the arrows shown, many proton peaks are shifted upon integration of the Re(V) core into the Ac-octreotide peptide structure. Also, the amide protons of Phe<sup>3</sup> and Thr<sup>6</sup> are missing from the Re−Ac-octreotide spectrum (the corresponding disulfide-cyclized Ac-octreotide protons are labeled in green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/large/jm-2007-01056x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701056x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Re-Cyclized Peptide Complex Coordination Sites and Somatostatin Receptor Binding Affinities (AR42J Cells)</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead valign="middle"><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="middle">Re−peptide complex</th><th class="rowsep1" align="center" valign="middle">Re coordination Sites<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></th><th class="rowsep1" align="center" valign="middle" char="±">IC<sub>50</sub> values (nM)<a class="ref internalNav" href="#tbl5-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td rowspan="4" align="left">Re−octreotide</td><td align="left"><span class="smallcaps smallerCapital">d</span>Phe<sup>1</sup> NH<sub>2</sub></td><td rowspan="4" align="char" char="±">328 ± 65</td></tr><tr valign="top"><td align="left">Cys<sup>2</sup> sulfhydryl</td></tr><tr valign="top"><td align="left">Phe<sup>3</sup><i>N</i>-amide</td></tr><tr valign="top"><td align="left">Cys<sup>7</sup> sulfhydryl</td></tr><tr valign="top"><td rowspan="4" align="left">Re−Ac-octreotide</td><td align="left">Cys<sup>2</sup> sulfhydryl</td><td rowspan="4" align="char" char="±">637 ± 125</td></tr><tr valign="top"><td align="left">Phe<sup>3</sup><i>N</i>-amide</td></tr><tr valign="top"><td align="left">Thr<sup>6</sup><i>N</i>-amide</td></tr><tr valign="top"><td align="left">Cys<sup>7</sup> sulfhydryl</td></tr><tr valign="top"><td rowspan="4" align="left">Re−Tyr<sup>3</sup>-octreotate</td><td align="left"><span class="smallcaps smallerCapital">d</span>Phe<sup>1</sup> NH<sub>2</sub></td><td rowspan="4" align="char" char="±">29.2 ± 6.1</td></tr><tr valign="top"><td align="left">Cys<sup>2</sup> sulfhydryl</td></tr><tr valign="top"><td align="left">Tyr<sup>3</sup><i>N</i>-amide</td></tr><tr valign="top"><td align="left">Cys<sup>7</sup> sulfhydryl</td></tr><tr valign="top"><td rowspan="4" align="left">Re−Ac-Tyr<sup>3</sup>-octreotate</td><td align="left">Cys<sup>2</sup> sulfhydryl</td><td rowspan="4" align="char" char="±">106 ± 12</td></tr><tr valign="top"><td align="left">Tyr<sup>3</sup><i>N</i>-amide</td></tr><tr valign="top"><td align="left">Thr<sup>6</sup><i>N</i>-amide</td></tr><tr valign="top"><td align="left">Cys<sup>7</sup> sulfhydryl</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Re(V) metal coordination sites were assigned from 2D <sup>1</sup>H−<sup>1</sup>H TOCSY and <sup>1</sup>H−<sup>13</sup>C HSQC NMR data analysis.</p></div><div class="footnote" id="tbl5-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values were determined from competitive binding assays with <sup>111</sup>In-DOTA-Tyr<sup>3</sup>-octreotide in AR42J cells and are presented as average ± SEM from triplicate measurements.</p></div></div></div><div class="NLM_p">A single stable conformation was observed in the NMR spectra of the acetylated metal-cyclized peptides (Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref internalNav" href="#si1" aria-label="S1 (Supporting Information)">S1 (Supporting Information)</a>). In further contrast to the acetylated peptides, the <i>N</i>-NH<sub>2</sub> peptide complex NMR spectra showed two distinct sets of signals for each peptide, indicating that two isomers existed in solution (<a class="ref internalNav" href="#si1" aria-label="Tables S3 and S5, Supporting Information">Tables S3 and S5, Supporting Information</a>). An integration of NMR peak volumes indicated the presence of approximately 65% and 35% for major and minor isomers, respectively. Each set of peaks identified the same coordination ligands for the Re(V) metal centers, suggesting that these isomers differed from one another in overall structure, but not in complexation to the metal. The Re(V) coordination spheres for complexes of the octreotide sequence, with and without <i>N</i>-terminal acetylation, are illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, with the Re−free parent peptide shown for comparison.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/medium/jm-2007-01056x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/large/jm-2007-01056x_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of Re−octreotide (left) and Re−Ac-octreotide (middle) with somatostatin pharmacophore sequences shown in bold. Disulfide-cyclized octreotide is shown (right) for comparison.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/large/jm-2007-01056x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701056x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Disulfide-bridged octreotide (<i>N</i>-NH<sub>2</sub>) has a large ring of 20 atoms that positions the peptide in the β-turn configuration and is responsible for high-affinity SSTR binding. When octreotide was cyclized with Re, the 17-atom large ring formed was more constrained, leading to perturbations in the structure of the β turn relative to that of the parent peptide. Here, the <i>N</i>-terminus coordinated to the metal, forming an eight-membered ring with the basic NH<sub>2</sub> donor in preference to a five- or six-membered ring with one of the amide nitrogen donors that neighbor the cysteine residues. This coordination certainly affected the structure of the peptide near the <i>N</i>-terminus but likely did not contribute considerable strain on the pharmacophore-containing ring. Acetylating the <i>N</i>-terminus disfavored its coordination to Re and resulted in the amide nitrogen of Thr<sup>6</sup> replacing it in the metal coordination sphere. Consequently, the large ring in the Re−Ac-octreotide consisted of only 11 atoms, which brought the metal center closer to the receptor pharmacophore and further disrupted its configuration relative to the parent peptide. As expected, the same ring sizes were observed for the Tyr<sup>3</sup>-octreotate and Ac-Tyr<sup>3</sup>-octreotate Re complexes, since the location of the differences between octreotide and Tyr<sup>3</sup>-octreotate were not involved in metal cyclization. These results indicated that, due to their proximity to the receptor binding sequence, the Re(V) centers of the metal-peptide complexes may interfere with SSTR binding and that a greater negative effect would be expected for the acetylated Re complexes.</div><div class="NLM_p">Comparable findings were reported for a Re-cyclized α-MSH peptide containing two Cys residues (Ac-Cys-Glu-His-<span class="smallcaps smallerCapital">d</span>-Phe-Arg-Trp-Cys-Lys-Pro-Val-NH<sub>2</sub>, (Cys<sup>4,10</sup>,<span class="smallcaps smallerCapital">d</span>-Phe<sup>7</sup>)-α-MSH<sub>4–13</sub>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Though the eight amino acid octreotide analogues and the 10 amino acid α-MSH peptide have different sequences and target different receptors, the disulfide- and Re-cyclized peptides have several interesting similarities. The octreotide analogues have a four amino acid receptor pharmacophore (Phe<sup>3</sup>/Tyr<sup>3</sup>-<span class="smallcaps smallerCapital">d</span>-Trp<sup>4</sup>-Lys<sup>5</sup>-Thr<sup>6</sup>) immediately bordered by two Cys residues. The α-MSH peptide also has a four amino acid receptor binding sequence (His<sup>6</sup>-<span class="smallcaps smallerCapital">d</span>-Phe<sup>7</sup>-Arg<sup>8</sup>-Trp<sup>9</sup>) between two flanking Cys residues, yet with an additional amino acid (Glu<sup>5</sup>) between Cys<sup>4</sup> and the binding sequence. This extra amino acid resulted in a 23-membered ring for the Re−free cyclic peptide, three atoms larger in size than the disulfide-cyclized octreotide analogues. Upon coordination of Re, however, the ring size was reduced from 23 atoms to 18 atoms (a 22% decrease). As described above, the octreotide analogues rings were reduced in size as well, from 20 atoms for the parent disulfide peptides to either 17 atoms (a 15% decrease) or 11 atoms (a 45% decrease) for the nonacetylated and acetylated peptides, respectively. Furthermore, in each of the Re−peptide complexes, one or more of the binding sequence amino acids was involved in coordination to the metal; Trp<sup>9</sup> for Re-(Cys<sup>4,10</sup>,<span class="smallcaps smallerCapital">d</span>-Phe<sup>7</sup>)-α-MSH<sub>4–13</sub>, Phe<sup>3</sup>/Tyr<sup>3</sup> for the nonacetylated Re−octreotide analogues, and Phe<sup>3</sup>/Tyr<sup>3</sup> and Thr<sup>6</sup> for the acetylated Re−octreotide analogues. For the (Cys<sup>4,10</sup>,<span class="smallcaps smallerCapital">d</span>-Phe<sup>7</sup>)-α-MSH<sub>4–13</sub> peptide, direct metal cyclization resulted in nearly a 100-fold reduction in receptor affinity relative to its disulfide-cyclized counterpart. This loss of binding affinity was attributed to both the proximity of the Re-coordination sphere to the receptor binding amino acids and to the involvement of Trp<sup>9</sup> in metal binding.</div><div class="NLM_p">Consequently, to determine the extent of the effect on receptor binding caused by integration of the metal center, SSTR binding affinity values were obtained for the Re-cyclized peptide series and were correlated to the NMR structural findings. The concentrations of peptides that caused half-maximal inhibition (IC<sub>50</sub> values) of <sup>111</sup>In-DOTA-Tyr<sup>3</sup>-octreotide binding to AR42J rat pancreatic carcinoma cells are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Each of the Re−peptide complexes was found to target the receptor; IC<sub>50</sub> values ranged from 29 to 636 nM, and the associated receptor binding affinities were in the following order: Re−Ac-octreotide < Re−octreotide < Re−Ac-Tyr<sup>3</sup>-octreotate < Re−Tyr<sup>3</sup>-octreotate. Reubi et al.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> reported IC<sub>50</sub> values for the human somatostatin receptor subtype 2 (hsst2) of 22 and 11 nM, respectively, for In-DTPA-octreotide and Y-DOTA-Tyr<sup>3</sup>-octreotide, the nonradioactive forms of two of the most characterized clinical PRRT agents. Therefore, the 29 nM IC<sub>50</sub> value for Re−Tyr<sup>3</sup>-octreotate, the highest affinity complex of the present study, demonstrated the potential of the direct metal cyclization approach in designing SRIF analogues with reasonable in vitro SSTR targeting.</div><div class="NLM_p">The magnitude and order of the IC<sub>50</sub> values correlated well with the NMR data. First, all of the Re−peptide spectra showed shifted <sup>1</sup>H and <sup>13</sup>C NMR signals of the receptor pharmacophore residues, suggesting differences in the structure and/or the electronic environment of the β turns with respect to their parent disulfide peptides. Such changes are consistent with the somewhat elevated IC<sub>50</sub> values observed for the series (target IC<sub>50</sub> range is 1–30 nM) and suggest that modifications made to reduce or eliminate these differences may improve SSTR affinity. Second, the acetylated peptide analogues showed lower receptor affinities (higher values) than their counterparts with amine <i>N</i>-termini. The NMR data also agreed with this outcome, showing that the metal centers of the <i>N</i>-acetylated peptide complexes actually coordinated to two amino acids of the receptor binding sequence, namely the amide nitrogens of Phe<sup>3</sup>/Tyr<sup>3</sup> and Thr<sup>6</sup>. Furthermore, as observed by others in the field,<a onclick="showRef(event, 'ref2 ref8 ref20'); return false;" href="javascript:void(0);" class="ref ref2 ref8 ref20">(2, 8, 20)</a> the Tyr<sup>3</sup>-octreotate analogues bound to the receptor with a higher affinity than their octreotide counterparts. Further NMR characterization of the Re-cyclized peptides by full three-dimensional structure analysis is currently underway.</div><div class="NLM_p">These findings may shed light on the less than ideal outcomes previously published for <sup>188</sup>Re/<sup>99m</sup>Tc-cyclized octreotide analogues.<a onclick="showRef(event, 'ref18 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref21">(18, 21)</a> We have shown that <sup>99m</sup>Tc−Tyr<sup>3</sup>-octreotate and nonradioactive Re−Tyr<sup>3</sup>-octreotate coelute following RP-HPLC coinjection, suggesting similar structures at the macroscopic and radiotracer levels.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> It is therefore reasonable to assume a similar coordination scheme for <sup>188</sup>Re−octreotide as for the nonradioactive Re−octreotide complex reported herein. Hence, both <sup>188</sup>Re−octreotide and <sup>99m</sup>Tc−Tyr<sup>3</sup>-octreotate would be expected to have perturbed SSTR pharmacophore structures compared not only to their disulfide-cyclized parent peptides, but also to octreotide derivatives radiolabeled at locations remote to the receptor binding sequence (e.g., BFC-radiolabeled analogues). We also reported in vitro instability of <sup>99m</sup>Tc-Tyr<sup>3</sup>-octreotate in phosphate-buffered saline at pH 7.4 and 37 °C (physiologic conditions) and in vivo evidence supporting the oxidation and loss of the <sup>99m</sup>Tc(V) center from the radiotracer to generate pertechnetate (<sup>99m</sup>TcO<sub>4</sub><sup>−</sup>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Formation of an eight-membered ring through binding of the <i>N</i>-terminal amine to the <sup>99m</sup>Tc, as described above for Re−Tyr<sup>3</sup>-octreotate, may have resulted in loose coordination of the amine and vulnerability of the <sup>99m</sup>Tc(V) metal center toward oxidation. Since Re is more easily oxidized than Tc, similar <sup>188</sup>Re-cyclized octreotide analogues may also be expected to suffer instability at the radiotracer level. Taken together, the likely reduced affinity for SSTR binding and instability of the radiopeptide complex may explain the observed lower tumor-to-normal tissue ratios, higher background activity, and slower clearance of <sup>188</sup>Re−octreotide<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> relative to the octreotide radiotracer in which the radiometal was incorporated via a bifunctional chelating moiety.</div><div class="NLM_p last">An improved integrated radiolabeling design, in which the metal center is distanced from the SSTR pharmacophore, may increase receptor binding, tumor uptake and retention, and improve clearance properties of Re- and Tc-cyclized octreotide analogues. The potential for such a design improvement was reported for α-MSH peptide analogues by Giblin et al.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In this work, direct metalation into the disulfide bond of a peptide containing two cysteine residues resulted in a cyclic structure with lower receptor binding than the disulfide-cyclized analogue (metal coordination had interfered with receptor binding). The addition of a third Cys residue at the <i>N</i>-terminus yielded radiometalated derivatives with very high and specific receptor binding, high tumor uptake, and longer tumor residence times. The Tc- or Re-coordinated to three Cys sulfhydryls and one Cys amide, presumably distancing the metal coordination from the binding pharmacophore and restoring receptor affinity. Applying this strategy to Re- and Tc-cyclized octreotide analogues may also lead to a more tightly bound metal center and increased stability at the radiotracer level. A new generation of SSTR-targeting peptides, incorporating a third cysteine residue into the octreotide sequences, is currently under investigation.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of Re-cyclized octreotide derivatives was synthesized, assessed for their somatostatin receptor targeting abilities and structurally compared against their disulfide-cyclized parent peptides. Integrating a nonradioactive Re(V) metal into the disulfide bond of these octreotide analogues resulted in low SSTR binding affinities, likely due to perturbation of the peptide β turn relative to the metal-free parent structure. Altering the <i>N</i>-terminus of these peptides had a significant effect on the Re(V) coordination sphere, overall peptide structure, and SSTR binding affinity. The SSTR binding was disrupted to a greater degree in the <i>N</i>-acetylated peptides, where the Re(V) centers were in closer proximity to the β turns than in the <i>N</i>-NH<sub>2</sub> peptides, where coordination to the <i>N</i>-terminal amine moved the Re centers away from the SSTR binding sequence. These studies demonstrated the importance of understanding the structure–activity relationships of metal-cyclized Re/Tc-octreotide complexes and helped explain the shortcomings of complexes of this type in studies reported to date. The data suggest that structural modifications to distance the Re/Tc coordination sphere from the SSTR pharmacophore may lead to new radiopharmaceutical agents with enhanced receptor binding and improved radiopharmaceutical properties.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48314" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48314" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General Methods</h3><div class="NLM_p">Reagents and solvents were purchased from VWR Scientific Products (St. Louis, MO), Novabiochem (San Diego, CA), Fluka (Milwaukee, WI), Macrocyclics (Dallas, TX), and Fischer Scientific (Pittsburgh, PA). All reagents and solvents were HPLC grade, peptide synthesis grade, or of the highest purity obtainable and were used without further purification.</div><div class="NLM_p last">Reversed-phase HPLC (RP-HPLC) analysis and semipreparative purification were carried out on a Beckmann Coulter System Gold HPLC equipped with a 168 diode array detector, a 507e autoinjector, and the 32 KARAT software package (Beckmann Coulter, Fullerton, CA). Analytical HPLC was performed on a Grace Vydac (Hesperia, CA) Protein & Peptide C18 column (300 Å, 0.46 cm × 25 cm, 5 µm), or a Keystone Scientific, Inc. (Bellefonte, PA) C-18 Kromasil column (100 Å, 0.46 × 15 cm, 5 µm) with linear gradients of solvent B in solvent A (A = 0.1% TFA in water; B = 0.1% TFA in acetonitrile), a 1 mL/min flow rate, and UV detection at 214 and 280 nm. Semipreparative RP-HPLC was performed on a Waters (Milford, MA) Prep Nova-Pak HR C18 column (60 Å, 1.9 cm × 30 cm, 6 µm), also using linear gradients of solvent B in solvent A, but with flow rates up to 10 mL/min and UV detection at 225 and 280 nm. Liquid chromatography−electrospray ionization−mass spectrometry (LC−ESI−MS) analyses were carried out on a Thermo Finnigan LC system consisting of a P4000 quaternary LC pump and SCM1000 vacuum degasser, an AS3000 autosampler, and a UV6000LP diode-array detector connected to a Thermo Finnigan TSQ7000 triple-quadrupole mass spectrometer (Thermo Finnigan, San Jose, CA). A Waters Nova-Pak C18 column (60 Å, 0.39 × 30 cm, 4 µm) was used for the LC−ESI−MS experiments.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Synthesis and Purification of Parent Peptides</h3><div class="NLM_p">The reduced form “linear” peptides (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were synthesized with the Advanced ChemTech (Louisville, KY) 396 Omega multiple peptide synthesizer, using standard solid-phase 9-fluorenylmethoxycarbonyl (Fmoc) chemistry. Each Fmoc amino acid was coupled at least twice. To prepare the linear DOTA-Tyr<sup>3</sup>-octreotide peptide, a tris(tertiary butyl ester)-protected DOTA building block was used in the final coupling step. Cleavage and side chain deprotection were achieved by treating the resin with a trifluoroacetic acid solution containing 2.5% each of thioanisole, phenol, water, ethanedithiol, and triisopropylsilane. The crude peptides obtained were characterized by HPLC and LC-MS and were purified by semipreparative HPLC using an in-house optimized multistep gradient.</div><div class="NLM_p last">The disulfide-cyclized “parent” peptides, along with disulfide-bridged DOTA-Tyr<sup>3</sup>-octreotide (for IC<sub>50</sub> experiments below), were prepared by adding 2.8 mL of a 1:1 water/acetonitrile (v/v) solution, 8.5 mL of 0.2 M ammonium acetate, and 1.7 mL of dimethyl sulfoxide to 13 mg of the linear peptides. The 1 mg/mL peptide mixtures were shaken overnight, resulting in near quantitative yields of the disulfide-cyclized peptides. The products were isolated with semipreparative RP-HPLC, characterized by LC−ESI−MS (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), and subsequently lyophilized. Each peptide had a purity of >98%.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Synthesis and Purification of Rhenium−Peptide Complexes</h3><div class="NLM_p last">The syntheses of the Re(V) cyclic complexes were achieved via transchelation reactions utilizing modified literature procedures.<a onclick="showRef(event, 'ref13 ref22'); return false;" href="javascript:void(0);" class="ref ref13 ref22">(13, 22)</a> In general, a linear peptide (5–15 mg) was dissolved in an aqueous MeOH solution (62–75%) and the pH was adjusted to 8–9 with 1 N NaOH. Addition of 1.5 mol equiv of the Re(V) complex [ReOCl<sub>3</sub>(OPPh<sub>3</sub>)(SMe<sub>2</sub>)], prepared as previously described,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> resulted in a mint green suspension that, with heating at 65–70 °C for 1 h, gradually cleared to give a brown-orange solution and a gray-black precipitate. After filtration of the crude reaction mixture, semipreparative RP-HPLC separation of the filtrate was employed to isolate the desired Re-cyclized peptide, and the purity and mass of the purified product were verified by LC−ESI−MS (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Each Re−peptide complex had a purity of >95%.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> NMR Studies</h3><div class="NLM_p last">NMR spectra were collected on a Varian Unity Inova 600 MHz spectrometer equipped with a 5 mm [<sup>1</sup>H, <sup>15</sup>N, <sup>13</sup>C] triple-resonance cold probe. NMR experiments, 2D <sup>1</sup>H−<sup>1</sup>H total correlated spectroscopy (TOCSY) (80 ms mixing time), and <sup>1</sup>H−<sup>13</sup>C heteronuclear single quantum coherence (HSQC), were performed for peptide solution samples. The <sup>1</sup>H and <sup>13</sup>C chemical shifts were measured at 25 °C from samples in 9:1 H<sub>2</sub>O/D<sub>2</sub>O, with concentrations ranging from 0.8 to 1.4 mM in 400 µL for Re-cyclized peptides and from 4.2 to 4.5 mM in 600 µL for the parent peptides (e.g., Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> for Re−Ac-octreotide and Ac-octreotide, respectively; other NMR data tables, <a class="ref internalNav" href="#si1" aria-label="Tables S1−S6">Tables S1−S6</a>, are given in the Supporting Information). Re-cyclized complex samples were prepared in SHIGEMI NMR tubes (Shigemi Co., Japan), while the standard NMR tubes were used for the disulfide samples. The pH values of the NMR samples ranged from 2.4 to 4.5. NMR data were processed with NMRPipe<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and analyzed in SPARKY (Goddard, T.D. and Kneller, D.G., SPARKY3, University of California, San Francisco). Indirect dimensions were normally extended by linear prediction and zero-filled prior to Fourier transformation, and only spectral regions containing signals were retained. The <sup>1</sup>H and <sup>13</sup>C chemical shifts were referenced to 2,2-dimethylsilapentane-5-sulfonic acid (DSS) as an external standard.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> [<sup>111</sup>In-DOTA]Tyr<sup>3</sup>-octreotide</h3><div class="NLM_p last"><sup>111</sup>InCl<sub>3</sub> was obtained from Mallinckrodt Medical (St. Louis, MO). The radiolabeling of DOTA-Tyr<sup>3</sup>-octreotide was carried out following a modified literature procedure.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> To 100 µL of a 30 mM sodium acetate/25 mM sodium ascorbate solution (pH = 5.0) were added 50 µL of <sup>111</sup>InCl<sub>3</sub> and 1 µg of disulfide-cyclized DOTA-Tyr<sup>3</sup>-octreotide, and the mixture was heated for 30 min at 99 °C. The <sup>111</sup>In-DOTA-Tyr<sup>3</sup>-octreotide was purified by RP-HPLC using a 1 mL/min flow rate through a Phenomenex Jupiter (Torrance, CA) C18 column (300Å, 0.46 cm × 25 cm, 5 µm) with a 0–50% linear gradient of solvent B in solvent A over 30 min and UV absorbance monitored at 214 and 280 nm. RP-HPLC coinjection of the purified product with <sup>nat</sup>In-DOTA-Tyr<sup>3</sup>-octreotide gave a single radioactive peak that coeluted with the UV peak of the nonradioactive standard.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Cell Culture</h3><div class="NLM_p last">AR42J rat pancreatic carcinoma cells, known to express the somatostatin receptor subtype 2 (SSTR2), were obtained from the American type Culture Collection (Manassas, VA) and initially maintained by the Cell and Immunobiology Core Facility at the University of Missouri-Columbia. Monolayer cell cultures were maintained by serial passage in exponential growth phase in RPMI 1640 medium (GIBCO-Invitrogen, Carlsbad, CA), supplemented with 10% fetal bovine serum, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, and 48 µg/mL gentamycin, in a humidified atmosphere of 5% CO<sub>2</sub>/air at 37 °C. Cell viability was determined to be >98% by trypan blue exclusion and hemacytometry. Prior to cell experiments, the growth media was removed and the cells were gently washed with Ca<sup>2+</sup>/Mg<sup>2+</sup>-free phosphate-buffered saline. Following removal of the phosphate-buffered saline, the cells were typsinized with 5 mL of TrypLE Express (GIBCO-Invitrogen, Carlsbad, CA). Trypsin was quenched by the addition of complete medium (RPMI 1640 Medium (Custom), GIBCO-Invitrogen, Carlsbad, CA, supplemented with 10–20% fetal bovine serum). The cells were collected by centrifugation, the supernatant was removed, and the cells were resuspended in complete medium and counted.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> IC<sub>50</sub> Cell Studies</h3><div class="NLM_p last">The in vitro somatostatin receptor binding affinities of the Re-cyclized peptides were determined from competitive binding assays with <sup>111</sup>In-DOTA-Tyr<sup>3</sup>-octreotide in AR42J rat pancreatic tumor cells. The procedures used in these studies were based on methods reported by Smith et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Briefly, trypsinized SSTR2-expressing cells were suspended in fresh media at a concentration of 1 × 10<sup>7</sup> cells/mL. Triplicate aliquots of cells (2 × 10<sup>6</sup> cells/assay) were incubated at 37 °C in a shaking water bath with a fixed quantity of <sup>111</sup>In-DOTA-Tyr<sup>3</sup>-octreotide (0.2 µCi/assay) and various concentrations of the Re−peptide complexes (ranging from 10<sup>−5</sup> to 10<sup>−10</sup> M). After 2 h, the cell-bound radioactivity was separated by centrifugation (1 min at 10,000 rpm), the incubation medium was aspirated, and the cell pellet was subsequently cooled on an ice block and washed three times with fresh 4 °C media. The amount of <sup>111</sup>In-DOTA-Tyr<sup>3</sup>-octreotide bound to the cells was determined by measuring the radioactivity of the cell pellets on a Wallac 1480 Wizard 3′′ automated gamma counter (PerkinElmer Life Sciences, Gaithersburg, MD). The percent of cell-bound radioactivity versus the Re-cyclized peptide concentration was plotted and analyzed using GraFit software (Version 4.0.10, Erithacus Software Ltd., Horley, Surrey, UK). The concentration of Re−peptide ligands that caused half-maximal inhibition (IC<sub>50</sub> values) of <sup>111</sup>In-DOTA-Tyr<sup>3</sup>-octreotide binding are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18"><a href="/doi/suppl/10.1021/jm701056x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H and <sup>13</sup>C NMR chemical shift tables (Tables S1−S6) for Re- and disulfide-cyclized Ac-Tyr<sup>3</sup>-octreotate, octreotide, and Tyr<sup>3</sup>-octreotate. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701056x/suppl_file/jm701056x-file003.pdf">jm701056x-file003.pdf (105.08 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm701056x" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38422" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38422" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael R. Lewis</span> - <span class="hlFld-Affiliation affiliation">Life Sciences Fellowships Program, Department of Veterinary Medicine and Surgery, Department of Chemistry, Department of Radiology, International Institute of Nano and Molecular Medicine, Nuclear Science and Engineering Institute, and Structural Biology Core, University of Missouri—Columbia, Columbia, Missouri 65211, and Research Service, Harry S. Truman Memorial Veterans’ Hospital, Columbia, Missouri 65201</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#38524d4a514b4b57566b7855514b4b574d4a51165d5c4d18545d4f514b55515b7855514b4b574d4a51165d5c4d"><span class="__cf_email__" data-cfemail="731906011a00001c1d20331e1a00001c06011a5d161706">[email protected]</span> <span class="__cf_email__" data-cfemail="c3afa6b4aab0aeaaa083aeaab0b0acb6b1aaeda6a7b6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia S. Jurisson</span> - <span class="hlFld-Affiliation affiliation">Life Sciences Fellowships Program, Department of Veterinary Medicine and Surgery, Department of Chemistry, Department of Radiology, International Institute of Nano and Molecular Medicine, Nuclear Science and Engineering Institute, and Structural Biology Core, University of Missouri—Columbia, Columbia, Missouri 65211, and Research Service, Harry S. Truman Memorial Veterans’ Hospital, Columbia, Missouri 65201</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#650f10170c16160a0b3625080c16160a10170c4b000110450900120c16080c0625080c16160a10170c4b000110"><span class="__cf_email__" data-cfemail="cda7b8bfa4bebea2a39e8da0a4bebea2b8bfa4e3a8a9b8">[email protected]</span> <span class="__cf_email__" data-cfemail="ddb1b8aab4aeb0b4be9db0b4aeaeb2a8afb4f3b8b9a8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather M. Bigott-Hennkens</span> - <span class="hlFld-Affiliation affiliation">Life Sciences Fellowships Program, Department of Veterinary Medicine and Surgery, Department of Chemistry, Department of Radiology, International Institute of Nano and Molecular Medicine, Nuclear Science and Engineering Institute, and Structural Biology Core, University of Missouri—Columbia, Columbia, Missouri 65211, and Research Service, Harry S. Truman Memorial Veterans’ Hospital, Columbia, Missouri 65201</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sulochana Junnotula</span> - <span class="hlFld-Affiliation affiliation">Life Sciences Fellowships Program, Department of Veterinary Medicine and Surgery, Department of Chemistry, Department of Radiology, International Institute of Nano and Molecular Medicine, Nuclear Science and Engineering Institute, and Structural Biology Core, University of Missouri—Columbia, Columbia, Missouri 65211, and Research Service, Harry S. Truman Memorial Veterans’ Hospital, Columbia, Missouri 65201</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lixin Ma</span> - <span class="hlFld-Affiliation affiliation">Life Sciences Fellowships Program, Department of Veterinary Medicine and Surgery, Department of Chemistry, Department of Radiology, International Institute of Nano and Molecular Medicine, Nuclear Science and Engineering Institute, and Structural Biology Core, University of Missouri—Columbia, Columbia, Missouri 65211, and Research Service, Harry S. Truman Memorial Veterans’ Hospital, Columbia, Missouri 65201</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabio Gallazzi</span> - <span class="hlFld-Affiliation affiliation">Life Sciences Fellowships Program, Department of Veterinary Medicine and Surgery, Department of Chemistry, Department of Radiology, International Institute of Nano and Molecular Medicine, Nuclear Science and Engineering Institute, and Structural Biology Core, University of Missouri—Columbia, Columbia, Missouri 65211, and Research Service, Harry S. Truman Memorial Veterans’ Hospital, Columbia, Missouri 65201</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Whitney Wells for technical assistance. This research was supported through a University of Missouri Life Sciences Postdoctoral Fellowship (H.M.B.-H.), by NIH Grant Nos. DHHS1 F32 CA119894 (H.M.B.-H.) and DHHS1 P50 CA103130 (S.S.J. and M.R.L.; WA Volkert, PI), and by DOE Grant No. DE-FG02-01ER63192 (S.S.J.). We acknowledge the Department of Veterans Affairs for providing resources and use of facilities at the Harry S. Truman Memorial Veterans’ Hospital in Columbia, MO.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18636" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18636" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Van Essen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning Eric, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valkema, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwekkeboom Dik, J.</span><span> </span><span class="NLM_article-title">Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues in Patients with Somatostatin Receptor Positive Tumours</span> <span class="citation_source-journal">Acta Oncol.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">46</span> <span class="NLM_fpage">723</span> <span class="NLM_lpage">734</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1080%2F02841860701441848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=17653893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotV2qsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=723-734&author=M.+Van+Essenauthor=P.+Krenning+Ericauthor=M.+de+Jongauthor=R.+Valkemaauthor=J.+Kwekkeboom+Dik&title=Peptide+Receptor+Radionuclide+Therapy+with+Radiolabelled+Somatostatin+Analogues+in+Patients+with+Somatostatin+Receptor+Positive+Tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumors</span></div><div class="casAuthors">Van Essen, Martijn; Krenning, Eric P.; De Jong, Marion; Valkema, Roelf; Kwekkeboom, Dik J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Oncologica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">723-734</span>CODEN:
                <span class="NLM_cas:coden">ACTOEL</span>;
        ISSN:<span class="NLM_cas:issn">0284-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis</span>)
        </div><div class="casAbstract">A review.  Peptide Receptor Radionuclide Therapy (PRRT) with radiolabeled somatostatin analogs is a promising treatment option for patients with inoperable or metastasised neuroendocrine tumors.  Symptomatic improvement may occur with all of the various 111In, 90Y, or 177Lu-labeled somatostatin analogs that have been used.  Since tumor size redn. was seldom achieved with 111Indium labeled somatostatin analogs, radiolabeled somatostatin analogs with beta-emitting isotopes like 90Y and 177Lu were developed.  Reported anti-tumor effects of [90Y-DOTA0,Tyr3]octreotide vary considerably between various studies: Tumor regression of 50% or more was achieved in 9 to 33% (mean 22%).  With [177Lu-DOTA0,Tyr3]octreotate treatments, tumor regression of 50% or more was achieved in 28% of patients and tumor regression of 25 to 50% in 19% of patients, stable disease was demonstrated in 35% and progressive disease in 18%.  Predictive factors for tumor remission were high tumor uptake on somatostatin receptor scintigraphy and limited amt. of liver metastases.  The side-effects of PRRT are few and mostly mild, certainly when using renal protective agents: Serious side-effects like myelodysplastic syndrome or renal failure are rare.  The median duration of the therapy response for [90Y-DOTA0,Tyr3]octreotide and [177Lu-DOTA0,Tyr3]octreotate is 30 mo and more than 36 mo resp.  Lastly, quality of life improves significantly after treatment with [177Lu-DOTA0,Tyr3]octreotate.  These data compare favorably with the limited no. of alternative treatment approaches, like chemotherapy.  If more widespread use of PRRT is possible, such therapy might become the therapy of first choice in patients with metastasised or inoperable gastroenteropancreatic neuroendocrine tumors.  Also the role in somatostatin receptor expressing non-GEP tumors, like metastasised paraganglioma/pheochromocytoma and non-radioiodine-avid differentiated thyroid carcinoma might become more important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3RxF_9CdIvLVg90H21EOLACvtfcHk0liXElCc9L7FUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotV2qsr8%253D&md5=d137fe3a1fb1182f6363b7acc56ad897</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1080%2F02841860701441848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02841860701441848%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BEssen%26aufirst%3DM.%26aulast%3DKrenning%2BEric%26aufirst%3DP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DValkema%26aufirst%3DR.%26aulast%3DKwekkeboom%2BDik%26aufirst%3DJ.%26atitle%3DPeptide%2520Receptor%2520Radionuclide%2520Therapy%2520with%2520Radiolabelled%2520Somatostatin%2520Analogues%2520in%2520Patients%2520with%2520Somatostatin%2520Receptor%2520Positive%2520Tumours%26jtitle%3DActa%2520Oncol.%26date%3D2007%26volume%3D46%26spage%3D723%26epage%3D734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeman, W. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooij, P. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofland, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugaj, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macke, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Comparison of <sup>111</sup>In-Labeled Somatostatin Analogs for Tumor Scintigraphy and Radionuclide Therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">58</span> <span class="NLM_fpage">437</span> <span class="NLM_lpage">441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=437-441&author=M.+de+Jongauthor=W.+A.+P.+Breemanauthor=W.+H.+Bakkerauthor=P.+P.+M.+Kooijauthor=B.+F.+Bernardauthor=L.+J.+Hoflandauthor=T.+J.+Visserauthor=A.+Srinivasanauthor=M.+A.+Schmidtauthor=J.+L.+Erionauthor=J.+E.+Bugajauthor=H.+R.+Mackeauthor=E.+P.+Krenning&title=Comparison+of+111In-Labeled+Somatostatin+Analogs+for+Tumor+Scintigraphy+and+Radionuclide+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26aulast%3DBakker%26aufirst%3DW.%2BH.%26aulast%3DKooij%26aufirst%3DP.%2BP.%2BM.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3DHofland%26aufirst%3DL.%2BJ.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DM.%2BA.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DBugaj%26aufirst%3DJ.%2BE.%26aulast%3DMacke%26aufirst%3DH.%2BR.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DComparison%2520of%2520111In-Labeled%2520Somatostatin%2520Analogs%2520for%2520Tumor%2520Scintigraphy%2520and%2520Radionuclide%2520Therapy%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D437%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeman, W. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Pluijm, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jermann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macke, H. R.</span><span> </span><span class="NLM_article-title">Yttrium-90 and Indium-111 Labeling, Receptor Binding and Biodistribution of [DOTA<sup>0</sup>,D-Phe<sup>1</sup>,Tyr<sup>3</sup>]Octreotide, a Promising Somatostatin Analog for Radionuclide Therapy</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">368</span> <span class="NLM_lpage">371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2Fs002590050064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=9096086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlOmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1997&pages=368-371&author=M.+de+Jongauthor=W.+H.+Bakkerauthor=E.+P.+Krenningauthor=W.+A.+P.+Breemanauthor=M.+E.+van+der+Pluijmauthor=B.+F.+Bernardauthor=T.+J.+Visserauthor=E.+Jermannauthor=M.+Beheauthor=P.+Powellauthor=H.+R.+Macke&title=Yttrium-90+and+Indium-111+Labeling%2C+Receptor+Binding+and+Biodistribution+of+%5BDOTA0%2CD-Phe1%2CTyr3%5DOctreotide%2C+a+Promising+Somatostatin+Analog+for+Radionuclide+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Yttrium-90 and indium-111 labeling, receptor binding and biodistribution of [DOTA0,D-Phe1,Tyr3]octreotide, a promising somatostatin analog for radionuclide therapy</span></div><div class="casAuthors">De Jong, Marion; Bakker, Willem H.; Krenning, Eric P.; Breeman, Wout A.P.; Van Der Pluijm, Marcel E.; Bernard, Bert F.; Visser, Theo J.; Jermann, Eduard; Behe, Martin; et al.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">368-371</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In vitro octreotide receptor binding of [111In-DOTA0,D-Phe1,Try3]octreotide (111In-DOTATOC) and the in vivo metab. of 90Y- or 111In-labeled DOTATOC were investigated in rats in comparison with [111In-DTPA0]octreotide (111In-DTPAOC).  111In-DOTATOC was found to have an affinity similar to octreotide itself for the octreotide receptor in rat cerebral cortex microsomes.  Twenty-four hours after injection of 90Y- or 111In-labeled DOTATOC, uptake of radioactivity in the octreotide receptor-expressing tissues pancreas, pituitary, adrenals and tumor was a factor of 2-6 that after injection of 111In-DTPAOC.  Uptake of labeled DOTATOC in pituitary, pancreas, adrenals and tumor was almost completely blocked by pretreatment with 0.5 mg unlabeled octreotide, indicating specific binding to the octreotide receptors.  These findings strongly indicate that 90Y-DOTATOC is a promising radiopharmaceutical for radiotherapy and that 111In-DOTATOC is of potential value for diagnosis of patients with octreotide receptor-pos. lesions, such as most neuroendocrine tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr25_svQvxDLVg90H21EOLACvtfcHk0liXElCc9L7FUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlOmt7s%253D&md5=a95b8e176c862c41d7a3f4c68f5a66ec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs002590050064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590050064%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DBakker%26aufirst%3DW.%2BH.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26aulast%3Dvan%2Bder%2BPluijm%26aufirst%3DM.%2BE.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DJermann%26aufirst%3DE.%26aulast%3DBehe%26aufirst%3DM.%26aulast%3DPowell%26aufirst%3DP.%26aulast%3DMacke%26aufirst%3DH.%2BR.%26atitle%3DYttrium-90%2520and%2520Indium-111%2520Labeling%252C%2520Receptor%2520Binding%2520and%2520Biodistribution%2520of%2520%255BDOTA0%252CD-Phe1%252CTyr3%255DOctreotide%252C%2520a%2520Promising%2520Somatostatin%2520Analog%2520for%2520Radionuclide%2520Therapy%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D1997%26volume%3D24%26spage%3D368%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Heppeler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froidevaux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macke, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jermann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span> </span><span class="NLM_article-title">Radiometal-Labelled Macrocyclic Chelator-Derivatized Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">1974</span> <span class="NLM_lpage">1981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1002%2F%28SICI%291521-3765%2819990702%295%3A7%3C1974%3A%3AAID-CHEM1974%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK1MXksVansbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=1974-1981&author=A.+Heppelerauthor=S.+Froidevauxauthor=H.+R.+Mackeauthor=E.+Jermannauthor=M.+Beheauthor=P.+Powellauthor=M.+Hennig&title=Radiometal-Labelled+Macrocyclic+Chelator-Derivatized+Somatostatin+Analogue+with+Superb+Tumour-Targeting+Properties+and+Potential+for+Receptor-Mediated+Internal+Radiotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Radiometal-labelled macrocyclic chelator-derivatized somatostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy</span></div><div class="casAuthors">Heppeler, A.; Froidevaux, S.; Macke, H. R.; Jermann, E.; Behe, M.; Powell, P.; Hennig, M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1974-1981</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A monoreactive DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) prochelator (4,7,10-tricarboxymethyl-tert-Bu ester 1,4,7,10-tetraazacyclododecane-1-acetate) was synthesized which is useful in solid-phase and soln.-phase peptide synthesis; it was coupled to the somatostatin analog Tyr3-Lys5(BOC)-octreotide.  Deprotection in one step afforded DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC) in ≈65% yield.  This peptide, modified with a chelator, was complexed with the radiometals 67Ga3+, 111In3+ and 90Y3+ in high yields and with high specific activities.  The three radiopeptides show high stability in human serum and high affinity to the somatostatin receptor: it is four to five times higher for 67Ga-DOTATOC compared to 90Y-DOTATOC and 111In-DOTATOC.  The 67Ga-labeled compd. also shows significantly higher tumor and lower kidney uptake than the two congeners.  67Ga-DOTATOC was compared in patients with the com. available gold std. 111In-DTPA0-D-Phe1-octreotide.  The new compd. delineates SRIF-receptor pos. tumors very favorably and shows distinctly lower uptake by the kidneys.  Evidently, the differences in the coordination chem. of the metals causes the differences in the biol. behavior.  Indeed, a crystallog. study of the Ga3+ and Y3+ complexes of the model peptide DOTA-D-PheNH2 showed differences in the geometry of the complexes.  The gallium complex is hexacoordinated with pseudooctahedral cis geometry and a folded macrocyclic unit.  The equatorial plane is formed by two transannular nitrogens of the cyclen ring and two oxygens of the corresponding carboxylate groups.  The two axial positions are formed by the two remaining ring nitrogen atoms.  The amide carboxy oxygen is not bound to the metal and one carboxylate group is free and most likely contributes to the favorable handling of the radiopeptide by the kidneys.  In contrast, the structure of Y-DOTA-D-PheNH2 has eight-fold coordination, and includes the amide carboxy oxygen.  The geometry is a compact and somewhat distorted square-antiprism with two almost perfect planes (N4 and O4) with a max. deviation of 0.025 A.  The dihedral angle between the two planes is only 0.36°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0Gfh5NWZ6srVg90H21EOLACvtfcHk0ljJ5qKBQK4jZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVansbY%253D&md5=e8a573706ebe12220bda357f172eecf2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3765%2819990702%295%3A7%3C1974%3A%3AAID-CHEM1974%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3765%252819990702%25295%253A7%253C1974%253A%253AAID-CHEM1974%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DHeppeler%26aufirst%3DA.%26aulast%3DFroidevaux%26aufirst%3DS.%26aulast%3DMacke%26aufirst%3DH.%2BR.%26aulast%3DJermann%26aufirst%3DE.%26aulast%3DBehe%26aufirst%3DM.%26aulast%3DPowell%26aufirst%3DP.%26aulast%3DHennig%26aufirst%3DM.%26atitle%3DRadiometal-Labelled%2520Macrocyclic%2520Chelator-Derivatized%2520Somatostatin%2520Analogue%2520with%2520Superb%2520Tumour-Targeting%2520Properties%2520and%2520Potential%2520for%2520Receptor-Mediated%2520Internal%2520Radiotherapy%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D1999%26volume%3D5%26spage%3D1974%26epage%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laforest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugaj, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Toxicity and Dosimetry of <sup>177</sup>Lu-DOTA-Y3-Octreotate in a Rat Model</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">94</span> <span class="NLM_fpage">873</span> <span class="NLM_lpage">877</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1002%2Fijc.1540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=11745491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFOku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2001&pages=873-877&author=J.+S.+Lewisauthor=M.+Wangauthor=R.+Laforestauthor=F.+Wangauthor=J.+L.+Erionauthor=J.+E.+Bugajauthor=A.+Srinivasanauthor=C.+J.+Anderson&title=Toxicity+and+Dosimetry+of+177Lu-DOTA-Y3-Octreotate+in+a+Rat+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity and dosimetry of 177Lu-DOTA-Y3-octreotate in a rat model</span></div><div class="casAuthors">Lewis, Jason S.; Wang, Mu; Laforest, Richard; Wang, Fan; Erion, Jack L.; Bugaj, Joseph E.; Srinivasan, Ananth; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">873-877</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Radiolabeled somatostatin analogs have demonstrated effectiveness for targeted radiotherapy of somatostatin receptor-pos. tumors in both tumor-bearing rodent models and humans.  A radionuclide of interest for cancer therapy is reactor-produced 177Lu (t1/2 = 6.64 d; β- [100%]).  The high therapeutic efficacy of the somatostatin analog 177Lu-DOTA-Tyr3-octreotate (DOTA-Y3-TATE, where DOTA is 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) was previously demonstrated in a tumor-bearing rat model.  In the current study, the toxicity and dosimetry of 177Lu-DOTA-Y3-TATE were detd. in both normal and tumor-bearing rats.  Doses of 177Lu-DOTA-Y3-TATE ranging from 0 to 123 mCi/kg were administered to rats and complete blood counts (CBCs) and blood chemistries were analyzed out to 6 wk.  No overt signs of toxicity were obsd. with 177Lu-DOTA-Y3-TATE (i.e., lethargy, wt. loss, scruffy coat or diarrhea) at any of the dose levels.  Blood chemistries and CBCs were normal except for the white blood cell counts, which showed a dose-dependent decrease.  The max. tolerated dose was not reached at 123 mCi/kg.  The biodistribution of 177Lu-DOTA-Y3-TATE was detd. in CA20948 rat pancreatic tumor-bearing rats, and the data were used to est. human absorbed doses to normal tissues.  The dose-limiting organ was detd. to be the pancreas, followed by the adrenal glands.  The absorbed dose to the rat CA20948 tumor was estd. to be 336 rad/mCi (91 mGy/MBq).  These data demonstrate that 177Lu-DOTA-Y3-TATE is an effective targeted radiotherapy agent at levels that show minimal toxicity in this rat model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH6xVavDqdWLVg90H21EOLACvtfcHk0ljJ5qKBQK4jZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFOku7s%253D&md5=aa1af3b28431296ee641e4ad7b10c71d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fijc.1540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.1540%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DLaforest%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DBugaj%26aufirst%3DJ.%2BE.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DToxicity%2520and%2520Dosimetry%2520of%2520177Lu-DOTA-Y3-Octreotate%2520in%2520a%2520Rat%2520Model%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2001%26volume%3D94%26spage%3D873%26epage%3D877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kwekkeboom, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooij, P. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konijnenberg, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugaj, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">[<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]Octreotate: Comparison with [<sup>111</sup>In-DTPA<sup>0</sup>]Octreotide in Patients</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">28</span> <span class="NLM_fpage">1319</span> <span class="NLM_lpage">1325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2Fs002590100574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=11585290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmt1Gnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=1319-1325&author=D.+J.+Kwekkeboomauthor=W.+H.+Bakkerauthor=P.+P.+M.+Kooijauthor=M.+W.+Konijnenbergauthor=A.+Srinivasanauthor=J.+L.+Erionauthor=M.+A.+Schmidtauthor=J.+L.+Bugajauthor=M.+de+Jongauthor=E.+P.+Krenning&title=%5B177Lu-DOTA0%2CTyr3%5DOctreotate%3A+Comparison+with+%5B111In-DTPA0%5DOctreotide+in+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients</span></div><div class="casAuthors">Kwekkeboom, Dik J.; Bakker, Willem H.; Kooij, Peter P. M.; Konijnenberg, Mark W.; Srinivasan, Ananth; Erion, Jack L.; Schmidt, Michelle A.; Bugaj, Joe L.; de Jong, Marion; Krenning, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1319-1325</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The somatostatin analog [DOTA0,Tyr3]octreotate has a nine-fold higher affinity for the somatostatin receptor subtype 2 as compared with [DOTA0,Tyr3]octreotide.  Also, labeled with the beta- and gamma-emitting radionuclide lutetium-177, this compd. has been shown to have a very favorable impact on tumor regression and animal survival in a rat model.  Because of these reported advantages over the analogs currently used for somatostatin receptor-mediated radiotherapy, we decided to compare [177Lu-DOTA0,Tyr3]octreotate (177Lu-octreotate) with [111In-DTPA0]octreotide (111In-octreotide) in six patients with somatostatin receptor-pos. tumors.  Plasma radioactivity after 177Lu-octreotate expressed as a percentage of the injected dose was comparable with that after 111In-octreotide.  Urinary excretion of radioactivity was significantly lower than after 111In-octreotide, averaging 64% after 24 h.  The uptake after 24 h, expressed as a percentage of the injected dose of 177Lu-octreotate, was comparable to that after 111In-octreotide for kidneys, spleen and liver, but was three- to fourfold higher for four of five tumors.  The spleen and kidneys received the highest absorbed doses.  The doses to the kidneys were reduced by a mean of 47% after co-infusion of amino acids.  It is concluded that in comparison with the radionuclide-coupled somatostatin analogs that are currently available for somatostatin receptor-mediated radiotherapy, 177Lu-octreotate potentially represents an important improvement.  Higher absorbed doses can be achieved to most tumors, with about equal doses to potentially dose-limiting organs; furthermore, the lower tissue penetration range of 177Lu as compared with 90Y may be esp. important for small tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqCtJdtsKRXLVg90H21EOLACvtfcHk0ljJ5qKBQK4jZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmt1Gnt7w%253D&md5=84c733e92c9c6fec9d28580c54d5fb92</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs002590100574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590100574%26sid%3Dliteratum%253Aachs%26aulast%3DKwekkeboom%26aufirst%3DD.%2BJ.%26aulast%3DBakker%26aufirst%3DW.%2BH.%26aulast%3DKooij%26aufirst%3DP.%2BP.%2BM.%26aulast%3DKonijnenberg%26aufirst%3DM.%2BW.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DSchmidt%26aufirst%3DM.%2BA.%26aulast%3DBugaj%26aufirst%3DJ.%2BL.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3D%255B177Lu-DOTA0%252CTyr3%255DOctreotate%253A%2520Comparison%2520with%2520%255B111In-DTPA0%255DOctreotide%2520in%2520Patients%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D28%26spage%3D1319%26epage%3D1325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehdashti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laforest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D. W.</span><span> </span><span class="NLM_article-title"><sup>64</sup>Cu-TETA-Octreotide as a PET Imaging Agent for Patients with Neuroendocrine Tumors</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">213</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=11216519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlKmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=213-221&author=C.+J.+Andersonauthor=F.+Dehdashtiauthor=P.+D.+Cutlerauthor=S.+W.+Schwarzauthor=R.+Laforestauthor=L.+A.+Bassauthor=J.+S.+Lewisauthor=D.+W.+McCarthy&title=64Cu-TETA-Octreotide+as+a+PET+Imaging+Agent+for+Patients+with+Neuroendocrine+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">64Cu-TETA-octreotide64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors</span></div><div class="casAuthors">Anderson, Carolyn J.; Dehdashti, Farrokh; Cutler, P. Duffy; Schwarz, Sally W.; Laforest, Richard; Bass, Laura A.; Lewis, Jason S.; McCarthy, Deborah W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine, Inc.</span>)
        </div><div class="casAbstract">64Cu (half-life, 12.7 h; β+, 0.653 MeV [17.4%]; β-, 0.579 MeV [39%]) has shown potential as a radioisotope for PET imaging and radiotherapy.  111In-diethylenetriaminepentaacetic acid (DTPA)-D-Phe1-octreotide (OC) was developed for imaging somatostatin-receptor-pos. tumors using conventional scintigraphy.  With the advantages of PET over conventional scintigraphy, an agent for PET imaging of these tumors is desirable.  Here, we show that 64Cu-TETA-OC (where TETA is 1,4,8,11-tetraazacyclotetradecane-N,N1,N11, N111-tetraacetic acid) and PET can be used to detect somatostatin-receptor-pos. tumors in humans.  Eight patients with a history of neuroendocrine tumors (five patients with carcinoid tumors and three patients with islet cell tumors) were imaged by conventional scintigraphy with 111In-DTPA-OC (204-233 MBq [5.5-6.3 mCi]) and by PET imaging with 64Cu-TETA-OC (111 MBq [3 mCi]).  Blood and urine samples were collected for pharmacokinetic anal.  PET images were collected at times ranging from 0 to 36 h after injection, and the absorbed doses to normal organs were detd.  In six of the eight patients, cancerous lesions were visible by both 111In-DTPA-OC SPECT and 64Cu-TETA-OC PET.  In one patient, 111In-DTPA-OC showed mild uptake in a lung lesion that was not detected by 64Cu-TETA-OC PET.  In one patient, no tumors were detected by either agent; however, pathol. follow-up indicated that the patient had no tumors.  In two patients whose tumors were visualized with 111In-DTPA-OC and 64Cu-TETA-OC, 64Cu-TETA-OC and PET showed more lesions than 111In-DTPA-OC.  Pharmacokinetic studies showed that 64Cu-TETA-OC was rapidly cleared from the blood and that 59.2% ± 17.6% of the injected dose was excreted in the urine.  Absorbed dose measurements indicated that the bladder wall was the dose-limiting organ.  The high rate of lesion detection, sensitivity, and favorable dosimetry and pharmacokinetics of 64Cu-TETA-OC indicate that it is a promising radiopharmaceutical for PET imaging of patients with neuroendocrine tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVDhc6eRnTY7Vg90H21EOLACvtfcHk0lgG7UCMpWv4fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlKmtr0%253D&md5=75bf57acc0dfa41e5da8106de69bdc8d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DDehdashti%26aufirst%3DF.%26aulast%3DCutler%26aufirst%3DP.%2BD.%26aulast%3DSchwarz%26aufirst%3DS.%2BW.%26aulast%3DLaforest%26aufirst%3DR.%26aulast%3DBass%26aufirst%3DL.%2BA.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DMcCarthy%26aufirst%3DD.%2BW.%26atitle%3D64Cu-TETA-Octreotide%2520as%2520a%2520PET%2520Imaging%2520Agent%2520for%2520Patients%2520with%2520Neuroendocrine%2520Tumors%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D42%26spage%3D213%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Comparison of Four <sup>64</sup>Cu-Labeled Somatostatin Analogs in Vitro and in a Tumor-Bearing Rat Model: Evaluation of New Derivatives for Positron Emission Tomography Imaging and Targeted Radiotherapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">1341</span> <span class="NLM_lpage">1347</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980602h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1341-1347&author=J.+S.+Lewisauthor=M.+R.+Lewisauthor=A.+Srinivasanauthor=M.+A.+Schmidtauthor=J.+Wangauthor=C.+J.+Anderson&title=Comparison+of+Four+64Cu-Labeled+Somatostatin+Analogs+in+Vitro+and+in+a+Tumor-Bearing+Rat+Model%3A+Evaluation+of+New+Derivatives+for+Positron+Emission+Tomography+Imaging+and+Targeted+Radiotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm980602h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980602h%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DLewis%26aufirst%3DM.%2BR.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DComparison%2520of%2520Four%252064Cu-Labeled%2520Somatostatin%2520Analogs%2520in%2520Vitro%2520and%2520in%2520a%2520Tumor-Bearing%2520Rat%2520Model%253A%2520Evaluation%2520of%2520New%2520Derivatives%2520for%2520Positron%2520Emission%2520Tomography%2520Imaging%2520and%2520Targeted%2520Radiotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1341%26epage%3D1347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Evaluation of <sup>64</sup>Cu-TETA-Tyr<sup>3</sup>-Octreotate. A New Somatostatin Analog with Improved Target Tissue Uptake</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">26</span> <span class="NLM_fpage">267</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1016%2FS0969-8051%2898%2900105-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=10363797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK1MXisF2rt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1999&pages=267-273&author=J.+S.+Lewisauthor=A.+Srinivasanauthor=M.+A.+Schmidtauthor=C.+J.+Anderson&title=In+Vitro+and+in+Vivo+Evaluation+of+64Cu-TETA-Tyr3-Octreotate.+A+New+Somatostatin+Analog+with+Improved+Target+Tissue+Uptake"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake</span></div><div class="casAuthors">Lewis, Jason S.; Srinivasan, Ananth; Schmidt, Michelle A.; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-273</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Radiolabeled somatostatin analogs have demonstrated potential as cancer therapeutic agents.  Many of these agents are based on the analog octreotide (OC).  Recently it has been shown that substitution of a tyrosine for phenylalanine in the 3-position and changing the C-terminus from an alc. to an acid improves the targeting of somatostatin-rich tissues.  The compd., 1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid-Tyr3-octreotate (TETA-Y3-TATE), was synthesized and radiolabeled with 64Cu.  The receptor binding properties of 64Cu-TETA-Y3-TATE showed an estd. Kd value of 549 pM in somatostatin receptor-pos. CA20948 tissue membrane.  High tumor uptake was obsd. in two animal tumor models.  Tumor uptakes of 2.37% ID/g in CA20948 tumor-bearing rats and 21.60% ID/g in AR42J tumor-bearing SCID mice were obsd. at 1 h, compared with 1.09% ID/g and 11.24% ID/g for 64Cu-TETA-OC.  Higher uptake in other somatostatin-receptor rich tissues was also obsd., compared with 64Cu-TETA-OC.  Positron emission tomog. (PET) imaging with 64Cu-TETA-Y3-TATE in a baboon showed significant uptake in the pituitary and adrenals, and clearance through the kidneys.  64Cu-TETA-Y3-TATE, a new OC analog for binding somatostatin receptors, demonstrated significantly greater uptake in somatostatin-rich tissues in two tumor-bearing animal models, and demonstrated great potential as a radiopharmaceutical for imaging and therapy of somatostatin receptor-pos. tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0iJ5XyoCaybVg90H21EOLACvtfcHk0lgG7UCMpWv4fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisF2rt7c%253D&md5=e98dc9ca775fa7ebce442dc7473c504a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2898%2900105-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252898%252900105-X%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DM.%2BA.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Evaluation%2520of%252064Cu-TETA-Tyr3-Octreotate.%2520A%2520New%2520Somatostatin%2520Analog%2520with%2520Improved%2520Target%2520Tissue%2520Uptake%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1999%26volume%3D26%26spage%3D267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Decristoforo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cholewinski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnemiller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccabona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncayo, R.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-EDDA/HYNIC-TOC: A New <sup>99m</sup>Tc-Labelled Radiopharmaceutical for Imaging Somatostatin Receptor-Positive Tumours: First Clinical Results and Intra-Patient Comparison with <sup>111</sup>In-Labelled Octreotide Derivatives</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">1318</span> <span class="NLM_lpage">1325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2Fs002590000289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=11007513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsFCjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=1318-1325&author=C.+Decristoforoauthor=S.+J.+Matherauthor=W.+Cholewinskiauthor=E.+Donnemillerauthor=G.+Riccabonaauthor=R.+Moncayo&title=99mTc-EDDA%2FHYNIC-TOC%3A+A+New+99mTc-Labelled+Radiopharmaceutical+for+Imaging+Somatostatin+Receptor-Positive+Tumours%3A+First+Clinical+Results+and+Intra-Patient+Comparison+with+111In-Labelled+Octreotide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-EDDA/HYNIC-TOC: A new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: First clinical results and intra-patient comparison with 111In-labelled octreotide derivatives</span></div><div class="casAuthors">Decristoforo, Clemens; Mather, Stephen J.; Cholewinski, Witold; Donnemiller, Eveline; Riccabona, Georg; Moncayo, Roy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1318-1325</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">[111In-diethylene triamine penta-acetic acid-D-Phe1]-octreotide (DTPA-octreotide) scintigraphy has gained widespread acceptance as a diagnostic clin. procedure in oncol. for imaging somatostatin receptor-pos. tumors.  However, indium-111 as a radiolabel has several drawbacks, including limited availability, suboptimal gamma energy and high radiation burden to the patient.  We have recently reported on the preclin. development of 99mTc-EDDA/HYNIC-TOC, a new octreotide deriv. which showed promising results both in vitro and in vivo.  We now report our initial clin. experiences with this new radiopharmaceutical in ten oncol. patients.  The clin. diagnoses were: carcinoid syndrome (n=5), thyroid cancer (n=3), pancreatic cancer (n=1) and pituitary tumor (n=1).  The biodistribution and kinetics of 99mTc-EDDA/HYNIC-TOC were compared with those of 111In-DTPA-octreotide in six cases, and with those of 111In-DOTA-TOC in five cases.  With the new tracer tumors were imaged within 15 min after injection and showed the highest target/non-target ratios 4 h after injection.  Tumor uptake persisted up to 20 h p.i.  The rate of blood clearance was similar to that of 111In-DTPA-octreotide but faster than that of 111In-DOTA-TOC, while urinary excretion was lower compared with the 111In derivs.  Semi-quant. region of interest anal. showed that 99mTc-EDDA/HYNIC-TOC produced higher tumor/organ (target/non-target) ratios than the 111In derivs., esp. in relation to heart and muscle.  Significantly more lesions could be detected in 99mTc images.  We conclude that 99mTc-EDDA/HYNIC-TOC shows better imaging properties for the identification of somatostatin receptor-pos. tumor sites than currently available 111In-labeled octreotide derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgSJNmFLBGZbVg90H21EOLACvtfcHk0lh0TPZtCYC_Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsFCjsrc%253D&md5=4b570259d689b1ca1ed46d8b1947d76a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs002590000289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590000289%26sid%3Dliteratum%253Aachs%26aulast%3DDecristoforo%26aufirst%3DC.%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DCholewinski%26aufirst%3DW.%26aulast%3DDonnemiller%26aufirst%3DE.%26aulast%3DRiccabona%26aufirst%3DG.%26aulast%3DMoncayo%26aufirst%3DR.%26atitle%3D99mTc-EDDA%252FHYNIC-TOC%253A%2520A%2520New%252099mTc-Labelled%2520Radiopharmaceutical%2520for%2520Imaging%2520Somatostatin%2520Receptor-Positive%2520Tumours%253A%2520First%2520Clinical%2520Results%2520and%2520Intra-Patient%2520Comparison%2520with%2520111In-Labelled%2520Octreotide%2520Derivatives%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2000%26volume%3D27%26spage%3D1318%26epage%3D1325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Gabriel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decristoforo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnemiller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulmer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychlinski, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncayo, R.</span><span> </span><span class="NLM_article-title">An Intrapatient Comparison of <sup>99m</sup>Tc-EDDA/HYNIC-TOC with <sup>111</sup>In-DTPA-Octreotide for Diagnosis of Somatostatin Receptor-Expressing Tumors</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">44</span> <span class="NLM_fpage">708</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=12732671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1KisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=708-716&author=M.+Gabrielauthor=C.+Decristoforoauthor=E.+Donnemillerauthor=H.+Ulmerauthor=C.+W.+Rychlinskiauthor=S.+J.+Matherauthor=R.+Moncayo&title=An+Intrapatient+Comparison+of+99mTc-EDDA%2FHYNIC-TOC+with+111In-DTPA-Octreotide+for+Diagnosis+of+Somatostatin+Receptor-Expressing+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors</span></div><div class="casAuthors">Gabriel, Michael; Decristoforo, Clemens; Donnemiller, Eveline; Ulmer, Hanno; Rychlinski, Christine Watfah; Mather, Stephen J.; Moncayo, Roy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">708-716</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">The aim of this study was to compare the imaging abilities of the recently developed somatostatin analog, 99mTc-hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC [99mTc-TOC]), with 111In-diethylenediaminepentaacetic acid-D-Phe1-octreotide (111In-OCT [Octreoscan]) in patients undergoing routine somatostatin receptor (SSTR) scintigraphy.  Methods: Forty-one patients (20 men, 21 women; age range, 29-75 yr; mean age, 56.7 y) with either histol. proven or biol. and clin. suspected endocrine tumors were enrolled in the study.  Four groups were distinguished: (a) patients being evaluated for the detection and localization of neuroendocrine tumors (n = 6), (b) tumor staging (n = 19), (c) patients being investigated to det. the SSTR status of tumor lesions (n = 11), and (d) patient follow-up studies (n = 5).  Each patient received a mean activity of 150 MBq 111In-OCT and 350-400 MBq 99mTc-TOC.  Scintigraphy with 99mTc-TOC was performed 4 h after injection and scintigraphy with 111In-OCT was performed 4 and 24 h after injection.  SPECT studies of areas of interest were performed 4 h after injection for both tracers as well as at 24 h after injection for 111In-OCT.  The time interval between the studies using each tracer ranged from 2 to 22 d (mean interval, 9.3 d).  Results: 111In-OCT and 99mTc-TOC showed an equiv. scan result in 32 patients (78%), 9 cases showed discrepancies (22%), false-neg. results with 111In-OCT were seen in 6 cases (14.6%), whereas 99mTc-TOC was false-pos. in 2 cases (4.9%).  111In-OCT was true-neg. in both cases.  The false-pos. findings of the 99mTc-TOC studies were caused by nonspecific uptake in the bowel.  In 1 case, 99mTc-TOC correctly identified a metastasis in the lumbar spine but both scan results were false-pos. because of an inflammatory process.  In 21 patients with SSTR-expressing tumors, the semiquant. region-of-interest anal. showed that 99mTc-TOC achieved higher tumor-to-normal tissue ratios than 111In-OCT.  Conclusion: This study revealed a higher sensitivity of 99mTc-TOC as compared with 111In-OCT as an imaging agent for the localization of SSTR-expressing tumors.  To avoid false-pos. findings with 99mTc-OCT due to nonspecific tracer accumulation, addnl. scanning at 1-2 h after injection should be done.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovoLnNb1z7qLVg90H21EOLACvtfcHk0lh0TPZtCYC_Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1KisLs%253D&md5=080c44aa68360de5c91926cd0a18048d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGabriel%26aufirst%3DM.%26aulast%3DDecristoforo%26aufirst%3DC.%26aulast%3DDonnemiller%26aufirst%3DE.%26aulast%3DUlmer%26aufirst%3DH.%26aulast%3DRychlinski%26aufirst%3DC.%2BW.%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DMoncayo%26aufirst%3DR.%26atitle%3DAn%2520Intrapatient%2520Comparison%2520of%252099mTc-EDDA%252FHYNIC-TOC%2520with%2520111In-DTPA-Octreotide%2520for%2520Diagnosis%2520of%2520Somatostatin%2520Receptor-Expressing%2520Tumors%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2003%26volume%3D44%26spage%3D708%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. P.</span><span> </span><span class="NLM_article-title">Melanoma-Targeting Properties of <sup>99m</sup>Technetium-Labeled Cyclic α-Melanocyte-Stimulating Hormone Peptide Analogues</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">60</span> <span class="NLM_fpage">5649</span> <span class="NLM_lpage">5658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5649-5658&author=J.+Chenauthor=Z.+Chengauthor=T.+J.+Hoffmanauthor=S.+S.+Jurissonauthor=T.+P.+Quinn&title=Melanoma-Targeting+Properties+of+99mTechnetium-Labeled+Cyclic+%CE%B1-Melanocyte-Stimulating+Hormone+Peptide+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26aulast%3DQuinn%26aufirst%3DT.%2BP.%26atitle%3DMelanoma-Targeting%2520Properties%2520of%252099mTechnetium-Labeled%2520Cyclic%2520%25CE%25B1-Melanocyte-Stimulating%2520Hormone%2520Peptide%2520Analogues%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D5649%26epage%3D5658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Giblin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. P.</span><span> </span><span class="NLM_article-title">Design and Characterization of α-Melanotropin Peptide Analogs Cyclized through Rhenium and Technetium Metal Coordination</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">95</span> <span class="NLM_fpage">12814</span> <span class="NLM_lpage">12818</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1073%2Fpnas.95.22.12814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=9788997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK1cXntFWktr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12814-12818&author=M.+F.+Giblinauthor=N.+Wangauthor=T.+J.+Hoffmanauthor=S.+S.+Jurissonauthor=T.+P.+Quinn&title=Design+and+Characterization+of+%CE%B1-Melanotropin+Peptide+Analogs+Cyclized+through+Rhenium+and+Technetium+Metal+Coordination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design and characterization of α-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination</span></div><div class="casAuthors">Giblin, Michael F.; Wang, Nannan; Hoffman, Timothy J.; Jurisson, Silvia S.; Quinn, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">12814-12818</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">α-MSH analogs, cyclized through site-specific rhenium (Re) and technetium (Tc) metal coordination, were structurally characterized and analyzed for their abilities to bind α-MSH receptors present on melanoma cells and in tumor-bearing mice.  Results from receptor-binding assays conducted with B16 F1 murine melanoma cells indicated that receptor-binding affinity was reduced to approx. 1% of its original levels after Re incorporation into the cyclic Cys4,10,D-Phe7-α-MSH4-13 analog.  Structural anal. of the Re-peptide complex showed that the disulfide bond of the original peptide was replaced by thiolate-metal-thiolate cyclization.  A comparison of the metal-bound and metal-free structures indicated that metal complexation dramatically altered the structure of the receptor-binding core sequence.  Redesign of the metal binding site resulted in a second-generation Re-peptide complex (ReCCMSH) that displayed a receptor-binding affinity of 2.9 nM, 25-fold higher than the initial Re-α-MSH analog.  Characterization of the second-generation Re-peptide complex indicated that the peptide was still cyclized through Re coordination, but the structure of the receptor-binding sequence was no longer constrained.  The corresponding 99mTc- and 188ReCCMSH complexes were synthesized and shown to be stable in phosphate-buffered saline and to challenges from diethylenetriaminepentaacetic acid (DTPA) and free cysteine.  In vivo, the 99mTcCCMSH complex exhibited significant tumor uptake and retention and was effective in imaging melanoma in a murine-tumor model system.  Cyclization of α-MSH analogs via 99mTc and 188Re yields chem. stable and biol. active mols. with potential melanoma-imaging and therapeutic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmHQnbdmpujrVg90H21EOLACvtfcHk0lh0TPZtCYC_Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFWktr4%253D&md5=bb1f73dadd24cfbb744ac5745386c6a9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.22.12814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.22.12814%26sid%3Dliteratum%253Aachs%26aulast%3DGiblin%26aufirst%3DM.%2BF.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26aulast%3DQuinn%26aufirst%3DT.%2BP.%26atitle%3DDesign%2520and%2520Characterization%2520of%2520%25CE%25B1-Melanotropin%2520Peptide%2520Analogs%2520Cyclized%2520through%2520Rhenium%2520and%2520Technetium%2520Metal%2520Coordination%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D12814%26epage%3D12818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. P.</span><span> </span><span class="NLM_article-title">Evaluation of an <sup>111</sup>In-DOTA-Rhenium Cyclized Alpha-MSH Analog: A Novel Cyclic-Peptide Analog with Improved Tumor-Targeting Properties</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">1847</span> <span class="NLM_lpage">1855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1847-1855&author=J.+Chenauthor=Z.+Chengauthor=N.+K.+Owenauthor=T.+J.+Hoffmanauthor=Y.+Miaoauthor=S.+S.+Jurissonauthor=T.+P.+Quinn&title=Evaluation+of+an+111In-DOTA-Rhenium+Cyclized+Alpha-MSH+Analog%3A+A+Novel+Cyclic-Peptide+Analog+with+Improved+Tumor-Targeting+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DOwen%26aufirst%3DN.%2BK.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DMiao%26aufirst%3DY.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26aulast%3DQuinn%26aufirst%3DT.%2BP.%26atitle%3DEvaluation%2520of%2520an%2520111In-DOTA-Rhenium%2520Cyclized%2520Alpha-MSH%2520Analog%253A%2520A%2520Novel%2520Cyclic-Peptide%2520Analog%2520with%2520Improved%2520Tumor-Targeting%2520Properties%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D42%26spage%3D1847%26epage%3D1855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span> </span><span class="NLM_article-title">Radioiodination of Rhenium Cyclized α-Melanocyte-Stimulating Hormone Resulting in Enhanced Radioactivity Localization and Retention in Melanoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">64</span> <span class="NLM_fpage">1411</span> <span class="NLM_lpage">1418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1158%2F0008-5472.CAN-03-0193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=14973076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtleit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1411-1418&author=Z.+Chengauthor=J.+Chenauthor=T.+P.+Quinnauthor=S.+S.+Jurisson&title=Radioiodination+of+Rhenium+Cyclized+%CE%B1-Melanocyte-Stimulating+Hormone+Resulting+in+Enhanced+Radioactivity+Localization+and+Retention+in+Melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Radioiodination of Rhenium Cyclized α-Melanocyte-Stimulating Hormone Resulting in Enhanced Radioactivity Localization and Retention in Melanoma</span></div><div class="casAuthors">Cheng, Zhen; Chen, Jianqing; Quinn, Thomas P.; Jurisson, Silvia S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1411-1418</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Radiohalogenated α-MSH analogs were proposed for melanoma imaging and potential radiotherapy because α-MSH receptors are overexpressed on both mouse and human melanoma cell lines.  However, biodistribution studies in tumor-bearing mice with radiohalogenated α-MSH peptides showed very rapid tumor radioactivity wash out due to lysosomal degrdn. of the radiohalogenated complex after internalization, which decreased the therapeutic efficacy significantly (R. Stein et al., Cancer Res., 55: 3132-3139, 1995; P. K. Garg et al., Bioconjugate Chem., 6: 493-501, 1995.).  The melanoma-targeting metallopeptide ReO[Cys3,4,10,D-Phe7]α-MSH3-13 (ReCCMSH) was shown to possess high tumor uptake and retention properties (J. Chen et al., Cancer Res., 60: 5649-5658, 2000).  Therefore, three peptides, Ac-Lys-ReCCMSH(Arg11), Ac-D-Lys-ReCCMSH(Arg11), and [Nle4,D-Phe7]α-MSH (NDP) (for comparison), labeled with N-succinimidyl 4-[125I]iodobenzoate (125I-PIB), were prepd. and evaluated in vitro and in vivo to develop radiohalogenated α-MSH peptide analogs with high tumor uptake, retention, and favorable biodistribution characteristics.  In vitro cell binding and internalization data showed that approx. 90% of radioiodinated peptides were internalized at 2 h in cultured B16/F1 melanoma cells.  Cellular retention studies showed that the receptor-bound radioiodinated linear α-MSH analog NDP was released from the cells into the medium very quickly, whereas significant amts. of cell-assocd. radioactivity remained in the cells for Ac-Lys(125I-3- or 4-iodobenzoate (IBA))-ReCCMSH(Arg11) and Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11).  The in vitro data clearly demonstrate that rhenium cyclization significantly enhanced peptide trapping in the cells, as did D-amino acid incorporation.  The combination of these two effects resulted in a 2.9-fold increase in the retention of radioactivity for Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11) relative to 125I-IBA-NDP at 4 h.  In vivo studies also showed that Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11) exhibited extremely high radioactivity accumulation and prolonged retention in the tumor.  Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11) and Ac-Lys(125I-IBA)-ReCCMSH(Arg11) exhibited much higher tumor uptake at 24 h after injection compared with 125I-IBA-NDP [7.18% injected dose/g (ID/g), 4.92% ID/g, and 0.26% ID/g, resp.].  Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11) also showed very fast whole body clearance and low nonspecific radioactivity accumulation in normal tissues compared with 125I-IBA-NDP and Ac-Lys(125I-IBA)-ReCCMSH(Arg11).  A tumor:blood ratio of 34.3 was obsd. for Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11) at 24 h postinjection, whereas values of 4.3 and 2.0 were obsd. for Ac-Lys(125I-IBA)-ReCCMSH(Arg11) and 125I-IBA-NDP, resp.  The biodistribution data clearly demonstrate that both rhenium cyclization and D-Lys incorporation enhanced the tumor localization and retention of the radiolabel.  Therefore Ac-D-Lys-ReCCMSH(Arg11) is an excellent candidate for addnl. therapeutic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKPA9wRGdQQLVg90H21EOLACvtfcHk0licqd_eBo0YOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtleit78%253D&md5=572a664d2bb664397b70a69969524cc7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-0193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-0193%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DQuinn%26aufirst%3DT.%2BP.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26atitle%3DRadioiodination%2520of%2520Rhenium%2520Cyclized%2520%25CE%25B1-Melanocyte-Stimulating%2520Hormone%2520Resulting%2520in%2520Enhanced%2520Radioactivity%2520Localization%2520and%2520Retention%2520in%2520Melanoma%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1411%26epage%3D1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Zamora, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulhke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diekmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biersack, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, F. F.</span><span> </span><span class="NLM_article-title">Jr. Experimental Radiotherapy of Receptor-Positive Human Prostate Adenocarcinoma with <sup>188</sup>Re-RC-160, a Directly-Radiolabeled Somatostatin Analog</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">65</span> <span class="NLM_fpage">214</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1002%2F%28SICI%291097-0215%2819960117%2965%3A2%3C214%3A%3AAID-IJC15%3E3.0.CO%3B2-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=8567120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK28Xhtlyktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1996&pages=214-220&author=P.+O.+Zamoraauthor=S.+Gulhkeauthor=H.+Benderauthor=D.+Diekmannauthor=B.+A.+Rhodesauthor=H.-J.+Biersackauthor=F.+F.+Knapp&title=Jr.+Experimental+Radiotherapy+of+Receptor-Positive+Human+Prostate+Adenocarcinoma+with+188Re-RC-160%2C+a+Directly-Radiolabeled+Somatostatin+Analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental radiotherapy of receptor-positive human prostate adenocarcinoma with 188Re-RC-160, a directly-radiolabeled somatostatin analog</span></div><div class="casAuthors">Zamora, Paul O.; Gulhke, Stefan; Bender, Hans; Diekmann, Daniella; Rhodes, Buck A.; Biersack, Hans-Jurgen; Knapp, F. F. (Russ) Jr.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">214-20</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">The therapeutic potential of the somatostatin analog RC-160 radiolabeled with 188Re was evaluated in nude mice bearing xenografts of human prostate adenocarcinoma.  188Re-RC-160 was selectively retained in both DU-145 and PC-3 tumors following direct intratumor injection at all time points examd. (2, 6 and 24 h postinjection).  Unbound 188Re-RC-160 was rapidly excreted via the hepatobiliary system and, with the exception of the gastrointestinal tract, very little normal organ uptake was found at any time point examd.  Neg. control compds., 188Re-perrhenate and 188Re-mercaptoacetyltriglycine (188Re-MAG3), were essentially washed out of the tumor by 6 h postinjection and were rapidly excreted through the kidneys.  131I-RC-160, used as a ref. compd., had a biodistribution in tumor-bearing animals similar to that of 188Re-RC-160.  In PC-3 xenografts, 188Re-RC-160 gave a dose-dependent therapeutic response (stasis or regression) even in animals with relatively large tumor masses (greater than 600 mm3), whereas the macroaggregated form of 188Re-RC-160 did not.  Long-term studies with 188Re-RC-160 demonstrated a protracted redn. of tumor vol. and a pos. effect on animal survival.  Neither RC-160 by itself nor a 188Re-labeled peptide, unrelated to somatostatin (PA-22-2, a laminin peptide), demonstrated the redn. in tumor mass obsd. with 188Re-RC-160.  188Re-RC-160 shows potential as a new clin. agent for treatment of somatostatin-receptor-pos. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqcUBvIY1Bh7Vg90H21EOLACvtfcHk0licqd_eBo0YOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhtlyktro%253D&md5=69527f8991241a47b7988b9bbd4a0ba6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819960117%2965%3A2%3C214%3A%3AAID-IJC15%3E3.0.CO%3B2-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819960117%252965%253A2%253C214%253A%253AAID-IJC15%253E3.0.CO%253B2-D%26sid%3Dliteratum%253Aachs%26aulast%3DZamora%26aufirst%3DP.%2BO.%26aulast%3DGulhke%26aufirst%3DS.%26aulast%3DBender%26aufirst%3DH.%26aulast%3DDiekmann%26aufirst%3DD.%26aulast%3DRhodes%26aufirst%3DB.%2BA.%26aulast%3DBiersack%26aufirst%3DH.-J.%26aulast%3DKnapp%26aufirst%3DF.%2BF.%26atitle%3DJr.%2520Experimental%2520Radiotherapy%2520of%2520Receptor-Positive%2520Human%2520Prostate%2520Adenocarcinoma%2520with%2520188Re-RC-160%252C%2520a%2520Directly-Radiolabeled%2520Somatostatin%2520Analog%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1996%26volume%3D65%26spage%3D214%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zamora, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, F. F.</span><span> </span><span class="NLM_article-title">Jr.; Biersack, H. J. Radiotherapy of Intrathoracic Carcinoma Xenografts with <sup>188</sup>Re-RC-160, a Somatostatin Analog</span> <span class="citation_source-journal">Tumor Targeting</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">49</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK28XjvVSnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=49-59&author=P.+O.+Zamoraauthor=H.+Benderauthor=F.+F.+Knapp&title=Jr.%3B+Biersack%2C+H.+J.+Radiotherapy+of+Intrathoracic+Carcinoma+Xenografts+with+188Re-RC-160%2C+a+Somatostatin+Analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Radiotherapy of intrathoracic carcinoma xenografts with 188Re-RC-160, a somatostatin analog</span></div><div class="casAuthors">Zamora, P. O.; Bender, H.; Knapp, F. F., Jr.; Biersack, H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Targeting</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-59</span>CODEN:
                <span class="NLM_cas:coden">TUTAF9</span>;
        ISSN:<span class="NLM_cas:issn">1351-8488</span>.
    
            (<span class="NLM_cas:orgname">Chapman & Hall</span>)
        </div><div class="casAbstract">Rhenium 188-RC-160 (188Re-RC-160) is a radiolabeled somatostatin analog under evaluation for internal, targeted radiation therapy of somatostatin-receptor-pos. cancers.  In this study, regionally delivered 188Re-RC-160 (administered into the thoracic cavity) was evaluated in exptl. models of metastasis to the pleural cavity.  Cells known to express somatostatin receptors - NCI-H69 (human small cell lung carcinoma); and ZR-75-1 (human breast carcinoma) - were inoculated into the thoracic cavity of athymic mice and rats, and tumors allowed to develop.  Raji cells (human Burkitt's lymphoma), pre-detd. in vitro not to bind RC-160, were used as neg. control cells.  Inoculated animals were left untreated or treated with either unlabeled RC-160 or 188Re-RC-160.  In untreated animals inoculated with NCI-H69 or ZR-75-1, tumors developed in 100% of the animals; animals treated with unlabeled RC-160 had similar tumor burdens.  On the other hand, animals bearing somatostatin-pos. tumors (NCI-H69 and ZR-75-1) and treated with 188Re-RC-160 had a marked redn. in tumor burden.  188Re-RC-160 did not substantially alter the development of Raji tumors (neg. for RC-160 binding) compared with untreated controls.  Biodistribution and scintigraphy studies of tumor-bearing animals support the hypothesis of the specific targeting of 188Re-RC-160 to somatostatin-receptor-pos. tumors.  The results indicated that 188Re-RC-160 restricted the growth of NCI-H69 and ZR-75-1 tumors in the thoracic cavity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHBKr3upVZVLVg90H21EOLACvtfcHk0lgM7VeGDc_NoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVSnt7c%253D&md5=d2d7c8f9433dbcd7271a17746195f4d6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZamora%26aufirst%3DP.%2BO.%26aulast%3DBender%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DF.%2BF.%26atitle%3DJr.%253B%2520Biersack%252C%2520H.%2520J.%2520Radiotherapy%2520of%2520Intrathoracic%2520Carcinoma%2520Xenografts%2520with%2520188Re-RC-160%252C%2520a%2520Somatostatin%2520Analog%26jtitle%3DTumor%2520Targeting%26date%3D1996%26volume%3D2%26spage%3D49%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hosono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosono, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamora, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guhlke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, F. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biersack, H. J.</span><span> </span><span class="NLM_article-title">Localization of Small-Cell Lung Cancer Xenografts with Iodine-125-, Indium-111-, and Rhenium-188-Somatostatin Analogs</span> <span class="citation_source-journal">Jpn. J. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">87</span> <span class="NLM_fpage">995</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=8878464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK28XlslCqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=995-1000&author=M.+Hosonoauthor=M.+N.+Hosonoauthor=T.+Haberbergerauthor=P.+O.+Zamoraauthor=S.+Guhlkeauthor=H.+Benderauthor=F.+F.+R.+Knappauthor=H.+J.+Biersack&title=Localization+of+Small-Cell+Lung+Cancer+Xenografts+with+Iodine-125-%2C+Indium-111-%2C+and+Rhenium-188-Somatostatin+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of small-cell lung cancer xenografts with iodine-125-, indium-111-, and rhenium-188-somatostatin analogs</span></div><div class="casAuthors">Hosono, Makoto; Hosono, Masako N.; Haberberger, Thomas; Zamora, Paul O.; Guhlke, Stefan; Bender, Hans; Knapp, F. F. Russ; Biersack, Hans J.</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Cancer Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">995-1000</span>CODEN:
                <span class="NLM_cas:coden">JJCREP</span>;
        ISSN:<span class="NLM_cas:issn">0910-5050</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">We examd. the potential of radiolabeled somatostatin analogs, 125I-Tyr-3-octreotide (125I-octreotide), 111In-DTPA-D-Phe-1-octreotide (111In-octreotide), and 188Re-octreotide for targeting small-cell lung cancer (SCLC) in a mouse model.  Tyr-3-octreotide was labeled with 125I by the chloramine T method, and 111In-octreotide was obtained as a kit, while 188Re was eluted from a 188W/188Re generator, and octreotide was directly labeled with 188Re by reducing disulfide bonds.  The 125I-, 111In-, and 188Re-octreotides were injected i.v. into athymic mice bearing NCI-H69 tumors, and the biodistributions were detd. at 15 min, and 2, 4, 8, and 24 h.  Tumor uptakes were 0.5 ± 0.2, 0.3 ± 0.1, 0.3 ± 0.1 %ID/g, and tumor-to-blood ratios were 1.8, 11.9, 1.2 at 8 h for 125I-, 111In-, and 188Re-octreotides, resp.  Accumulations of 111In-octreotide in normal tissues were lower than those of 125I- and 188Re-octreotides.  188Re-octreotide can be used to localize SCLC lesions as efficiently as radioiodinated octreotide.  However, 111In-octreotide was the most suitable agent to obtain high tumor-to-normal tissue contrast for localizing SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrStDfX-HDsPLVg90H21EOLACvtfcHk0lgM7VeGDc_NoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlslCqsLg%253D&md5=c02af2ef26b4d51700bcc376b95e3e49</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DHosono%26aufirst%3DM.%2BN.%26aulast%3DHaberberger%26aufirst%3DT.%26aulast%3DZamora%26aufirst%3DP.%2BO.%26aulast%3DGuhlke%26aufirst%3DS.%26aulast%3DBender%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DF.%2BF.%2BR.%26aulast%3DBiersack%26aufirst%3DH.%2BJ.%26atitle%3DLocalization%2520of%2520Small-Cell%2520Lung%2520Cancer%2520Xenografts%2520with%2520Iodine-125-%252C%2520Indium-111-%252C%2520and%2520Rhenium-188-Somatostatin%2520Analogs%26jtitle%3DJpn.%2520J.%2520Cancer%2520Res.%26date%3D1996%26volume%3D87%26spage%3D995%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Haberberger, T.; Zamora, P.; Hosono, M.; Hosono, M. N.; Bender, H.; Guhlke, S.; Knapp, F. F.; Biersack, H. J.</span><span> </span><span class="NLM_article-title">Initial Studies on <sup>99m</sup>Tc- and <sup>188</sup>Re-Somatostatin Analogues: Stannous-Mediated Direct-Labelling and Biodistribution in Normal Mice.</span> In  <span class="citation_source-book">Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine</span>; <span class="NLM_contrib-group">Nicolini, M.; Mazzi, U.</span>, Eds.; <span class="NLM_publisher-name">SGE Editoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>. <span class="NLM_year">1995</span>;  <span class="NLM_volume">Vol. 4</span>,  <span class="NLM_fpage">367</span>− <span class="NLM_lpage">372</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=367-372&author=T.+Haberberger&author=P.+Zamora&author=M.+Hosono&author=M.+N.+Hosono&author=H.+Bender&author=S.+Guhlke&author=F.+F.+Knapp&author=H.+J.+Biersackauthor=M.+Nicolini&author=U.+Mazzi&title=Technetium%2C+Rhenium+and+Other+Metals+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHaberberger%26aufirst%3DT.%26atitle%3DInitial%2520Studies%2520on%252099mTc-%2520and%2520188Re-Somatostatin%2520Analogues%253A%2520Stannous-Mediated%2520Direct-Labelling%2520and%2520Biodistribution%2520in%2520Normal%2520Mice.%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Metals%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26aulast%3DNicolini%26aufirst%3DM.%26pub%3DSGE%2520Editoriali%26date%3D1995%26volume%3DVol.%25204%26spage%3D367%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schar, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heppeler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macke, H. R.</span><span> </span><span class="NLM_article-title">Affinity Profiles for Human Somatostatin Receptor Subtypes SST1-SST5 of Somatostatin Radiotracers Selected for Scintigraphic and Radiotherapeutic Use</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">273</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2Fs002590050034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=10774879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVWns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=273-282&author=J.+C.+Reubiauthor=J.-C.+Scharauthor=B.+Waserauthor=S.+Wengerauthor=A.+Heppelerauthor=J.+S.+Schmittauthor=H.+R.+Macke&title=Affinity+Profiles+for+Human+Somatostatin+Receptor+Subtypes+SST1-SST5+of+Somatostatin+Radiotracers+Selected+for+Scintigraphic+and+Radiotherapeutic+Use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use</span></div><div class="casAuthors">Reubi, Jean Claude; Schar, Jean-Claude; Waser, Beatrice; Wenger, Sandra; Heppeler, Axel; Schmitt, Jorg S.; Macke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-282</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">In vivo somatostatin receptor scintigraphy using Octreoscan is a valuable method for the visualization of human endocrine tumors and their metastases.  Recently, several new, alternative somatostatin radioligands have been synthesized for diagnostic and radiotherapeutic use in vivo.  Since human tumors are known to express various somatostatin receptor subtypes, it is mandatory to assess the receptor subtype affinity profile of such somatostatin radiotracers.  Using cell lines transfected with somatostatin receptor subtypes sst1, sst2, sst3, sst4 and sst5, we have evaluated the in vitro binding characteristics of labeled (indium, yttrium, gallium) and unlabeled DOTA-[Tyr3]-octreotide, DOTA-octreotide, DOTA-lanreotide, DOTA-vapreotide, DTPA-[Tyr3]-octreotate and DOTA-[Tyr3]-octreotate.  Small structural modifications, chelator substitution or metal replacement were shown to considerably affect the binding affinity.  A marked improvement of sst2 affinity was found for Ga-DOTA-[Tyr3]-octreotide (IC50 2.5 nM) compared with the Y-labeled compd. and Octreoscan.  An excellent binding affinity for sst2 in the same range was also found for In-DTPA-[Tyr3]-octreotate (IC50 1.3 nM) and for Y-DOTA-[Tyr3]-octreotate (IC50 1.6 nM).  Remarkably, Ga-DOTA-[Tyr3]-octreotate bound at sst2 with a considerably higher affinity (IC50 0.2 nM).  An up to 30-fold improvement in sst3 affinity was obsd. for unlabeled or Y-labeled DOTA-octreotide compared with their Tyr3-contg. analog, suggesting that replacement of Tyr3 by Phe is crucial for high sst3 affinity.  Substitution in the octreotide mol. of the DTPA by DOTA improved the sst3 binding affinity 14-fold.  Whereas Y-DOTA-lanreotide had only low affinity for sst3 and sst4, it had the highest affinity for sst5 among the tested compds. (IC50 16 nM).  Increased binding affinity for sst3 and sst5 was obsd. for DOTA-[Tyr3]-octreotide, DOTA-lanreotide and DOTA-vapreotide when they were labeled with yttrium.  These marked changes in subtype affinity profiles are due not only to the different chem. structures but also to the different charges and hydrophilicity of these compds.  Interestingly, even the coordination geometry of the radiometal complex remote from the pharmacophoric amino acids has a significant influence on affinity profiles as shown with Y-DOTA vs. Ga-DOTA in either [Tyr3]-octreotide or [Tyr3]-octreotate.  Such changes in sst affinity profiles must be identified in newly designed radiotracers used for somatostatin receptor scintigraphy in order to correctly interpret in vivo scintigraphic data.  These observations may represent basic principles relevant to the development of other peptide radioligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRKqYdWT35ELVg90H21EOLACvtfcHk0lgM7VeGDc_NoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVWns7w%253D&md5=3f9cd3963bcc09b71c4c6d38a2487b14</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs002590050034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590050034%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DSchar%26aufirst%3DJ.-C.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DWenger%26aufirst%3DS.%26aulast%3DHeppeler%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%2BS.%26aulast%3DMacke%26aufirst%3DH.%2BR.%26atitle%3DAffinity%2520Profiles%2520for%2520Human%2520Somatostatin%2520Receptor%2520Subtypes%2520SST1-SST5%2520of%2520Somatostatin%2520Radiotracers%2520Selected%2520for%2520Scintigraphic%2520and%2520Radiotherapeutic%2520Use%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2000%26volume%3D27%26spage%3D273%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Bigott, H. M.; Dannoon, S. F.; Figueroa, S. D.; Hoffman, T. J.; Jurisson, S. S.; Lewis, M. R.</span><span> </span><span class="NLM_article-title">Biodistribution and Imaging Studies of Somatostatin Receptors Using Technetium-99m-Cyclized Tyrosine-3-Octreotate</span>. In  <span class="citation_source-book">Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine</span>, <span class="NLM_contrib-group">Mazzi, U.</span>, Ed.; <span class="NLM_publisher-name">SGE Editoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>, <span class="NLM_year">2006</span>; Vol.  <span class="NLM_volume">7</span>, pp  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">300.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=295-300.&author=H.+M.+Bigott&author=S.+F.+Dannoon&author=S.+D.+Figueroa&author=T.+J.+Hoffman&author=S.+S.+Jurisson&author=M.+R.+Lewisauthor=U.+Mazzi&title=Technetium%2C+Rhenium+and+Other+Metals+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBigott%26aufirst%3DH.%2BM.%26atitle%3DBiodistribution%2520and%2520Imaging%2520Studies%2520of%2520Somatostatin%2520Receptors%2520Using%2520Technetium-99m-Cyclized%2520Tyrosine-3-Octreotate%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Metals%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26aulast%3DMazzi%26aufirst%3DU.%26pub%3DSGE%2520Editoriali%26date%3D2006%26volume%3D7%26spage%3D295%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Giblin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. P.</span><span> </span><span class="NLM_article-title">Synthesis and Characterization of Rhenium-Complexed α-Melanotropin Analogs</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">8</span> <span class="NLM_fpage">347</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9700291" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK2sXivF2hu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=347-353&author=M.+F.+Giblinauthor=S.+S.+Jurissonauthor=T.+P.+Quinn&title=Synthesis+and+Characterization+of+Rhenium-Complexed+%CE%B1-Melanotropin+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of Rhenium-Complexed α-Melanotropin Analogs</span></div><div class="casAuthors">Giblin, Michael F.; Jurisson, Silvia S.; Quinn, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-353</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Receptor binding peptides labeled with medically important radionuclides such as technetium and rhenium are an important tool for the imaging and treatment of many forms of cancer.  This paper describes a method of labeling peptides with rhenium using a natural amino acid chelating moiety.  The structural characteristics of this chelate moiety, N-acetyl-cysteine-glycine-cysteine-glycine (NAc-CGCG) complexed with nonradioactive rhenium, have been investigated.  The stability of this peptide-metal complex has been evaluated on the tracer level using radioactive rhenium-186.  The rhenium-bound peptide has been appended to the N termini of receptor binding α-MSH (NAc-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2) fragments via solid phase peptide synthesis.  Bioassays and receptor binding studies of the resulting complexes demonstrate that the fragments retained biol. activity and exhibited receptor binding consts. ranging from 0.3 to 1.1 nM.  This method could provide a general means of labeling bioactive peptide fragments that would simplify product purifn. and characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7W1ECQjXyq7Vg90H21EOLACvtfcHk0lgL8sKfp8aP2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivF2hu7g%253D&md5=fad47f23df50264a32368e545d4616c2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbc9700291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9700291%26sid%3Dliteratum%253Aachs%26aulast%3DGiblin%26aufirst%3DM.%2BF.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26aulast%3DQuinn%26aufirst%3DT.%2BP.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520Rhenium-Complexed%2520%25CE%25B1-Melanotropin%2520Analogs%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D347%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Grove, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, G.</span><span> </span><span class="NLM_article-title">Oxo-Complexes of Rhenium(V)</span> <span class="citation_source-journal">J. Chem. Soc., A, Inorg. Phys. Theoret.</span><span class="NLM_year" style="font-weight: bold;">1966</span> <span class="NLM_volume">1224</span> <span class="NLM_fpage">1230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1224&publication_year=1966&pages=1230&author=D.+E.+Groveauthor=G.+Wilkinson&title=Oxo-Complexes+of+Rhenium%28V%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrove%26aufirst%3DD.%2BE.%26aulast%3DWilkinson%26aufirst%3DG.%26atitle%3DOxo-Complexes%2520of%2520Rhenium%2528V%2529%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520A%252C%2520Inorg.%2520Phys.%2520Theoret.%26date%3D1966%26volume%3D1224%26spage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Delaglio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzesiek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuister, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeifer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, A.</span><span> </span><span class="NLM_article-title">NMRPipe: A Multidimensional Spectral Processing System Based on UNIX Pipes</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">277</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2FBF00197809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=8520220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVSmurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=277-293&author=F.+Delaglioauthor=S.+Grzesiekauthor=G.+W.+Vuisterauthor=G.+Zhuauthor=J.+Pfeiferauthor=A.+Bax&title=NMRPipe%3A+A+Multidimensional+Spectral+Processing+System+Based+on+UNIX+Pipes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">NMRPipe: a multidimensional spectral processing system based on UNIX pipes</span></div><div class="casAuthors">Delaglio, Frank; Grzesiek, Stephan; Vuister, Geerten W.; Zhu, Guang; Pfeifer, John; Bax, Ad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-93</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">ESCOM</span>)
        </div><div class="casAbstract">The NMRPipe system is a UNIX software environment of processing, graphics, and anal. tools designed to meet current routine and research-oriented multidimensional processing requirements, and to anticipate and accommodate future demands and developments.  The system is based on UNIX pipes, which allow programs running simultaneously to exchange streams of data under user control.  In an NMRPipe processing scheme, a stream of spectral data flows through a pipeline of processing programs, each of which performs one component of the overall scheme, such as Fourier transformation or linear prediction.  Complete multidimensional processing schemes are constructed as simple UNIX shell scripts.  The processing modules themselves maintain and exploit accurate records of data sizes, detection modes, and calibration information in all dimensions, so that schemes can be constructed without the need to explicitly define or anticipate data sizes or storage details of real and imaginary channels during processing.  The asynchronous pipeline scheme provides other substantial advantages, including high flexibility, favorable processing speeds, choice of both all-in-memory and disk-bound processing, easy adaptation to different data formats, simpler software development and maintenance, and the ability to distribute processing tasks on multi-CPU computers and computer networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSIUdXrdcEgbVg90H21EOLACvtfcHk0lgL8sKfp8aP2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVSmurfK&md5=a670fca5b164083e2178fafd2fb951ff</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2FBF00197809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00197809%26sid%3Dliteratum%253Aachs%26aulast%3DDelaglio%26aufirst%3DF.%26aulast%3DGrzesiek%26aufirst%3DS.%26aulast%3DVuister%26aufirst%3DG.%2BW.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DPfeifer%26aufirst%3DJ.%26aulast%3DBax%26aufirst%3DA.%26atitle%3DNMRPipe%253A%2520A%2520Multidimensional%2520Spectral%2520Processing%2520System%2520Based%2520on%2520UNIX%2520Pipes%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1995%26volume%3D6%26spage%3D277%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wishart, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigam, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abildgaard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyson, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, B. D.</span><span> </span><span class="NLM_article-title"><sup>1</sup>H, <sup>13</sup>C and <sup>15</sup>N Chemical Shift Referencing in Biomolecular NMR</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">135</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2FBF00211777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=8589602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK2MXoslWmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=135-140&author=D.+S.+Wishartauthor=C.+G.+Bigamauthor=J.+Yaoauthor=F.+Abildgaardauthor=H.+J.+Dysonauthor=E.+Oldfieldauthor=J.+L.+Markleyauthor=B.+D.+Sykes&title=1H%2C+13C+and+15N+Chemical+Shift+Referencing+in+Biomolecular+NMR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">1H, 13C and 15N chemical shift referencing in biomolecular NMR</span></div><div class="casAuthors">Wishart, David S.; Bigam, Colin G.; Yao, Jian; Abildgaard, Frits; Dyson, H. Jane; Oldfield, Eric; Markley, John L.; Sykes, Brian D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-40</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">ESCOM</span>)
        </div><div class="casAbstract">A considerable degree of variability exists in the way that 1H, 13C and 15N chem. shifts are reported and referenced for biomols.  In this article we explore some of the reasons for this situation and propose guidelines for future chem. shift referencing and for conversion from many common 1H, 13C and 15N chem. shift stds., now used in biomol. NMR, to those proposed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFRqdN7SPVg7Vg90H21EOLACvtfcHk0lgL8sKfp8aP2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslWmtLk%253D&md5=536db79e0759864bf3ddb9961d985ba4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2FBF00211777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00211777%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DD.%2BS.%26aulast%3DBigam%26aufirst%3DC.%2BG.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DAbildgaard%26aufirst%3DF.%26aulast%3DDyson%26aufirst%3DH.%2BJ.%26aulast%3DOldfield%26aufirst%3DE.%26aulast%3DMarkley%26aufirst%3DJ.%2BL.%26aulast%3DSykes%26aufirst%3DB.%2BD.%26atitle%3D1H%252C%252013C%2520and%252015N%2520Chemical%2520Shift%2520Referencing%2520in%2520Biomolecular%2520NMR%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1995%26volume%3D6%26spage%3D135%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Breeman, W. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Optimizing Conditions for Radiolabeling of DOTA-Peptides with <sup>90</sup>Y, <sup>111</sup>In and <sup>177</sup>Lu at High Specific Activities</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">30</span> <span class="NLM_fpage">917</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2Fs00259-003-1142-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=12677301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvF2lsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=917-920&author=W.+A.+P.+Breemanauthor=M.+de+Jongauthor=T.+J.+Visserauthor=J.+L.+Erionauthor=E.+P.+Krenning&title=Optimizing+Conditions+for+Radiolabeling+of+DOTA-Peptides+with+90Y%2C+111In+and+177Lu+at+High+Specific+Activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing conditions for radiolabeling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities</span></div><div class="casAuthors">Breeman, Wouter A. P.; de Jong, Marion; Visser, Theo J.; Erion, Jack L.; Krenning, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">917-920</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">DOTA-conjugated peptides, such as [DOTA0,Tyr3]octreotide (DOTATOC) and [DOTA0,Tyr3]octreotate (DOTA-tate), can be labeled with radionuclides such as 90Y, 111In and 177Lu.  These radiolabeled somatostatin analogs are used for peptide receptor radionuclide therapy (PRRT).  Radioligands for PRRT require high specific activities.  However, although these radionuclides are produced without addn. of carrier, contaminants are introduced during prodn. and as decay products.  In this study, parameters influencing the kinetics of labeling of DOTA-peptides were investigated and conditions were optimized to obtain the highest achievable specific activity.  The effects of contaminants were systematically investigated, concn. dependently, in a test model mimicking conditions for labeling with minimal molar excess of DOTA-peptides over radionuclide.  Kinetics of labeling of DOTA-peptides were optimal at pH 4-4.5; pH <4 strongly slowed down the kinetics.  Above pH 5, reaction kinetics varied owing to the formation of radionuclide hydroxides.  Labeling with 90Y and 177Lu was completed after 20 min at 80°C, while labeling with 111In was completed after 30 min at 100°C.  The effects of contaminants were systematically categorized, e.g., Cd2+ is the target and decay product of 111In and it was found to be a strong competitor with 111In for incorporation in DOTA.  In contrast, Zr4+ and Hf4+, decay products of 90Y and 177Lu, resp., did not interfere with the incorporation of these radionuclides.  The following conclusions are drawn: (a) DOTA-peptides can be radiolabeled at high specific activity, (b) reaction kinetics differ for each radionuclide, and (c) reactions can be hampered by contaminants, such as target material and decay products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppyPxAqfM4yLVg90H21EOLACvtfcHk0liIOsmKBP0KJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvF2lsb4%253D&md5=24bd1047a2ded6a7710b48608776551c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00259-003-1142-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-003-1142-0%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DOptimizing%2520Conditions%2520for%2520Radiolabeling%2520of%2520DOTA-Peptides%2520with%252090Y%252C%2520111In%2520and%2520177Lu%2520at%2520High%2520Specific%2520Activities%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2003%26volume%3D30%26spage%3D917%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Smith, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gali, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sieckman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higginbotham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkert, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Radiochemical Investigations of <sup>99m</sup>Tc-N<sub>3</sub>S-X-BBN[7–14]NH<sub>2</sub>: An in Vitro/in Vivo Structure-Activity Relationship Study Where <i>X</i> = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">93</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc020034r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFWmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=93-102&author=C.+J.+Smithauthor=H.+Galiauthor=G.+L.+Sieckmanauthor=C.+Higginbothamauthor=W.+A.+Volkertauthor=T.+J.+Hoffman&title=Radiochemical+Investigations+of+99mTc-N3S-X-BBN%5B7%E2%80%9314%5DNH2%3A+An+in+Vitro%2Fin+Vivo+Structure-Activity+Relationship+Study+Where+X+%3D+0-%2C+3-%2C+5-%2C+8-%2C+and+11-Carbon+Tethering+Moieties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Radiochemical Investigations of 99mTc-N3S-X-BBN[7-14]NH2: An in Vitro/in Vivo Structure-Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties</span></div><div class="casAuthors">Smith, C. Jeffrey; Gali, Hariprasad; Sieckman, Gary L.; Higginbotham, Chris; Volkert, Wynn A.; Hoffman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bombesin (BBN), a 14 amino acid peptide, is an analog of human gastrin releasing peptide (GRP) that binds to GRP receptors (GRPr) with high affinity and specificity.  The GRPr is overexpressed on a variety of human cancer cells, including prostate, breast, lung, and pancreatic cancers.  The specific aim of this study was to develop 99mTc-radiolabeled BBN analogs that maintain high specificity for the GRPr in vivo.  A preselected synthetic sequence via solid-phase peptide synthesis (SPPS) was designed to produce N3S-BBN (N3S = dimethylglycyl-L-seryl-L-cysteinylglycinamide) conjugates with the following general structure: DMG-S-C-G-X-Q-W-A-V-G-H-L-M-(NH2), where the spacer group, X = 0 (no spacer), ω-NH2(CH2)2COOH, ω-NH2(CH2)4COOH, ω-NH2(CH2)7COOH, or ω-NH2-(CH2)10COOH.  The new BBN constructs were purified by reversed phase-HPLC (RP-HPLC).  Electrospray mass spectrometry (ES-MS) was used to characterize the nonmetalated BBN conjugates.  Re(V)-BBN conjugates were prepd. by the reaction of Re(V)gluconate with N3S-X-BBN[7-14]NH2 (X = 0 carbons, β-Ala (β-alanine), 5-Ava (5-aminovaleric acid), 8-Aoc (8-aminooctanoic acid), and 11-Aun (11-aminoundecanoic acid)) with gentle heating. Re-N3S-5-Ava-BBN[7-14]NH2 was also prepd. by the reaction of [Re(V)dimethylglycyl-L-seryl-L-cysteinylglycinamide] with 5-Ava-BBN[7-14]NH2. ES-MS was used to det. the mol. constitution of the new Re(V) conjugates.  The 99mTc conjugates were prepd. at the tracer level by each the prelabeling, post-conjugation and pre-conjugation, postlabeling approaches from the reaction of Na[99mTcO4] with excess SnCl2, sodium gluconate, and corresponding ligand.  The 99mTc and Re(V) conjugates behaved similarly under identical RP-HPLC conditions.  In vitro and in vivo models demonstrated biol. integrity of the new conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3hpJybG-Tg7Vg90H21EOLACvtfcHk0liIOsmKBP0KJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFWmtrY%253D&md5=18c07e13b6fbb5a2c20d4fe0a4ca724b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fbc020034r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc020034r%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26aulast%3DGali%26aufirst%3DH.%26aulast%3DSieckman%26aufirst%3DG.%2BL.%26aulast%3DHigginbotham%26aufirst%3DC.%26aulast%3DVolkert%26aufirst%3DW.%2BA.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26atitle%3DRadiochemical%2520Investigations%2520of%252099mTc-N3S-X-BBN%255B7%25E2%2580%259314%255DNH2%253A%2520An%2520in%2520Vitro%252Fin%2520Vivo%2520Structure-Activity%2520Relationship%2520Study%2520Where%2520X%2520%253D%25200-%252C%25203-%252C%25205-%252C%25208-%252C%2520and%252011-Carbon%2520Tethering%2520Moieties%26jtitle%3DBioconjugate%2520Chem.%26date%3D2003%26volume%3D14%26spage%3D93%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Eszter Boros, <span class="NLM_string-name hlFld-ContribAuthor">Alan B. Packard</span>. </span><span class="cited-content_cbyCitation_article-title">Radioactive Transition Metals for Imaging and Therapy. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 870-901. <a href="https://doi.org/10.1021/acs.chemrev.8b00281" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00281%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DRadioactive%252BTransition%252BMetals%252Bfor%252BImaging%252Band%252BTherapy%26aulast%3DBoros%26aufirst%3DEszter%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D08052018%26date%3D09102018%26volume%3D119%26issue%3D2%26spage%3D870%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yawen  Li</span>, <span class="hlFld-ContribAuthor ">Lixin  Ma</span>, <span class="hlFld-ContribAuthor ">Vikram  Gaddam</span>, <span class="hlFld-ContribAuthor ">Fabio  Gallazzi</span>, <span class="hlFld-ContribAuthor ">Heather M.  Hennkens</span>, <span class="hlFld-ContribAuthor ">Michael  Harmata</span>, <span class="hlFld-ContribAuthor ">Michael R.  Lewis</span>, <span class="hlFld-ContribAuthor ">Carol A.  Deakyne</span>, and <span class="hlFld-ContribAuthor ">Silvia S.  Jurisson</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Characterization, and In Vitro Evaluation of New 99mTc/Re(V)-Cyclized Octreotide Analogues: An Experimental and Computational Approach. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2016,</strong> <em>55 </em>
                                    (3)
                                     , 1124-1133. <a href="https://doi.org/10.1021/acs.inorgchem.5b02306" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.5b02306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.5b02306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.5b02306%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252BCharacterization%25252C%252Band%252BIn%252BVitro%252BEvaluation%252Bof%252BNew%252B99mTc%25252FRe%252528V%252529-Cyclized%252BOctreotide%252BAnalogues%25253A%252BAn%252BExperimental%252Band%252BComputational%252BApproach%26aulast%3DLi%26aufirst%3DYawen%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06102015%26date%3D20012016%26date%3D01022016%26volume%3D55%26issue%3D3%26spage%3D1124%26epage%3D1133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cathy S.  Cutler</span>, <span class="hlFld-ContribAuthor ">Heather M.  Hennkens</span>, <span class="hlFld-ContribAuthor ">Nebiat  Sisay</span>, <span class="hlFld-ContribAuthor ">Sandrine  Huclier-Markai</span>, and <span class="hlFld-ContribAuthor ">Silvia S.  Jurisson</span>  . </span><span class="cited-content_cbyCitation_article-title">Radiometals for Combined Imaging and Therapy. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2013,</strong> <em>113 </em>
                                    (2)
                                     , 858-883. <a href="https://doi.org/10.1021/cr3003104" title="DOI URL">https://doi.org/10.1021/cr3003104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr3003104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr3003104%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DRadiometals%252Bfor%252BCombined%252BImaging%252Band%252BTherapy%26aulast%3DCutler%26aufirst%3DCathy%2BS.%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D01082012%26date%3D30112012%26date%3D13022013%26volume%3D113%26issue%3D2%26spage%3D858%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dina  Rosita</span>, <span class="hlFld-ContribAuthor ">Matthew A.  DeWit</span> and <span class="hlFld-ContribAuthor ">Leonard G.  Luyt</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine and Rhenium Substituted Ghrelin Analogues as Potential Imaging Probes for the Growth Hormone Secretagogue Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (8)
                                     , 2196-2203. <a href="https://doi.org/10.1021/jm8014519" title="DOI URL">https://doi.org/10.1021/jm8014519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm8014519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm8014519%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFluorine%252Band%252BRhenium%252BSubstituted%252BGhrelin%252BAnalogues%252Bas%252BPotential%252BImaging%252BProbes%252Bfor%252Bthe%252BGrowth%252BHormone%252BSecretagogue%252BReceptor%26aulast%3DRosita%26aufirst%3DDina%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D17%252011%25202008%26date%3D26032009%26date%3D23042009%26volume%3D52%26issue%3D8%26spage%3D2196%26epage%3D2203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">George  Makris</span>, <span class="hlFld-ContribAuthor ">Marina  Kuchuk</span>, <span class="hlFld-ContribAuthor ">Lauren  Radford</span>, <span class="hlFld-ContribAuthor ">Fabio  Gallazzi</span>, <span class="hlFld-ContribAuthor ">Michael R.  Lewis</span>, <span class="hlFld-ContribAuthor ">Silvia S.  Jurisson</span>, <span class="hlFld-ContribAuthor ">Heather M.  Hennkens</span>. </span><span class="cited-content_cbyCitation_article-title">Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, 99mTc and 186Re metal centers: Radiochemistry and in vitro evaluation. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2021,</strong> <em>94-95 </em>, 46-52. <a href="https://doi.org/10.1016/j.nucmedbio.2020.12.007" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.12.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.12.007%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DDirect%252Blabeling%252Bof%252Ba%252Bsomatostatin%252Breceptor%252Bantagonist%252Bvia%252Bpeptide%252Bcyclization%252Bwith%252BRe%25252C%252B99mTc%252Band%252B186Re%252Bmetal%252Bcenters%25253A%252BRadiochemistry%252Band%252Bin%252Bvitro%252Bevaluation%26aulast%3DWang%26aufirst%3DJing%26date%3D2021%26volume%3D94-95%26spage%3D46%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dionysia  Papagiannopoulou</span>. </span><span class="cited-content_cbyCitation_article-title">
                99m
                Tc
              
              Radiopharmaceutical Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 375-433. <a href="https://doi.org/10.1002/9781119500575.ch12" title="DOI URL">https://doi.org/10.1002/9781119500575.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119500575.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119500575.ch12%26sid%3Dliteratum%253Aachs%26atitle%3D99m%252BTc%252BRadiopharmaceutical%252BChemistry%26aulast%3DPapagiannopoulou%26aufirst%3DDionysia%26date%3D2020%26date%3D2021%26spage%3D375%26epage%3D433%26pub%3DWiley%26atitle%3DHandbook%252Bof%252BRadiopharmaceuticals%26aulast%3DScott%26aufirst%3DPeter%26date%3D2020%26date%3D2021%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanaa S.  El-Desoky</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Ghoneim</span>, <span class="hlFld-ContribAuthor ">Ahmed E.  Khattab</span>. </span><span class="cited-content_cbyCitation_article-title">A First Efficient Voltammetric Approach for Detection of Octreotide, an Octapeptide Analogue of Somatostatin Natural Hormone, in Sandostatin Intramuscular Injection and Human Plasma Based on Modification Free Electrochemical Sensor. </span><span class="cited-content_cbyCitation_journal-name">Journal of The Electrochemical Society</span><span> <strong>2019,</strong> <em>166 </em>
                                    (4)
                                     , B276-B289. <a href="https://doi.org/10.1149/2.0911904jes" title="DOI URL">https://doi.org/10.1149/2.0911904jes</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1149/2.0911904jes&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1149%2F2.0911904jes%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520The%2520Electrochemical%2520Society%26atitle%3DA%252BFirst%252BEfficient%252BVoltammetric%252BApproach%252Bfor%252BDetection%252Bof%252BOctreotide%25252C%252Ban%252BOctapeptide%252BAnalogue%252Bof%252BSomatostatin%252BNatural%252BHormone%25252C%252Bin%252BSandostatin%252BIntramuscular%252BInjection%252Band%252BHuman%252BPlasma%252BBased%252Bon%252BModification%252BFree%252BElectrochemical%252BSensor%26aulast%3DEl-Desoky%26aufirst%3DHanaa%2BS.%26date%3D2019%26date%3D2019%26volume%3D166%26issue%3D4%26spage%3DB276%26epage%3DB289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muthuraman  Karthikeyan</span>, <span class="hlFld-ContribAuthor ">Ramadoss  Govindarajan</span>, <span class="hlFld-ContribAuthor ">Ezhumalai  Duraisamy</span>, <span class="hlFld-ContribAuthor ">Vijayakumar  Veena</span>, <span class="hlFld-ContribAuthor ">Natarajan  Sakthivel</span>, <span class="hlFld-ContribAuthor ">Bala.  Manimaran</span>. </span><span class="cited-content_cbyCitation_article-title">Self-Assembly of Chalcogenolato-Bridged Ester and Amide Functionalized Dinuclear Re(I) Metallacycles: Synthesis, Structural Characterization and Preliminary Cytotoxicity Studies. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (11)
                                     , 3362-3368. <a href="https://doi.org/10.1002/slct.201700646" title="DOI URL">https://doi.org/10.1002/slct.201700646</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201700646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201700646%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSelf-Assembly%252Bof%252BChalcogenolato-Bridged%252BEster%252Band%252BAmide%252BFunctionalized%252BDinuclear%252BRe%252528I%252529%252BMetallacycles%25253A%252BSynthesis%25252C%252BStructural%252BCharacterization%252Band%252BPreliminary%252BCytotoxicity%252BStudies%26aulast%3DKarthikeyan%26aufirst%3DMuthuraman%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D11%26spage%3D3362%26epage%3D3368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer L.  Hickey</span>, <span class="hlFld-ContribAuthor ">Emily J.  Simpson</span>, <span class="hlFld-ContribAuthor ">Jinqiang  Hou</span>, <span class="hlFld-ContribAuthor ">Leonard G.  Luyt</span>. </span><span class="cited-content_cbyCitation_article-title">An Integrated Imaging Probe Design: The Synthesis of
              99m
              Tc/Re-Containing Macrocyclic Peptide Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2015,</strong> <em>21 </em>
                                    (2)
                                     , 568-578. <a href="https://doi.org/10.1002/chem.201404774" title="DOI URL">https://doi.org/10.1002/chem.201404774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201404774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201404774%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DAn%252BIntegrated%252BImaging%252BProbe%252BDesign%25253A%252BThe%252BSynthesis%252Bof%252B99m%252BTc%25252FRe-Containing%252BMacrocyclic%252BPeptide%252BScaffolds%26aulast%3DHickey%26aufirst%3DJennifer%2BL.%26date%3D2015%26date%3D2014%26volume%3D21%26issue%3D2%26spage%3D568%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yawen  Li</span>, <span class="hlFld-ContribAuthor ">Jacob A.  Kreuer</span>, <span class="hlFld-ContribAuthor ">Dustin Wayne  Demoin</span>, <span class="hlFld-ContribAuthor ">Silvia S.  Jurisson</span>, <span class="hlFld-ContribAuthor ">Carol A.  Deakyne</span>. </span><span class="cited-content_cbyCitation_article-title">Using potential energy surface scans to examine the bond dissociation energies of trans-ReOS2N2 and [ReOS3N]1− model complexes. </span><span class="cited-content_cbyCitation_journal-name">Computational and Theoretical Chemistry</span><span> <strong>2014,</strong> <em>1048 </em>, 25-34. <a href="https://doi.org/10.1016/j.comptc.2014.08.017" title="DOI URL">https://doi.org/10.1016/j.comptc.2014.08.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.comptc.2014.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.comptc.2014.08.017%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Theoretical%2520Chemistry%26atitle%3DUsing%252Bpotential%252Benergy%252Bsurface%252Bscans%252Bto%252Bexamine%252Bthe%252Bbond%252Bdissociation%252Benergies%252Bof%252Btrans-ReOS2N2%252Band%252B%25255BReOS3N%25255D1%2525E2%252588%252592%252Bmodel%252Bcomplexes%26aulast%3DLi%26aufirst%3DYawen%26date%3D2014%26volume%3D1048%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhanzhao  Fu</span>, <span class="hlFld-ContribAuthor ">Dawei  Gao</span>, <span class="hlFld-ContribAuthor ">Faming  Gao</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoning  Zhao</span>, <span class="hlFld-ContribAuthor ">Yanping  Liu</span>, <span class="hlFld-ContribAuthor ">Zi  Wang</span>, <span class="hlFld-ContribAuthor ">Guangxia  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Fabrication of Gold Nanochains with Octreotide Acetate Template. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nanomaterials</span><span> <strong>2013,</strong> <em>2013 </em>, 1-9. <a href="https://doi.org/10.1155/2013/346274" title="DOI URL">https://doi.org/10.1155/2013/346274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2013/346274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2013%2F346274%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nanomaterials%26atitle%3DFabrication%252Bof%252BGold%252BNanochains%252Bwith%252BOctreotide%252BAcetate%252BTemplate%26aulast%3DZhou%26aufirst%3DJing%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan T.  McDonough</span>, <span class="hlFld-ContribAuthor ">Geeta  Paranjape</span>, <span class="hlFld-ContribAuthor ">Fabio  Gallazzi</span>, <span class="hlFld-ContribAuthor ">Michael R.  Nichols</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted tryptophans at amyloid-β(1–40) residues 19 and 20 experience different environments after fibril formation. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2011,</strong> <em>514 </em>
                                    (1-2)
                                     , 27-32. <a href="https://doi.org/10.1016/j.abb.2011.07.018" title="DOI URL">https://doi.org/10.1016/j.abb.2011.07.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2011.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2011.07.018%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DSubstituted%252Btryptophans%252Bat%252Bamyloid-%2525CE%2525B2%2525281%2525E2%252580%25259340%252529%252Bresidues%252B19%252Band%252B20%252Bexperience%252Bdifferent%252Benvironments%252Bafter%252Bfibril%252Bformation%26aulast%3DMcDonough%26aufirst%3DRyan%2BT.%26date%3D2011%26volume%3D514%26issue%3D1-2%26spage%3D27%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Le Gal</span>, <span class="hlFld-ContribAuthor ">Marta  Gonera</span>, <span class="hlFld-ContribAuthor ">Marie-Anne  Lelait</span>, <span class="hlFld-ContribAuthor ">Denis  Servent</span>, <span class="hlFld-ContribAuthor ">Christophe  Dugave</span>. </span><span class="cited-content_cbyCitation_article-title">Chelate oxorhenium to assemble new integrin antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2011,</strong> <em>105 </em>
                                    (6)
                                     , 880-886. <a href="https://doi.org/10.1016/j.jinorgbio.2011.03.008" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2011.03.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2011.03.008%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DChelate%252Boxorhenium%252Bto%252Bassemble%252Bnew%252Bintegrin%252Bantagonists%26aulast%3DLe%2BGal%26aufirst%3DJulien%26date%3D2011%26volume%3D105%26issue%3D6%26spage%3D880%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Aufort</span>, <span class="hlFld-ContribAuthor ">Marta  Gonera</span>, <span class="hlFld-ContribAuthor ">Marie-Anne  Lelait</span>, <span class="hlFld-ContribAuthor ">Bertrand  Czarny</span>, <span class="hlFld-ContribAuthor ">Loïc  Le Clainche</span>, <span class="hlFld-ContribAuthor ">Robert  Thaï</span>, <span class="hlFld-ContribAuthor ">Amandine  Landra</span>, <span class="hlFld-ContribAuthor ">Mathias  Ruinart de Brimont</span>, <span class="hlFld-ContribAuthor ">Christophe  Dugave</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, in vitro screening and in vivo evaluation of cyclic RGD analogs cyclized through oxorhenium and oxotechnetium coordination. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (5)
                                     , 1779-1788. <a href="https://doi.org/10.1016/j.ejmech.2011.02.032" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.02.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.02.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.02.032%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bin%252Bvitro%252Bscreening%252Band%252Bin%252Bvivo%252Bevaluation%252Bof%252Bcyclic%252BRGD%252Banalogs%252Bcyclized%252Bthrough%252Boxorhenium%252Band%252Boxotechnetium%252Bcoordination%26aulast%3DAufort%26aufirst%3DMarie%26date%3D2011%26volume%3D46%26issue%3D5%26spage%3D1779%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heather M.  Bigott-Hennkens</span>, <span class="hlFld-ContribAuthor ">Shorouk F.  Dannoon</span>, <span class="hlFld-ContribAuthor ">Samantha M.  Noll</span>, <span class="hlFld-ContribAuthor ">Varyanna C.  Ruthengael</span>, <span class="hlFld-ContribAuthor ">Silvia S.  Jurisson</span>, <span class="hlFld-ContribAuthor ">Michael R.  Lewis</span>. </span><span class="cited-content_cbyCitation_article-title">Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivatives. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2011,</strong> <em>38 </em>
                                    (4)
                                     , 549-555. <a href="https://doi.org/10.1016/j.nucmedbio.2010.10.006" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2010.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2010.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2010.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DLabeling%25252C%252Bstability%252Band%252Bbiodistribution%252Bstudies%252Bof%252B99mTc-cyclized%252BTyr3-octreotate%252Bderivatives%26aulast%3DBigott-Hennkens%26aufirst%3DHeather%2BM.%26date%3D2011%26volume%3D38%26issue%3D4%26spage%3D549%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonard G.  Luyt</span>. </span><span class="cited-content_cbyCitation_article-title">The Design of Radiolabeled Peptides for Targeting Malignancies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 101-120. <a href="https://doi.org/10.1002/9780470613214.ch3" title="DOI URL">https://doi.org/10.1002/9780470613214.ch3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470613214.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470613214.ch3%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDesign%252Bof%252BRadiolabeled%252BPeptides%252Bfor%252BTargeting%252BMalignancies%26aulast%3DLuyt%26aufirst%3DLeonard%2BG.%26date%3D2010%26date%3D2010%26spage%3D101%26epage%3D120%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DMonoclonal%252BAntibody%252Band%252BPeptide-Targeted%252BRadiotherapy%252Bof%252BCancer%26aulast%3DReilly%26aufirst%3DRaymond%2BM.%26date%3D2010%26date%3D2010%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shorouk F.  Dannoon</span>, <span class="hlFld-ContribAuthor ">Heather M.  Bigott-Hennkens</span>, <span class="hlFld-ContribAuthor ">Lixin  Ma</span>, <span class="hlFld-ContribAuthor ">Fabio  Gallazzi</span>, <span class="hlFld-ContribAuthor ">Michael R.  Lewis</span>, <span class="hlFld-ContribAuthor ">Silvia S.  Jurisson</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro structure–activity relationship of Re-cyclized octreotide analogues. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2010,</strong> <em>37 </em>
                                    (5)
                                     , 527-537. <a href="https://doi.org/10.1016/j.nucmedbio.2010.03.008" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2010.03.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2010.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2010.03.008%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DIn%252Bvitro%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252BRe-cyclized%252Boctreotide%252Banalogues%26aulast%3DDannoon%26aufirst%3DShorouk%2BF.%26date%3D2010%26volume%3D37%26issue%3D5%26spage%3D527%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jillienne C.  Touchette</span>, <span class="hlFld-ContribAuthor ">Laura L.  Williams</span>, <span class="hlFld-ContribAuthor ">Deepa  Ajit</span>, <span class="hlFld-ContribAuthor ">Fabio  Gallazzi</span>, <span class="hlFld-ContribAuthor ">Michael R.  Nichols</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the amyloid-β(1–40) fibril environment with substituted tryptophan residues. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2010,</strong> <em>494 </em>
                                    (2)
                                     , 192-197. <a href="https://doi.org/10.1016/j.abb.2009.12.007" title="DOI URL">https://doi.org/10.1016/j.abb.2009.12.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2009.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2009.12.007%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DProbing%252Bthe%252Bamyloid-%2525CE%2525B2%2525281%2525E2%252580%25259340%252529%252Bfibril%252Benvironment%252Bwith%252Bsubstituted%252Btryptophan%252Bresidues%26aulast%3DTouchette%26aufirst%3DJillienne%2BC.%26date%3D2010%26volume%3D494%26issue%3D2%26spage%3D192%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Aufort</span>, <span class="hlFld-ContribAuthor ">Marta  Gonera</span>, <span class="hlFld-ContribAuthor ">Nicolas  Chaignon</span>, <span class="hlFld-ContribAuthor ">Loïc  Le Clainche</span>, <span class="hlFld-ContribAuthor ">Christophe  Dugave</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biochemical evaluation of a cyclic RGD oxorhenium complex as new ligand of αVβ3 integrin. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>44 </em>
                                    (9)
                                     , 3394-3401. <a href="https://doi.org/10.1016/j.ejmech.2009.02.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2009.02.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2009.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2009.02.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiochemical%252Bevaluation%252Bof%252Ba%252Bcyclic%252BRGD%252Boxorhenium%252Bcomplex%252Bas%252Bnew%252Bligand%252Bof%252B%2525CE%2525B1V%2525CE%2525B23%252Bintegrin%26aulast%3DAufort%26aufirst%3DMarie%26date%3D2009%26volume%3D44%26issue%3D9%26spage%3D3394%26epage%3D3401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/medium/jm-2007-01056x_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/large/jm-2007-01056x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701056x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/medium/jm-2007-01056x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/large/jm-2007-01056x_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overlay of 2D <sup>1</sup>H−<sup>1</sup>H TOCSY NMR spectra of Re−Ac-octreotide (red) and disulfide-cyclized Ac-octreotide (blue). As indicated by the arrows shown, many proton peaks are shifted upon integration of the Re(V) core into the Ac-octreotide peptide structure. Also, the amide protons of Phe<sup>3</sup> and Thr<sup>6</sup> are missing from the Re−Ac-octreotide spectrum (the corresponding disulfide-cyclized Ac-octreotide protons are labeled in green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/large/jm-2007-01056x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701056x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/medium/jm-2007-01056x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/large/jm-2007-01056x_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of Re−octreotide (left) and Re−Ac-octreotide (middle) with somatostatin pharmacophore sequences shown in bold. Disulfide-cyclized octreotide is shown (right) for comparison.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701056x/production/images/large/jm-2007-01056x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701056x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i19">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Van Essen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning Eric, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valkema, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwekkeboom Dik, J.</span><span> </span><span class="NLM_article-title">Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues in Patients with Somatostatin Receptor Positive Tumours</span> <span class="citation_source-journal">Acta Oncol.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">46</span> <span class="NLM_fpage">723</span> <span class="NLM_lpage">734</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1080%2F02841860701441848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=17653893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotV2qsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=723-734&author=M.+Van+Essenauthor=P.+Krenning+Ericauthor=M.+de+Jongauthor=R.+Valkemaauthor=J.+Kwekkeboom+Dik&title=Peptide+Receptor+Radionuclide+Therapy+with+Radiolabelled+Somatostatin+Analogues+in+Patients+with+Somatostatin+Receptor+Positive+Tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumors</span></div><div class="casAuthors">Van Essen, Martijn; Krenning, Eric P.; De Jong, Marion; Valkema, Roelf; Kwekkeboom, Dik J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Oncologica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">723-734</span>CODEN:
                <span class="NLM_cas:coden">ACTOEL</span>;
        ISSN:<span class="NLM_cas:issn">0284-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis</span>)
        </div><div class="casAbstract">A review.  Peptide Receptor Radionuclide Therapy (PRRT) with radiolabeled somatostatin analogs is a promising treatment option for patients with inoperable or metastasised neuroendocrine tumors.  Symptomatic improvement may occur with all of the various 111In, 90Y, or 177Lu-labeled somatostatin analogs that have been used.  Since tumor size redn. was seldom achieved with 111Indium labeled somatostatin analogs, radiolabeled somatostatin analogs with beta-emitting isotopes like 90Y and 177Lu were developed.  Reported anti-tumor effects of [90Y-DOTA0,Tyr3]octreotide vary considerably between various studies: Tumor regression of 50% or more was achieved in 9 to 33% (mean 22%).  With [177Lu-DOTA0,Tyr3]octreotate treatments, tumor regression of 50% or more was achieved in 28% of patients and tumor regression of 25 to 50% in 19% of patients, stable disease was demonstrated in 35% and progressive disease in 18%.  Predictive factors for tumor remission were high tumor uptake on somatostatin receptor scintigraphy and limited amt. of liver metastases.  The side-effects of PRRT are few and mostly mild, certainly when using renal protective agents: Serious side-effects like myelodysplastic syndrome or renal failure are rare.  The median duration of the therapy response for [90Y-DOTA0,Tyr3]octreotide and [177Lu-DOTA0,Tyr3]octreotate is 30 mo and more than 36 mo resp.  Lastly, quality of life improves significantly after treatment with [177Lu-DOTA0,Tyr3]octreotate.  These data compare favorably with the limited no. of alternative treatment approaches, like chemotherapy.  If more widespread use of PRRT is possible, such therapy might become the therapy of first choice in patients with metastasised or inoperable gastroenteropancreatic neuroendocrine tumors.  Also the role in somatostatin receptor expressing non-GEP tumors, like metastasised paraganglioma/pheochromocytoma and non-radioiodine-avid differentiated thyroid carcinoma might become more important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3RxF_9CdIvLVg90H21EOLACvtfcHk0li9xTx30F14BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotV2qsr8%253D&md5=d137fe3a1fb1182f6363b7acc56ad897</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1080%2F02841860701441848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02841860701441848%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BEssen%26aufirst%3DM.%26aulast%3DKrenning%2BEric%26aufirst%3DP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DValkema%26aufirst%3DR.%26aulast%3DKwekkeboom%2BDik%26aufirst%3DJ.%26atitle%3DPeptide%2520Receptor%2520Radionuclide%2520Therapy%2520with%2520Radiolabelled%2520Somatostatin%2520Analogues%2520in%2520Patients%2520with%2520Somatostatin%2520Receptor%2520Positive%2520Tumours%26jtitle%3DActa%2520Oncol.%26date%3D2007%26volume%3D46%26spage%3D723%26epage%3D734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeman, W. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooij, P. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofland, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugaj, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macke, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Comparison of <sup>111</sup>In-Labeled Somatostatin Analogs for Tumor Scintigraphy and Radionuclide Therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">58</span> <span class="NLM_fpage">437</span> <span class="NLM_lpage">441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=437-441&author=M.+de+Jongauthor=W.+A.+P.+Breemanauthor=W.+H.+Bakkerauthor=P.+P.+M.+Kooijauthor=B.+F.+Bernardauthor=L.+J.+Hoflandauthor=T.+J.+Visserauthor=A.+Srinivasanauthor=M.+A.+Schmidtauthor=J.+L.+Erionauthor=J.+E.+Bugajauthor=H.+R.+Mackeauthor=E.+P.+Krenning&title=Comparison+of+111In-Labeled+Somatostatin+Analogs+for+Tumor+Scintigraphy+and+Radionuclide+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26aulast%3DBakker%26aufirst%3DW.%2BH.%26aulast%3DKooij%26aufirst%3DP.%2BP.%2BM.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3DHofland%26aufirst%3DL.%2BJ.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DM.%2BA.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DBugaj%26aufirst%3DJ.%2BE.%26aulast%3DMacke%26aufirst%3DH.%2BR.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DComparison%2520of%2520111In-Labeled%2520Somatostatin%2520Analogs%2520for%2520Tumor%2520Scintigraphy%2520and%2520Radionuclide%2520Therapy%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D437%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeman, W. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Pluijm, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jermann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macke, H. R.</span><span> </span><span class="NLM_article-title">Yttrium-90 and Indium-111 Labeling, Receptor Binding and Biodistribution of [DOTA<sup>0</sup>,D-Phe<sup>1</sup>,Tyr<sup>3</sup>]Octreotide, a Promising Somatostatin Analog for Radionuclide Therapy</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">368</span> <span class="NLM_lpage">371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2Fs002590050064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=9096086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlOmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1997&pages=368-371&author=M.+de+Jongauthor=W.+H.+Bakkerauthor=E.+P.+Krenningauthor=W.+A.+P.+Breemanauthor=M.+E.+van+der+Pluijmauthor=B.+F.+Bernardauthor=T.+J.+Visserauthor=E.+Jermannauthor=M.+Beheauthor=P.+Powellauthor=H.+R.+Macke&title=Yttrium-90+and+Indium-111+Labeling%2C+Receptor+Binding+and+Biodistribution+of+%5BDOTA0%2CD-Phe1%2CTyr3%5DOctreotide%2C+a+Promising+Somatostatin+Analog+for+Radionuclide+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Yttrium-90 and indium-111 labeling, receptor binding and biodistribution of [DOTA0,D-Phe1,Tyr3]octreotide, a promising somatostatin analog for radionuclide therapy</span></div><div class="casAuthors">De Jong, Marion; Bakker, Willem H.; Krenning, Eric P.; Breeman, Wout A.P.; Van Der Pluijm, Marcel E.; Bernard, Bert F.; Visser, Theo J.; Jermann, Eduard; Behe, Martin; et al.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">368-371</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In vitro octreotide receptor binding of [111In-DOTA0,D-Phe1,Try3]octreotide (111In-DOTATOC) and the in vivo metab. of 90Y- or 111In-labeled DOTATOC were investigated in rats in comparison with [111In-DTPA0]octreotide (111In-DTPAOC).  111In-DOTATOC was found to have an affinity similar to octreotide itself for the octreotide receptor in rat cerebral cortex microsomes.  Twenty-four hours after injection of 90Y- or 111In-labeled DOTATOC, uptake of radioactivity in the octreotide receptor-expressing tissues pancreas, pituitary, adrenals and tumor was a factor of 2-6 that after injection of 111In-DTPAOC.  Uptake of labeled DOTATOC in pituitary, pancreas, adrenals and tumor was almost completely blocked by pretreatment with 0.5 mg unlabeled octreotide, indicating specific binding to the octreotide receptors.  These findings strongly indicate that 90Y-DOTATOC is a promising radiopharmaceutical for radiotherapy and that 111In-DOTATOC is of potential value for diagnosis of patients with octreotide receptor-pos. lesions, such as most neuroendocrine tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr25_svQvxDLVg90H21EOLACvtfcHk0ljKA1d4YzBXrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlOmt7s%253D&md5=a95b8e176c862c41d7a3f4c68f5a66ec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs002590050064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590050064%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DBakker%26aufirst%3DW.%2BH.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26aulast%3Dvan%2Bder%2BPluijm%26aufirst%3DM.%2BE.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DJermann%26aufirst%3DE.%26aulast%3DBehe%26aufirst%3DM.%26aulast%3DPowell%26aufirst%3DP.%26aulast%3DMacke%26aufirst%3DH.%2BR.%26atitle%3DYttrium-90%2520and%2520Indium-111%2520Labeling%252C%2520Receptor%2520Binding%2520and%2520Biodistribution%2520of%2520%255BDOTA0%252CD-Phe1%252CTyr3%255DOctreotide%252C%2520a%2520Promising%2520Somatostatin%2520Analog%2520for%2520Radionuclide%2520Therapy%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D1997%26volume%3D24%26spage%3D368%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Heppeler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froidevaux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macke, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jermann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span> </span><span class="NLM_article-title">Radiometal-Labelled Macrocyclic Chelator-Derivatized Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">1974</span> <span class="NLM_lpage">1981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1002%2F%28SICI%291521-3765%2819990702%295%3A7%3C1974%3A%3AAID-CHEM1974%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK1MXksVansbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=1974-1981&author=A.+Heppelerauthor=S.+Froidevauxauthor=H.+R.+Mackeauthor=E.+Jermannauthor=M.+Beheauthor=P.+Powellauthor=M.+Hennig&title=Radiometal-Labelled+Macrocyclic+Chelator-Derivatized+Somatostatin+Analogue+with+Superb+Tumour-Targeting+Properties+and+Potential+for+Receptor-Mediated+Internal+Radiotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Radiometal-labelled macrocyclic chelator-derivatized somatostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy</span></div><div class="casAuthors">Heppeler, A.; Froidevaux, S.; Macke, H. R.; Jermann, E.; Behe, M.; Powell, P.; Hennig, M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1974-1981</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A monoreactive DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) prochelator (4,7,10-tricarboxymethyl-tert-Bu ester 1,4,7,10-tetraazacyclododecane-1-acetate) was synthesized which is useful in solid-phase and soln.-phase peptide synthesis; it was coupled to the somatostatin analog Tyr3-Lys5(BOC)-octreotide.  Deprotection in one step afforded DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC) in ≈65% yield.  This peptide, modified with a chelator, was complexed with the radiometals 67Ga3+, 111In3+ and 90Y3+ in high yields and with high specific activities.  The three radiopeptides show high stability in human serum and high affinity to the somatostatin receptor: it is four to five times higher for 67Ga-DOTATOC compared to 90Y-DOTATOC and 111In-DOTATOC.  The 67Ga-labeled compd. also shows significantly higher tumor and lower kidney uptake than the two congeners.  67Ga-DOTATOC was compared in patients with the com. available gold std. 111In-DTPA0-D-Phe1-octreotide.  The new compd. delineates SRIF-receptor pos. tumors very favorably and shows distinctly lower uptake by the kidneys.  Evidently, the differences in the coordination chem. of the metals causes the differences in the biol. behavior.  Indeed, a crystallog. study of the Ga3+ and Y3+ complexes of the model peptide DOTA-D-PheNH2 showed differences in the geometry of the complexes.  The gallium complex is hexacoordinated with pseudooctahedral cis geometry and a folded macrocyclic unit.  The equatorial plane is formed by two transannular nitrogens of the cyclen ring and two oxygens of the corresponding carboxylate groups.  The two axial positions are formed by the two remaining ring nitrogen atoms.  The amide carboxy oxygen is not bound to the metal and one carboxylate group is free and most likely contributes to the favorable handling of the radiopeptide by the kidneys.  In contrast, the structure of Y-DOTA-D-PheNH2 has eight-fold coordination, and includes the amide carboxy oxygen.  The geometry is a compact and somewhat distorted square-antiprism with two almost perfect planes (N4 and O4) with a max. deviation of 0.025 A.  The dihedral angle between the two planes is only 0.36°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0Gfh5NWZ6srVg90H21EOLACvtfcHk0ljKA1d4YzBXrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVansbY%253D&md5=e8a573706ebe12220bda357f172eecf2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3765%2819990702%295%3A7%3C1974%3A%3AAID-CHEM1974%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3765%252819990702%25295%253A7%253C1974%253A%253AAID-CHEM1974%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DHeppeler%26aufirst%3DA.%26aulast%3DFroidevaux%26aufirst%3DS.%26aulast%3DMacke%26aufirst%3DH.%2BR.%26aulast%3DJermann%26aufirst%3DE.%26aulast%3DBehe%26aufirst%3DM.%26aulast%3DPowell%26aufirst%3DP.%26aulast%3DHennig%26aufirst%3DM.%26atitle%3DRadiometal-Labelled%2520Macrocyclic%2520Chelator-Derivatized%2520Somatostatin%2520Analogue%2520with%2520Superb%2520Tumour-Targeting%2520Properties%2520and%2520Potential%2520for%2520Receptor-Mediated%2520Internal%2520Radiotherapy%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D1999%26volume%3D5%26spage%3D1974%26epage%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laforest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugaj, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Toxicity and Dosimetry of <sup>177</sup>Lu-DOTA-Y3-Octreotate in a Rat Model</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">94</span> <span class="NLM_fpage">873</span> <span class="NLM_lpage">877</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1002%2Fijc.1540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=11745491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFOku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2001&pages=873-877&author=J.+S.+Lewisauthor=M.+Wangauthor=R.+Laforestauthor=F.+Wangauthor=J.+L.+Erionauthor=J.+E.+Bugajauthor=A.+Srinivasanauthor=C.+J.+Anderson&title=Toxicity+and+Dosimetry+of+177Lu-DOTA-Y3-Octreotate+in+a+Rat+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity and dosimetry of 177Lu-DOTA-Y3-octreotate in a rat model</span></div><div class="casAuthors">Lewis, Jason S.; Wang, Mu; Laforest, Richard; Wang, Fan; Erion, Jack L.; Bugaj, Joseph E.; Srinivasan, Ananth; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">873-877</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Radiolabeled somatostatin analogs have demonstrated effectiveness for targeted radiotherapy of somatostatin receptor-pos. tumors in both tumor-bearing rodent models and humans.  A radionuclide of interest for cancer therapy is reactor-produced 177Lu (t1/2 = 6.64 d; β- [100%]).  The high therapeutic efficacy of the somatostatin analog 177Lu-DOTA-Tyr3-octreotate (DOTA-Y3-TATE, where DOTA is 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) was previously demonstrated in a tumor-bearing rat model.  In the current study, the toxicity and dosimetry of 177Lu-DOTA-Y3-TATE were detd. in both normal and tumor-bearing rats.  Doses of 177Lu-DOTA-Y3-TATE ranging from 0 to 123 mCi/kg were administered to rats and complete blood counts (CBCs) and blood chemistries were analyzed out to 6 wk.  No overt signs of toxicity were obsd. with 177Lu-DOTA-Y3-TATE (i.e., lethargy, wt. loss, scruffy coat or diarrhea) at any of the dose levels.  Blood chemistries and CBCs were normal except for the white blood cell counts, which showed a dose-dependent decrease.  The max. tolerated dose was not reached at 123 mCi/kg.  The biodistribution of 177Lu-DOTA-Y3-TATE was detd. in CA20948 rat pancreatic tumor-bearing rats, and the data were used to est. human absorbed doses to normal tissues.  The dose-limiting organ was detd. to be the pancreas, followed by the adrenal glands.  The absorbed dose to the rat CA20948 tumor was estd. to be 336 rad/mCi (91 mGy/MBq).  These data demonstrate that 177Lu-DOTA-Y3-TATE is an effective targeted radiotherapy agent at levels that show minimal toxicity in this rat model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH6xVavDqdWLVg90H21EOLACvtfcHk0ljKA1d4YzBXrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFOku7s%253D&md5=aa1af3b28431296ee641e4ad7b10c71d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fijc.1540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.1540%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DLaforest%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DBugaj%26aufirst%3DJ.%2BE.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DToxicity%2520and%2520Dosimetry%2520of%2520177Lu-DOTA-Y3-Octreotate%2520in%2520a%2520Rat%2520Model%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2001%26volume%3D94%26spage%3D873%26epage%3D877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kwekkeboom, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooij, P. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konijnenberg, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugaj, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">[<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]Octreotate: Comparison with [<sup>111</sup>In-DTPA<sup>0</sup>]Octreotide in Patients</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">28</span> <span class="NLM_fpage">1319</span> <span class="NLM_lpage">1325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2Fs002590100574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=11585290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmt1Gnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=1319-1325&author=D.+J.+Kwekkeboomauthor=W.+H.+Bakkerauthor=P.+P.+M.+Kooijauthor=M.+W.+Konijnenbergauthor=A.+Srinivasanauthor=J.+L.+Erionauthor=M.+A.+Schmidtauthor=J.+L.+Bugajauthor=M.+de+Jongauthor=E.+P.+Krenning&title=%5B177Lu-DOTA0%2CTyr3%5DOctreotate%3A+Comparison+with+%5B111In-DTPA0%5DOctreotide+in+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients</span></div><div class="casAuthors">Kwekkeboom, Dik J.; Bakker, Willem H.; Kooij, Peter P. M.; Konijnenberg, Mark W.; Srinivasan, Ananth; Erion, Jack L.; Schmidt, Michelle A.; Bugaj, Joe L.; de Jong, Marion; Krenning, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1319-1325</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The somatostatin analog [DOTA0,Tyr3]octreotate has a nine-fold higher affinity for the somatostatin receptor subtype 2 as compared with [DOTA0,Tyr3]octreotide.  Also, labeled with the beta- and gamma-emitting radionuclide lutetium-177, this compd. has been shown to have a very favorable impact on tumor regression and animal survival in a rat model.  Because of these reported advantages over the analogs currently used for somatostatin receptor-mediated radiotherapy, we decided to compare [177Lu-DOTA0,Tyr3]octreotate (177Lu-octreotate) with [111In-DTPA0]octreotide (111In-octreotide) in six patients with somatostatin receptor-pos. tumors.  Plasma radioactivity after 177Lu-octreotate expressed as a percentage of the injected dose was comparable with that after 111In-octreotide.  Urinary excretion of radioactivity was significantly lower than after 111In-octreotide, averaging 64% after 24 h.  The uptake after 24 h, expressed as a percentage of the injected dose of 177Lu-octreotate, was comparable to that after 111In-octreotide for kidneys, spleen and liver, but was three- to fourfold higher for four of five tumors.  The spleen and kidneys received the highest absorbed doses.  The doses to the kidneys were reduced by a mean of 47% after co-infusion of amino acids.  It is concluded that in comparison with the radionuclide-coupled somatostatin analogs that are currently available for somatostatin receptor-mediated radiotherapy, 177Lu-octreotate potentially represents an important improvement.  Higher absorbed doses can be achieved to most tumors, with about equal doses to potentially dose-limiting organs; furthermore, the lower tissue penetration range of 177Lu as compared with 90Y may be esp. important for small tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqCtJdtsKRXLVg90H21EOLACvtfcHk0lgCKVkb_Tp8jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmt1Gnt7w%253D&md5=84c733e92c9c6fec9d28580c54d5fb92</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs002590100574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590100574%26sid%3Dliteratum%253Aachs%26aulast%3DKwekkeboom%26aufirst%3DD.%2BJ.%26aulast%3DBakker%26aufirst%3DW.%2BH.%26aulast%3DKooij%26aufirst%3DP.%2BP.%2BM.%26aulast%3DKonijnenberg%26aufirst%3DM.%2BW.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DSchmidt%26aufirst%3DM.%2BA.%26aulast%3DBugaj%26aufirst%3DJ.%2BL.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3D%255B177Lu-DOTA0%252CTyr3%255DOctreotate%253A%2520Comparison%2520with%2520%255B111In-DTPA0%255DOctreotide%2520in%2520Patients%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D28%26spage%3D1319%26epage%3D1325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehdashti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laforest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D. W.</span><span> </span><span class="NLM_article-title"><sup>64</sup>Cu-TETA-Octreotide as a PET Imaging Agent for Patients with Neuroendocrine Tumors</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">213</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=11216519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlKmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=213-221&author=C.+J.+Andersonauthor=F.+Dehdashtiauthor=P.+D.+Cutlerauthor=S.+W.+Schwarzauthor=R.+Laforestauthor=L.+A.+Bassauthor=J.+S.+Lewisauthor=D.+W.+McCarthy&title=64Cu-TETA-Octreotide+as+a+PET+Imaging+Agent+for+Patients+with+Neuroendocrine+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">64Cu-TETA-octreotide64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors</span></div><div class="casAuthors">Anderson, Carolyn J.; Dehdashti, Farrokh; Cutler, P. Duffy; Schwarz, Sally W.; Laforest, Richard; Bass, Laura A.; Lewis, Jason S.; McCarthy, Deborah W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine, Inc.</span>)
        </div><div class="casAbstract">64Cu (half-life, 12.7 h; β+, 0.653 MeV [17.4%]; β-, 0.579 MeV [39%]) has shown potential as a radioisotope for PET imaging and radiotherapy.  111In-diethylenetriaminepentaacetic acid (DTPA)-D-Phe1-octreotide (OC) was developed for imaging somatostatin-receptor-pos. tumors using conventional scintigraphy.  With the advantages of PET over conventional scintigraphy, an agent for PET imaging of these tumors is desirable.  Here, we show that 64Cu-TETA-OC (where TETA is 1,4,8,11-tetraazacyclotetradecane-N,N1,N11, N111-tetraacetic acid) and PET can be used to detect somatostatin-receptor-pos. tumors in humans.  Eight patients with a history of neuroendocrine tumors (five patients with carcinoid tumors and three patients with islet cell tumors) were imaged by conventional scintigraphy with 111In-DTPA-OC (204-233 MBq [5.5-6.3 mCi]) and by PET imaging with 64Cu-TETA-OC (111 MBq [3 mCi]).  Blood and urine samples were collected for pharmacokinetic anal.  PET images were collected at times ranging from 0 to 36 h after injection, and the absorbed doses to normal organs were detd.  In six of the eight patients, cancerous lesions were visible by both 111In-DTPA-OC SPECT and 64Cu-TETA-OC PET.  In one patient, 111In-DTPA-OC showed mild uptake in a lung lesion that was not detected by 64Cu-TETA-OC PET.  In one patient, no tumors were detected by either agent; however, pathol. follow-up indicated that the patient had no tumors.  In two patients whose tumors were visualized with 111In-DTPA-OC and 64Cu-TETA-OC, 64Cu-TETA-OC and PET showed more lesions than 111In-DTPA-OC.  Pharmacokinetic studies showed that 64Cu-TETA-OC was rapidly cleared from the blood and that 59.2% ± 17.6% of the injected dose was excreted in the urine.  Absorbed dose measurements indicated that the bladder wall was the dose-limiting organ.  The high rate of lesion detection, sensitivity, and favorable dosimetry and pharmacokinetics of 64Cu-TETA-OC indicate that it is a promising radiopharmaceutical for PET imaging of patients with neuroendocrine tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVDhc6eRnTY7Vg90H21EOLACvtfcHk0lgCKVkb_Tp8jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlKmtr0%253D&md5=75bf57acc0dfa41e5da8106de69bdc8d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DDehdashti%26aufirst%3DF.%26aulast%3DCutler%26aufirst%3DP.%2BD.%26aulast%3DSchwarz%26aufirst%3DS.%2BW.%26aulast%3DLaforest%26aufirst%3DR.%26aulast%3DBass%26aufirst%3DL.%2BA.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DMcCarthy%26aufirst%3DD.%2BW.%26atitle%3D64Cu-TETA-Octreotide%2520as%2520a%2520PET%2520Imaging%2520Agent%2520for%2520Patients%2520with%2520Neuroendocrine%2520Tumors%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D42%26spage%3D213%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Comparison of Four <sup>64</sup>Cu-Labeled Somatostatin Analogs in Vitro and in a Tumor-Bearing Rat Model: Evaluation of New Derivatives for Positron Emission Tomography Imaging and Targeted Radiotherapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">1341</span> <span class="NLM_lpage">1347</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980602h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1341-1347&author=J.+S.+Lewisauthor=M.+R.+Lewisauthor=A.+Srinivasanauthor=M.+A.+Schmidtauthor=J.+Wangauthor=C.+J.+Anderson&title=Comparison+of+Four+64Cu-Labeled+Somatostatin+Analogs+in+Vitro+and+in+a+Tumor-Bearing+Rat+Model%3A+Evaluation+of+New+Derivatives+for+Positron+Emission+Tomography+Imaging+and+Targeted+Radiotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm980602h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980602h%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DLewis%26aufirst%3DM.%2BR.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DComparison%2520of%2520Four%252064Cu-Labeled%2520Somatostatin%2520Analogs%2520in%2520Vitro%2520and%2520in%2520a%2520Tumor-Bearing%2520Rat%2520Model%253A%2520Evaluation%2520of%2520New%2520Derivatives%2520for%2520Positron%2520Emission%2520Tomography%2520Imaging%2520and%2520Targeted%2520Radiotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1341%26epage%3D1347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Evaluation of <sup>64</sup>Cu-TETA-Tyr<sup>3</sup>-Octreotate. A New Somatostatin Analog with Improved Target Tissue Uptake</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">26</span> <span class="NLM_fpage">267</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1016%2FS0969-8051%2898%2900105-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=10363797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK1MXisF2rt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1999&pages=267-273&author=J.+S.+Lewisauthor=A.+Srinivasanauthor=M.+A.+Schmidtauthor=C.+J.+Anderson&title=In+Vitro+and+in+Vivo+Evaluation+of+64Cu-TETA-Tyr3-Octreotate.+A+New+Somatostatin+Analog+with+Improved+Target+Tissue+Uptake"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake</span></div><div class="casAuthors">Lewis, Jason S.; Srinivasan, Ananth; Schmidt, Michelle A.; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-273</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Radiolabeled somatostatin analogs have demonstrated potential as cancer therapeutic agents.  Many of these agents are based on the analog octreotide (OC).  Recently it has been shown that substitution of a tyrosine for phenylalanine in the 3-position and changing the C-terminus from an alc. to an acid improves the targeting of somatostatin-rich tissues.  The compd., 1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid-Tyr3-octreotate (TETA-Y3-TATE), was synthesized and radiolabeled with 64Cu.  The receptor binding properties of 64Cu-TETA-Y3-TATE showed an estd. Kd value of 549 pM in somatostatin receptor-pos. CA20948 tissue membrane.  High tumor uptake was obsd. in two animal tumor models.  Tumor uptakes of 2.37% ID/g in CA20948 tumor-bearing rats and 21.60% ID/g in AR42J tumor-bearing SCID mice were obsd. at 1 h, compared with 1.09% ID/g and 11.24% ID/g for 64Cu-TETA-OC.  Higher uptake in other somatostatin-receptor rich tissues was also obsd., compared with 64Cu-TETA-OC.  Positron emission tomog. (PET) imaging with 64Cu-TETA-Y3-TATE in a baboon showed significant uptake in the pituitary and adrenals, and clearance through the kidneys.  64Cu-TETA-Y3-TATE, a new OC analog for binding somatostatin receptors, demonstrated significantly greater uptake in somatostatin-rich tissues in two tumor-bearing animal models, and demonstrated great potential as a radiopharmaceutical for imaging and therapy of somatostatin receptor-pos. tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0iJ5XyoCaybVg90H21EOLACvtfcHk0lh9TEUuUKQc7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisF2rt7c%253D&md5=e98dc9ca775fa7ebce442dc7473c504a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2898%2900105-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252898%252900105-X%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DM.%2BA.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Evaluation%2520of%252064Cu-TETA-Tyr3-Octreotate.%2520A%2520New%2520Somatostatin%2520Analog%2520with%2520Improved%2520Target%2520Tissue%2520Uptake%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1999%26volume%3D26%26spage%3D267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Decristoforo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cholewinski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnemiller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccabona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncayo, R.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-EDDA/HYNIC-TOC: A New <sup>99m</sup>Tc-Labelled Radiopharmaceutical for Imaging Somatostatin Receptor-Positive Tumours: First Clinical Results and Intra-Patient Comparison with <sup>111</sup>In-Labelled Octreotide Derivatives</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">1318</span> <span class="NLM_lpage">1325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2Fs002590000289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=11007513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsFCjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=1318-1325&author=C.+Decristoforoauthor=S.+J.+Matherauthor=W.+Cholewinskiauthor=E.+Donnemillerauthor=G.+Riccabonaauthor=R.+Moncayo&title=99mTc-EDDA%2FHYNIC-TOC%3A+A+New+99mTc-Labelled+Radiopharmaceutical+for+Imaging+Somatostatin+Receptor-Positive+Tumours%3A+First+Clinical+Results+and+Intra-Patient+Comparison+with+111In-Labelled+Octreotide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-EDDA/HYNIC-TOC: A new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: First clinical results and intra-patient comparison with 111In-labelled octreotide derivatives</span></div><div class="casAuthors">Decristoforo, Clemens; Mather, Stephen J.; Cholewinski, Witold; Donnemiller, Eveline; Riccabona, Georg; Moncayo, Roy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1318-1325</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">[111In-diethylene triamine penta-acetic acid-D-Phe1]-octreotide (DTPA-octreotide) scintigraphy has gained widespread acceptance as a diagnostic clin. procedure in oncol. for imaging somatostatin receptor-pos. tumors.  However, indium-111 as a radiolabel has several drawbacks, including limited availability, suboptimal gamma energy and high radiation burden to the patient.  We have recently reported on the preclin. development of 99mTc-EDDA/HYNIC-TOC, a new octreotide deriv. which showed promising results both in vitro and in vivo.  We now report our initial clin. experiences with this new radiopharmaceutical in ten oncol. patients.  The clin. diagnoses were: carcinoid syndrome (n=5), thyroid cancer (n=3), pancreatic cancer (n=1) and pituitary tumor (n=1).  The biodistribution and kinetics of 99mTc-EDDA/HYNIC-TOC were compared with those of 111In-DTPA-octreotide in six cases, and with those of 111In-DOTA-TOC in five cases.  With the new tracer tumors were imaged within 15 min after injection and showed the highest target/non-target ratios 4 h after injection.  Tumor uptake persisted up to 20 h p.i.  The rate of blood clearance was similar to that of 111In-DTPA-octreotide but faster than that of 111In-DOTA-TOC, while urinary excretion was lower compared with the 111In derivs.  Semi-quant. region of interest anal. showed that 99mTc-EDDA/HYNIC-TOC produced higher tumor/organ (target/non-target) ratios than the 111In derivs., esp. in relation to heart and muscle.  Significantly more lesions could be detected in 99mTc images.  We conclude that 99mTc-EDDA/HYNIC-TOC shows better imaging properties for the identification of somatostatin receptor-pos. tumor sites than currently available 111In-labeled octreotide derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgSJNmFLBGZbVg90H21EOLACvtfcHk0lh9TEUuUKQc7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsFCjsrc%253D&md5=4b570259d689b1ca1ed46d8b1947d76a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs002590000289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590000289%26sid%3Dliteratum%253Aachs%26aulast%3DDecristoforo%26aufirst%3DC.%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DCholewinski%26aufirst%3DW.%26aulast%3DDonnemiller%26aufirst%3DE.%26aulast%3DRiccabona%26aufirst%3DG.%26aulast%3DMoncayo%26aufirst%3DR.%26atitle%3D99mTc-EDDA%252FHYNIC-TOC%253A%2520A%2520New%252099mTc-Labelled%2520Radiopharmaceutical%2520for%2520Imaging%2520Somatostatin%2520Receptor-Positive%2520Tumours%253A%2520First%2520Clinical%2520Results%2520and%2520Intra-Patient%2520Comparison%2520with%2520111In-Labelled%2520Octreotide%2520Derivatives%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2000%26volume%3D27%26spage%3D1318%26epage%3D1325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Gabriel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decristoforo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnemiller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulmer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychlinski, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncayo, R.</span><span> </span><span class="NLM_article-title">An Intrapatient Comparison of <sup>99m</sup>Tc-EDDA/HYNIC-TOC with <sup>111</sup>In-DTPA-Octreotide for Diagnosis of Somatostatin Receptor-Expressing Tumors</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">44</span> <span class="NLM_fpage">708</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=12732671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1KisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=708-716&author=M.+Gabrielauthor=C.+Decristoforoauthor=E.+Donnemillerauthor=H.+Ulmerauthor=C.+W.+Rychlinskiauthor=S.+J.+Matherauthor=R.+Moncayo&title=An+Intrapatient+Comparison+of+99mTc-EDDA%2FHYNIC-TOC+with+111In-DTPA-Octreotide+for+Diagnosis+of+Somatostatin+Receptor-Expressing+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors</span></div><div class="casAuthors">Gabriel, Michael; Decristoforo, Clemens; Donnemiller, Eveline; Ulmer, Hanno; Rychlinski, Christine Watfah; Mather, Stephen J.; Moncayo, Roy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">708-716</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">The aim of this study was to compare the imaging abilities of the recently developed somatostatin analog, 99mTc-hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC [99mTc-TOC]), with 111In-diethylenediaminepentaacetic acid-D-Phe1-octreotide (111In-OCT [Octreoscan]) in patients undergoing routine somatostatin receptor (SSTR) scintigraphy.  Methods: Forty-one patients (20 men, 21 women; age range, 29-75 yr; mean age, 56.7 y) with either histol. proven or biol. and clin. suspected endocrine tumors were enrolled in the study.  Four groups were distinguished: (a) patients being evaluated for the detection and localization of neuroendocrine tumors (n = 6), (b) tumor staging (n = 19), (c) patients being investigated to det. the SSTR status of tumor lesions (n = 11), and (d) patient follow-up studies (n = 5).  Each patient received a mean activity of 150 MBq 111In-OCT and 350-400 MBq 99mTc-TOC.  Scintigraphy with 99mTc-TOC was performed 4 h after injection and scintigraphy with 111In-OCT was performed 4 and 24 h after injection.  SPECT studies of areas of interest were performed 4 h after injection for both tracers as well as at 24 h after injection for 111In-OCT.  The time interval between the studies using each tracer ranged from 2 to 22 d (mean interval, 9.3 d).  Results: 111In-OCT and 99mTc-TOC showed an equiv. scan result in 32 patients (78%), 9 cases showed discrepancies (22%), false-neg. results with 111In-OCT were seen in 6 cases (14.6%), whereas 99mTc-TOC was false-pos. in 2 cases (4.9%).  111In-OCT was true-neg. in both cases.  The false-pos. findings of the 99mTc-TOC studies were caused by nonspecific uptake in the bowel.  In 1 case, 99mTc-TOC correctly identified a metastasis in the lumbar spine but both scan results were false-pos. because of an inflammatory process.  In 21 patients with SSTR-expressing tumors, the semiquant. region-of-interest anal. showed that 99mTc-TOC achieved higher tumor-to-normal tissue ratios than 111In-OCT.  Conclusion: This study revealed a higher sensitivity of 99mTc-TOC as compared with 111In-OCT as an imaging agent for the localization of SSTR-expressing tumors.  To avoid false-pos. findings with 99mTc-OCT due to nonspecific tracer accumulation, addnl. scanning at 1-2 h after injection should be done.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovoLnNb1z7qLVg90H21EOLACvtfcHk0lh9TEUuUKQc7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1KisLs%253D&md5=080c44aa68360de5c91926cd0a18048d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGabriel%26aufirst%3DM.%26aulast%3DDecristoforo%26aufirst%3DC.%26aulast%3DDonnemiller%26aufirst%3DE.%26aulast%3DUlmer%26aufirst%3DH.%26aulast%3DRychlinski%26aufirst%3DC.%2BW.%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DMoncayo%26aufirst%3DR.%26atitle%3DAn%2520Intrapatient%2520Comparison%2520of%252099mTc-EDDA%252FHYNIC-TOC%2520with%2520111In-DTPA-Octreotide%2520for%2520Diagnosis%2520of%2520Somatostatin%2520Receptor-Expressing%2520Tumors%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2003%26volume%3D44%26spage%3D708%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. P.</span><span> </span><span class="NLM_article-title">Melanoma-Targeting Properties of <sup>99m</sup>Technetium-Labeled Cyclic α-Melanocyte-Stimulating Hormone Peptide Analogues</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">60</span> <span class="NLM_fpage">5649</span> <span class="NLM_lpage">5658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5649-5658&author=J.+Chenauthor=Z.+Chengauthor=T.+J.+Hoffmanauthor=S.+S.+Jurissonauthor=T.+P.+Quinn&title=Melanoma-Targeting+Properties+of+99mTechnetium-Labeled+Cyclic+%CE%B1-Melanocyte-Stimulating+Hormone+Peptide+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26aulast%3DQuinn%26aufirst%3DT.%2BP.%26atitle%3DMelanoma-Targeting%2520Properties%2520of%252099mTechnetium-Labeled%2520Cyclic%2520%25CE%25B1-Melanocyte-Stimulating%2520Hormone%2520Peptide%2520Analogues%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D5649%26epage%3D5658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Giblin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. P.</span><span> </span><span class="NLM_article-title">Design and Characterization of α-Melanotropin Peptide Analogs Cyclized through Rhenium and Technetium Metal Coordination</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">95</span> <span class="NLM_fpage">12814</span> <span class="NLM_lpage">12818</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1073%2Fpnas.95.22.12814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=9788997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK1cXntFWktr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12814-12818&author=M.+F.+Giblinauthor=N.+Wangauthor=T.+J.+Hoffmanauthor=S.+S.+Jurissonauthor=T.+P.+Quinn&title=Design+and+Characterization+of+%CE%B1-Melanotropin+Peptide+Analogs+Cyclized+through+Rhenium+and+Technetium+Metal+Coordination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design and characterization of α-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination</span></div><div class="casAuthors">Giblin, Michael F.; Wang, Nannan; Hoffman, Timothy J.; Jurisson, Silvia S.; Quinn, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">12814-12818</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">α-MSH analogs, cyclized through site-specific rhenium (Re) and technetium (Tc) metal coordination, were structurally characterized and analyzed for their abilities to bind α-MSH receptors present on melanoma cells and in tumor-bearing mice.  Results from receptor-binding assays conducted with B16 F1 murine melanoma cells indicated that receptor-binding affinity was reduced to approx. 1% of its original levels after Re incorporation into the cyclic Cys4,10,D-Phe7-α-MSH4-13 analog.  Structural anal. of the Re-peptide complex showed that the disulfide bond of the original peptide was replaced by thiolate-metal-thiolate cyclization.  A comparison of the metal-bound and metal-free structures indicated that metal complexation dramatically altered the structure of the receptor-binding core sequence.  Redesign of the metal binding site resulted in a second-generation Re-peptide complex (ReCCMSH) that displayed a receptor-binding affinity of 2.9 nM, 25-fold higher than the initial Re-α-MSH analog.  Characterization of the second-generation Re-peptide complex indicated that the peptide was still cyclized through Re coordination, but the structure of the receptor-binding sequence was no longer constrained.  The corresponding 99mTc- and 188ReCCMSH complexes were synthesized and shown to be stable in phosphate-buffered saline and to challenges from diethylenetriaminepentaacetic acid (DTPA) and free cysteine.  In vivo, the 99mTcCCMSH complex exhibited significant tumor uptake and retention and was effective in imaging melanoma in a murine-tumor model system.  Cyclization of α-MSH analogs via 99mTc and 188Re yields chem. stable and biol. active mols. with potential melanoma-imaging and therapeutic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmHQnbdmpujrVg90H21EOLACvtfcHk0ljf5KMxvkZqfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFWktr4%253D&md5=bb1f73dadd24cfbb744ac5745386c6a9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.22.12814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.22.12814%26sid%3Dliteratum%253Aachs%26aulast%3DGiblin%26aufirst%3DM.%2BF.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26aulast%3DQuinn%26aufirst%3DT.%2BP.%26atitle%3DDesign%2520and%2520Characterization%2520of%2520%25CE%25B1-Melanotropin%2520Peptide%2520Analogs%2520Cyclized%2520through%2520Rhenium%2520and%2520Technetium%2520Metal%2520Coordination%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D12814%26epage%3D12818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. P.</span><span> </span><span class="NLM_article-title">Evaluation of an <sup>111</sup>In-DOTA-Rhenium Cyclized Alpha-MSH Analog: A Novel Cyclic-Peptide Analog with Improved Tumor-Targeting Properties</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">1847</span> <span class="NLM_lpage">1855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1847-1855&author=J.+Chenauthor=Z.+Chengauthor=N.+K.+Owenauthor=T.+J.+Hoffmanauthor=Y.+Miaoauthor=S.+S.+Jurissonauthor=T.+P.+Quinn&title=Evaluation+of+an+111In-DOTA-Rhenium+Cyclized+Alpha-MSH+Analog%3A+A+Novel+Cyclic-Peptide+Analog+with+Improved+Tumor-Targeting+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DOwen%26aufirst%3DN.%2BK.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DMiao%26aufirst%3DY.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26aulast%3DQuinn%26aufirst%3DT.%2BP.%26atitle%3DEvaluation%2520of%2520an%2520111In-DOTA-Rhenium%2520Cyclized%2520Alpha-MSH%2520Analog%253A%2520A%2520Novel%2520Cyclic-Peptide%2520Analog%2520with%2520Improved%2520Tumor-Targeting%2520Properties%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D42%26spage%3D1847%26epage%3D1855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span> </span><span class="NLM_article-title">Radioiodination of Rhenium Cyclized α-Melanocyte-Stimulating Hormone Resulting in Enhanced Radioactivity Localization and Retention in Melanoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">64</span> <span class="NLM_fpage">1411</span> <span class="NLM_lpage">1418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1158%2F0008-5472.CAN-03-0193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=14973076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtleit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1411-1418&author=Z.+Chengauthor=J.+Chenauthor=T.+P.+Quinnauthor=S.+S.+Jurisson&title=Radioiodination+of+Rhenium+Cyclized+%CE%B1-Melanocyte-Stimulating+Hormone+Resulting+in+Enhanced+Radioactivity+Localization+and+Retention+in+Melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Radioiodination of Rhenium Cyclized α-Melanocyte-Stimulating Hormone Resulting in Enhanced Radioactivity Localization and Retention in Melanoma</span></div><div class="casAuthors">Cheng, Zhen; Chen, Jianqing; Quinn, Thomas P.; Jurisson, Silvia S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1411-1418</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Radiohalogenated α-MSH analogs were proposed for melanoma imaging and potential radiotherapy because α-MSH receptors are overexpressed on both mouse and human melanoma cell lines.  However, biodistribution studies in tumor-bearing mice with radiohalogenated α-MSH peptides showed very rapid tumor radioactivity wash out due to lysosomal degrdn. of the radiohalogenated complex after internalization, which decreased the therapeutic efficacy significantly (R. Stein et al., Cancer Res., 55: 3132-3139, 1995; P. K. Garg et al., Bioconjugate Chem., 6: 493-501, 1995.).  The melanoma-targeting metallopeptide ReO[Cys3,4,10,D-Phe7]α-MSH3-13 (ReCCMSH) was shown to possess high tumor uptake and retention properties (J. Chen et al., Cancer Res., 60: 5649-5658, 2000).  Therefore, three peptides, Ac-Lys-ReCCMSH(Arg11), Ac-D-Lys-ReCCMSH(Arg11), and [Nle4,D-Phe7]α-MSH (NDP) (for comparison), labeled with N-succinimidyl 4-[125I]iodobenzoate (125I-PIB), were prepd. and evaluated in vitro and in vivo to develop radiohalogenated α-MSH peptide analogs with high tumor uptake, retention, and favorable biodistribution characteristics.  In vitro cell binding and internalization data showed that approx. 90% of radioiodinated peptides were internalized at 2 h in cultured B16/F1 melanoma cells.  Cellular retention studies showed that the receptor-bound radioiodinated linear α-MSH analog NDP was released from the cells into the medium very quickly, whereas significant amts. of cell-assocd. radioactivity remained in the cells for Ac-Lys(125I-3- or 4-iodobenzoate (IBA))-ReCCMSH(Arg11) and Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11).  The in vitro data clearly demonstrate that rhenium cyclization significantly enhanced peptide trapping in the cells, as did D-amino acid incorporation.  The combination of these two effects resulted in a 2.9-fold increase in the retention of radioactivity for Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11) relative to 125I-IBA-NDP at 4 h.  In vivo studies also showed that Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11) exhibited extremely high radioactivity accumulation and prolonged retention in the tumor.  Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11) and Ac-Lys(125I-IBA)-ReCCMSH(Arg11) exhibited much higher tumor uptake at 24 h after injection compared with 125I-IBA-NDP [7.18% injected dose/g (ID/g), 4.92% ID/g, and 0.26% ID/g, resp.].  Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11) also showed very fast whole body clearance and low nonspecific radioactivity accumulation in normal tissues compared with 125I-IBA-NDP and Ac-Lys(125I-IBA)-ReCCMSH(Arg11).  A tumor:blood ratio of 34.3 was obsd. for Ac-D-Lys(125I-IBA)-ReCCMSH(Arg11) at 24 h postinjection, whereas values of 4.3 and 2.0 were obsd. for Ac-Lys(125I-IBA)-ReCCMSH(Arg11) and 125I-IBA-NDP, resp.  The biodistribution data clearly demonstrate that both rhenium cyclization and D-Lys incorporation enhanced the tumor localization and retention of the radiolabel.  Therefore Ac-D-Lys-ReCCMSH(Arg11) is an excellent candidate for addnl. therapeutic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKPA9wRGdQQLVg90H21EOLACvtfcHk0ljf5KMxvkZqfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtleit78%253D&md5=572a664d2bb664397b70a69969524cc7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-0193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-0193%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DQuinn%26aufirst%3DT.%2BP.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26atitle%3DRadioiodination%2520of%2520Rhenium%2520Cyclized%2520%25CE%25B1-Melanocyte-Stimulating%2520Hormone%2520Resulting%2520in%2520Enhanced%2520Radioactivity%2520Localization%2520and%2520Retention%2520in%2520Melanoma%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1411%26epage%3D1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Zamora, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulhke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diekmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biersack, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, F. F.</span><span> </span><span class="NLM_article-title">Jr. Experimental Radiotherapy of Receptor-Positive Human Prostate Adenocarcinoma with <sup>188</sup>Re-RC-160, a Directly-Radiolabeled Somatostatin Analog</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">65</span> <span class="NLM_fpage">214</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1002%2F%28SICI%291097-0215%2819960117%2965%3A2%3C214%3A%3AAID-IJC15%3E3.0.CO%3B2-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=8567120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK28Xhtlyktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1996&pages=214-220&author=P.+O.+Zamoraauthor=S.+Gulhkeauthor=H.+Benderauthor=D.+Diekmannauthor=B.+A.+Rhodesauthor=H.-J.+Biersackauthor=F.+F.+Knapp&title=Jr.+Experimental+Radiotherapy+of+Receptor-Positive+Human+Prostate+Adenocarcinoma+with+188Re-RC-160%2C+a+Directly-Radiolabeled+Somatostatin+Analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental radiotherapy of receptor-positive human prostate adenocarcinoma with 188Re-RC-160, a directly-radiolabeled somatostatin analog</span></div><div class="casAuthors">Zamora, Paul O.; Gulhke, Stefan; Bender, Hans; Diekmann, Daniella; Rhodes, Buck A.; Biersack, Hans-Jurgen; Knapp, F. F. (Russ) Jr.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">214-20</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">The therapeutic potential of the somatostatin analog RC-160 radiolabeled with 188Re was evaluated in nude mice bearing xenografts of human prostate adenocarcinoma.  188Re-RC-160 was selectively retained in both DU-145 and PC-3 tumors following direct intratumor injection at all time points examd. (2, 6 and 24 h postinjection).  Unbound 188Re-RC-160 was rapidly excreted via the hepatobiliary system and, with the exception of the gastrointestinal tract, very little normal organ uptake was found at any time point examd.  Neg. control compds., 188Re-perrhenate and 188Re-mercaptoacetyltriglycine (188Re-MAG3), were essentially washed out of the tumor by 6 h postinjection and were rapidly excreted through the kidneys.  131I-RC-160, used as a ref. compd., had a biodistribution in tumor-bearing animals similar to that of 188Re-RC-160.  In PC-3 xenografts, 188Re-RC-160 gave a dose-dependent therapeutic response (stasis or regression) even in animals with relatively large tumor masses (greater than 600 mm3), whereas the macroaggregated form of 188Re-RC-160 did not.  Long-term studies with 188Re-RC-160 demonstrated a protracted redn. of tumor vol. and a pos. effect on animal survival.  Neither RC-160 by itself nor a 188Re-labeled peptide, unrelated to somatostatin (PA-22-2, a laminin peptide), demonstrated the redn. in tumor mass obsd. with 188Re-RC-160.  188Re-RC-160 shows potential as a new clin. agent for treatment of somatostatin-receptor-pos. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqcUBvIY1Bh7Vg90H21EOLACvtfcHk0ljf5KMxvkZqfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhtlyktro%253D&md5=69527f8991241a47b7988b9bbd4a0ba6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819960117%2965%3A2%3C214%3A%3AAID-IJC15%3E3.0.CO%3B2-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819960117%252965%253A2%253C214%253A%253AAID-IJC15%253E3.0.CO%253B2-D%26sid%3Dliteratum%253Aachs%26aulast%3DZamora%26aufirst%3DP.%2BO.%26aulast%3DGulhke%26aufirst%3DS.%26aulast%3DBender%26aufirst%3DH.%26aulast%3DDiekmann%26aufirst%3DD.%26aulast%3DRhodes%26aufirst%3DB.%2BA.%26aulast%3DBiersack%26aufirst%3DH.-J.%26aulast%3DKnapp%26aufirst%3DF.%2BF.%26atitle%3DJr.%2520Experimental%2520Radiotherapy%2520of%2520Receptor-Positive%2520Human%2520Prostate%2520Adenocarcinoma%2520with%2520188Re-RC-160%252C%2520a%2520Directly-Radiolabeled%2520Somatostatin%2520Analog%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1996%26volume%3D65%26spage%3D214%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zamora, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, F. F.</span><span> </span><span class="NLM_article-title">Jr.; Biersack, H. J. Radiotherapy of Intrathoracic Carcinoma Xenografts with <sup>188</sup>Re-RC-160, a Somatostatin Analog</span> <span class="citation_source-journal">Tumor Targeting</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">49</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK28XjvVSnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=49-59&author=P.+O.+Zamoraauthor=H.+Benderauthor=F.+F.+Knapp&title=Jr.%3B+Biersack%2C+H.+J.+Radiotherapy+of+Intrathoracic+Carcinoma+Xenografts+with+188Re-RC-160%2C+a+Somatostatin+Analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Radiotherapy of intrathoracic carcinoma xenografts with 188Re-RC-160, a somatostatin analog</span></div><div class="casAuthors">Zamora, P. O.; Bender, H.; Knapp, F. F., Jr.; Biersack, H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Targeting</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-59</span>CODEN:
                <span class="NLM_cas:coden">TUTAF9</span>;
        ISSN:<span class="NLM_cas:issn">1351-8488</span>.
    
            (<span class="NLM_cas:orgname">Chapman & Hall</span>)
        </div><div class="casAbstract">Rhenium 188-RC-160 (188Re-RC-160) is a radiolabeled somatostatin analog under evaluation for internal, targeted radiation therapy of somatostatin-receptor-pos. cancers.  In this study, regionally delivered 188Re-RC-160 (administered into the thoracic cavity) was evaluated in exptl. models of metastasis to the pleural cavity.  Cells known to express somatostatin receptors - NCI-H69 (human small cell lung carcinoma); and ZR-75-1 (human breast carcinoma) - were inoculated into the thoracic cavity of athymic mice and rats, and tumors allowed to develop.  Raji cells (human Burkitt's lymphoma), pre-detd. in vitro not to bind RC-160, were used as neg. control cells.  Inoculated animals were left untreated or treated with either unlabeled RC-160 or 188Re-RC-160.  In untreated animals inoculated with NCI-H69 or ZR-75-1, tumors developed in 100% of the animals; animals treated with unlabeled RC-160 had similar tumor burdens.  On the other hand, animals bearing somatostatin-pos. tumors (NCI-H69 and ZR-75-1) and treated with 188Re-RC-160 had a marked redn. in tumor burden.  188Re-RC-160 did not substantially alter the development of Raji tumors (neg. for RC-160 binding) compared with untreated controls.  Biodistribution and scintigraphy studies of tumor-bearing animals support the hypothesis of the specific targeting of 188Re-RC-160 to somatostatin-receptor-pos. tumors.  The results indicated that 188Re-RC-160 restricted the growth of NCI-H69 and ZR-75-1 tumors in the thoracic cavity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHBKr3upVZVLVg90H21EOLACvtfcHk0lhxviwpn6hgxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVSnt7c%253D&md5=d2d7c8f9433dbcd7271a17746195f4d6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZamora%26aufirst%3DP.%2BO.%26aulast%3DBender%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DF.%2BF.%26atitle%3DJr.%253B%2520Biersack%252C%2520H.%2520J.%2520Radiotherapy%2520of%2520Intrathoracic%2520Carcinoma%2520Xenografts%2520with%2520188Re-RC-160%252C%2520a%2520Somatostatin%2520Analog%26jtitle%3DTumor%2520Targeting%26date%3D1996%26volume%3D2%26spage%3D49%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hosono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosono, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamora, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guhlke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, F. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biersack, H. J.</span><span> </span><span class="NLM_article-title">Localization of Small-Cell Lung Cancer Xenografts with Iodine-125-, Indium-111-, and Rhenium-188-Somatostatin Analogs</span> <span class="citation_source-journal">Jpn. J. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">87</span> <span class="NLM_fpage">995</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=8878464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK28XlslCqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=995-1000&author=M.+Hosonoauthor=M.+N.+Hosonoauthor=T.+Haberbergerauthor=P.+O.+Zamoraauthor=S.+Guhlkeauthor=H.+Benderauthor=F.+F.+R.+Knappauthor=H.+J.+Biersack&title=Localization+of+Small-Cell+Lung+Cancer+Xenografts+with+Iodine-125-%2C+Indium-111-%2C+and+Rhenium-188-Somatostatin+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of small-cell lung cancer xenografts with iodine-125-, indium-111-, and rhenium-188-somatostatin analogs</span></div><div class="casAuthors">Hosono, Makoto; Hosono, Masako N.; Haberberger, Thomas; Zamora, Paul O.; Guhlke, Stefan; Bender, Hans; Knapp, F. F. Russ; Biersack, Hans J.</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Cancer Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">995-1000</span>CODEN:
                <span class="NLM_cas:coden">JJCREP</span>;
        ISSN:<span class="NLM_cas:issn">0910-5050</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">We examd. the potential of radiolabeled somatostatin analogs, 125I-Tyr-3-octreotide (125I-octreotide), 111In-DTPA-D-Phe-1-octreotide (111In-octreotide), and 188Re-octreotide for targeting small-cell lung cancer (SCLC) in a mouse model.  Tyr-3-octreotide was labeled with 125I by the chloramine T method, and 111In-octreotide was obtained as a kit, while 188Re was eluted from a 188W/188Re generator, and octreotide was directly labeled with 188Re by reducing disulfide bonds.  The 125I-, 111In-, and 188Re-octreotides were injected i.v. into athymic mice bearing NCI-H69 tumors, and the biodistributions were detd. at 15 min, and 2, 4, 8, and 24 h.  Tumor uptakes were 0.5 ± 0.2, 0.3 ± 0.1, 0.3 ± 0.1 %ID/g, and tumor-to-blood ratios were 1.8, 11.9, 1.2 at 8 h for 125I-, 111In-, and 188Re-octreotides, resp.  Accumulations of 111In-octreotide in normal tissues were lower than those of 125I- and 188Re-octreotides.  188Re-octreotide can be used to localize SCLC lesions as efficiently as radioiodinated octreotide.  However, 111In-octreotide was the most suitable agent to obtain high tumor-to-normal tissue contrast for localizing SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrStDfX-HDsPLVg90H21EOLACvtfcHk0lhxviwpn6hgxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlslCqsLg%253D&md5=c02af2ef26b4d51700bcc376b95e3e49</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DHosono%26aufirst%3DM.%2BN.%26aulast%3DHaberberger%26aufirst%3DT.%26aulast%3DZamora%26aufirst%3DP.%2BO.%26aulast%3DGuhlke%26aufirst%3DS.%26aulast%3DBender%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DF.%2BF.%2BR.%26aulast%3DBiersack%26aufirst%3DH.%2BJ.%26atitle%3DLocalization%2520of%2520Small-Cell%2520Lung%2520Cancer%2520Xenografts%2520with%2520Iodine-125-%252C%2520Indium-111-%252C%2520and%2520Rhenium-188-Somatostatin%2520Analogs%26jtitle%3DJpn.%2520J.%2520Cancer%2520Res.%26date%3D1996%26volume%3D87%26spage%3D995%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Haberberger, T.; Zamora, P.; Hosono, M.; Hosono, M. N.; Bender, H.; Guhlke, S.; Knapp, F. F.; Biersack, H. J.</span><span> </span><span class="NLM_article-title">Initial Studies on <sup>99m</sup>Tc- and <sup>188</sup>Re-Somatostatin Analogues: Stannous-Mediated Direct-Labelling and Biodistribution in Normal Mice.</span> In  <span class="citation_source-book">Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine</span>; <span class="NLM_contrib-group">Nicolini, M.; Mazzi, U.</span>, Eds.; <span class="NLM_publisher-name">SGE Editoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>. <span class="NLM_year">1995</span>;  <span class="NLM_volume">Vol. 4</span>,  <span class="NLM_fpage">367</span>− <span class="NLM_lpage">372</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=367-372&author=T.+Haberberger&author=P.+Zamora&author=M.+Hosono&author=M.+N.+Hosono&author=H.+Bender&author=S.+Guhlke&author=F.+F.+Knapp&author=H.+J.+Biersackauthor=M.+Nicolini&author=U.+Mazzi&title=Technetium%2C+Rhenium+and+Other+Metals+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHaberberger%26aufirst%3DT.%26atitle%3DInitial%2520Studies%2520on%252099mTc-%2520and%2520188Re-Somatostatin%2520Analogues%253A%2520Stannous-Mediated%2520Direct-Labelling%2520and%2520Biodistribution%2520in%2520Normal%2520Mice.%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Metals%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26aulast%3DNicolini%26aufirst%3DM.%26pub%3DSGE%2520Editoriali%26date%3D1995%26volume%3DVol.%25204%26spage%3D367%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schar, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heppeler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macke, H. R.</span><span> </span><span class="NLM_article-title">Affinity Profiles for Human Somatostatin Receptor Subtypes SST1-SST5 of Somatostatin Radiotracers Selected for Scintigraphic and Radiotherapeutic Use</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">273</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2Fs002590050034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=10774879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVWns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=273-282&author=J.+C.+Reubiauthor=J.-C.+Scharauthor=B.+Waserauthor=S.+Wengerauthor=A.+Heppelerauthor=J.+S.+Schmittauthor=H.+R.+Macke&title=Affinity+Profiles+for+Human+Somatostatin+Receptor+Subtypes+SST1-SST5+of+Somatostatin+Radiotracers+Selected+for+Scintigraphic+and+Radiotherapeutic+Use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use</span></div><div class="casAuthors">Reubi, Jean Claude; Schar, Jean-Claude; Waser, Beatrice; Wenger, Sandra; Heppeler, Axel; Schmitt, Jorg S.; Macke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-282</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">In vivo somatostatin receptor scintigraphy using Octreoscan is a valuable method for the visualization of human endocrine tumors and their metastases.  Recently, several new, alternative somatostatin radioligands have been synthesized for diagnostic and radiotherapeutic use in vivo.  Since human tumors are known to express various somatostatin receptor subtypes, it is mandatory to assess the receptor subtype affinity profile of such somatostatin radiotracers.  Using cell lines transfected with somatostatin receptor subtypes sst1, sst2, sst3, sst4 and sst5, we have evaluated the in vitro binding characteristics of labeled (indium, yttrium, gallium) and unlabeled DOTA-[Tyr3]-octreotide, DOTA-octreotide, DOTA-lanreotide, DOTA-vapreotide, DTPA-[Tyr3]-octreotate and DOTA-[Tyr3]-octreotate.  Small structural modifications, chelator substitution or metal replacement were shown to considerably affect the binding affinity.  A marked improvement of sst2 affinity was found for Ga-DOTA-[Tyr3]-octreotide (IC50 2.5 nM) compared with the Y-labeled compd. and Octreoscan.  An excellent binding affinity for sst2 in the same range was also found for In-DTPA-[Tyr3]-octreotate (IC50 1.3 nM) and for Y-DOTA-[Tyr3]-octreotate (IC50 1.6 nM).  Remarkably, Ga-DOTA-[Tyr3]-octreotate bound at sst2 with a considerably higher affinity (IC50 0.2 nM).  An up to 30-fold improvement in sst3 affinity was obsd. for unlabeled or Y-labeled DOTA-octreotide compared with their Tyr3-contg. analog, suggesting that replacement of Tyr3 by Phe is crucial for high sst3 affinity.  Substitution in the octreotide mol. of the DTPA by DOTA improved the sst3 binding affinity 14-fold.  Whereas Y-DOTA-lanreotide had only low affinity for sst3 and sst4, it had the highest affinity for sst5 among the tested compds. (IC50 16 nM).  Increased binding affinity for sst3 and sst5 was obsd. for DOTA-[Tyr3]-octreotide, DOTA-lanreotide and DOTA-vapreotide when they were labeled with yttrium.  These marked changes in subtype affinity profiles are due not only to the different chem. structures but also to the different charges and hydrophilicity of these compds.  Interestingly, even the coordination geometry of the radiometal complex remote from the pharmacophoric amino acids has a significant influence on affinity profiles as shown with Y-DOTA vs. Ga-DOTA in either [Tyr3]-octreotide or [Tyr3]-octreotate.  Such changes in sst affinity profiles must be identified in newly designed radiotracers used for somatostatin receptor scintigraphy in order to correctly interpret in vivo scintigraphic data.  These observations may represent basic principles relevant to the development of other peptide radioligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRKqYdWT35ELVg90H21EOLACvtfcHk0liuceyAHAj2Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVWns7w%253D&md5=3f9cd3963bcc09b71c4c6d38a2487b14</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs002590050034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590050034%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DSchar%26aufirst%3DJ.-C.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DWenger%26aufirst%3DS.%26aulast%3DHeppeler%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%2BS.%26aulast%3DMacke%26aufirst%3DH.%2BR.%26atitle%3DAffinity%2520Profiles%2520for%2520Human%2520Somatostatin%2520Receptor%2520Subtypes%2520SST1-SST5%2520of%2520Somatostatin%2520Radiotracers%2520Selected%2520for%2520Scintigraphic%2520and%2520Radiotherapeutic%2520Use%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2000%26volume%3D27%26spage%3D273%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Bigott, H. M.; Dannoon, S. F.; Figueroa, S. D.; Hoffman, T. J.; Jurisson, S. S.; Lewis, M. R.</span><span> </span><span class="NLM_article-title">Biodistribution and Imaging Studies of Somatostatin Receptors Using Technetium-99m-Cyclized Tyrosine-3-Octreotate</span>. In  <span class="citation_source-book">Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine</span>, <span class="NLM_contrib-group">Mazzi, U.</span>, Ed.; <span class="NLM_publisher-name">SGE Editoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>, <span class="NLM_year">2006</span>; Vol.  <span class="NLM_volume">7</span>, pp  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">300.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=295-300.&author=H.+M.+Bigott&author=S.+F.+Dannoon&author=S.+D.+Figueroa&author=T.+J.+Hoffman&author=S.+S.+Jurisson&author=M.+R.+Lewisauthor=U.+Mazzi&title=Technetium%2C+Rhenium+and+Other+Metals+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBigott%26aufirst%3DH.%2BM.%26atitle%3DBiodistribution%2520and%2520Imaging%2520Studies%2520of%2520Somatostatin%2520Receptors%2520Using%2520Technetium-99m-Cyclized%2520Tyrosine-3-Octreotate%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Metals%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26aulast%3DMazzi%26aufirst%3DU.%26pub%3DSGE%2520Editoriali%26date%3D2006%26volume%3D7%26spage%3D295%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Giblin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. P.</span><span> </span><span class="NLM_article-title">Synthesis and Characterization of Rhenium-Complexed α-Melanotropin Analogs</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">8</span> <span class="NLM_fpage">347</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9700291" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK2sXivF2hu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=347-353&author=M.+F.+Giblinauthor=S.+S.+Jurissonauthor=T.+P.+Quinn&title=Synthesis+and+Characterization+of+Rhenium-Complexed+%CE%B1-Melanotropin+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of Rhenium-Complexed α-Melanotropin Analogs</span></div><div class="casAuthors">Giblin, Michael F.; Jurisson, Silvia S.; Quinn, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-353</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Receptor binding peptides labeled with medically important radionuclides such as technetium and rhenium are an important tool for the imaging and treatment of many forms of cancer.  This paper describes a method of labeling peptides with rhenium using a natural amino acid chelating moiety.  The structural characteristics of this chelate moiety, N-acetyl-cysteine-glycine-cysteine-glycine (NAc-CGCG) complexed with nonradioactive rhenium, have been investigated.  The stability of this peptide-metal complex has been evaluated on the tracer level using radioactive rhenium-186.  The rhenium-bound peptide has been appended to the N termini of receptor binding α-MSH (NAc-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2) fragments via solid phase peptide synthesis.  Bioassays and receptor binding studies of the resulting complexes demonstrate that the fragments retained biol. activity and exhibited receptor binding consts. ranging from 0.3 to 1.1 nM.  This method could provide a general means of labeling bioactive peptide fragments that would simplify product purifn. and characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7W1ECQjXyq7Vg90H21EOLACvtfcHk0liuceyAHAj2Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivF2hu7g%253D&md5=fad47f23df50264a32368e545d4616c2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbc9700291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9700291%26sid%3Dliteratum%253Aachs%26aulast%3DGiblin%26aufirst%3DM.%2BF.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26aulast%3DQuinn%26aufirst%3DT.%2BP.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520Rhenium-Complexed%2520%25CE%25B1-Melanotropin%2520Analogs%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D347%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Grove, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, G.</span><span> </span><span class="NLM_article-title">Oxo-Complexes of Rhenium(V)</span> <span class="citation_source-journal">J. Chem. Soc., A, Inorg. Phys. Theoret.</span><span class="NLM_year" style="font-weight: bold;">1966</span> <span class="NLM_volume">1224</span> <span class="NLM_fpage">1230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1224&publication_year=1966&pages=1230&author=D.+E.+Groveauthor=G.+Wilkinson&title=Oxo-Complexes+of+Rhenium%28V%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrove%26aufirst%3DD.%2BE.%26aulast%3DWilkinson%26aufirst%3DG.%26atitle%3DOxo-Complexes%2520of%2520Rhenium%2528V%2529%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520A%252C%2520Inorg.%2520Phys.%2520Theoret.%26date%3D1966%26volume%3D1224%26spage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Delaglio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzesiek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuister, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeifer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, A.</span><span> </span><span class="NLM_article-title">NMRPipe: A Multidimensional Spectral Processing System Based on UNIX Pipes</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">277</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2FBF00197809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=8520220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVSmurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=277-293&author=F.+Delaglioauthor=S.+Grzesiekauthor=G.+W.+Vuisterauthor=G.+Zhuauthor=J.+Pfeiferauthor=A.+Bax&title=NMRPipe%3A+A+Multidimensional+Spectral+Processing+System+Based+on+UNIX+Pipes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">NMRPipe: a multidimensional spectral processing system based on UNIX pipes</span></div><div class="casAuthors">Delaglio, Frank; Grzesiek, Stephan; Vuister, Geerten W.; Zhu, Guang; Pfeifer, John; Bax, Ad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-93</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">ESCOM</span>)
        </div><div class="casAbstract">The NMRPipe system is a UNIX software environment of processing, graphics, and anal. tools designed to meet current routine and research-oriented multidimensional processing requirements, and to anticipate and accommodate future demands and developments.  The system is based on UNIX pipes, which allow programs running simultaneously to exchange streams of data under user control.  In an NMRPipe processing scheme, a stream of spectral data flows through a pipeline of processing programs, each of which performs one component of the overall scheme, such as Fourier transformation or linear prediction.  Complete multidimensional processing schemes are constructed as simple UNIX shell scripts.  The processing modules themselves maintain and exploit accurate records of data sizes, detection modes, and calibration information in all dimensions, so that schemes can be constructed without the need to explicitly define or anticipate data sizes or storage details of real and imaginary channels during processing.  The asynchronous pipeline scheme provides other substantial advantages, including high flexibility, favorable processing speeds, choice of both all-in-memory and disk-bound processing, easy adaptation to different data formats, simpler software development and maintenance, and the ability to distribute processing tasks on multi-CPU computers and computer networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSIUdXrdcEgbVg90H21EOLACvtfcHk0liuceyAHAj2Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVSmurfK&md5=a670fca5b164083e2178fafd2fb951ff</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2FBF00197809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00197809%26sid%3Dliteratum%253Aachs%26aulast%3DDelaglio%26aufirst%3DF.%26aulast%3DGrzesiek%26aufirst%3DS.%26aulast%3DVuister%26aufirst%3DG.%2BW.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DPfeifer%26aufirst%3DJ.%26aulast%3DBax%26aufirst%3DA.%26atitle%3DNMRPipe%253A%2520A%2520Multidimensional%2520Spectral%2520Processing%2520System%2520Based%2520on%2520UNIX%2520Pipes%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1995%26volume%3D6%26spage%3D277%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wishart, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigam, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abildgaard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyson, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, B. D.</span><span> </span><span class="NLM_article-title"><sup>1</sup>H, <sup>13</sup>C and <sup>15</sup>N Chemical Shift Referencing in Biomolecular NMR</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">135</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2FBF00211777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=8589602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADyaK2MXoslWmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=135-140&author=D.+S.+Wishartauthor=C.+G.+Bigamauthor=J.+Yaoauthor=F.+Abildgaardauthor=H.+J.+Dysonauthor=E.+Oldfieldauthor=J.+L.+Markleyauthor=B.+D.+Sykes&title=1H%2C+13C+and+15N+Chemical+Shift+Referencing+in+Biomolecular+NMR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">1H, 13C and 15N chemical shift referencing in biomolecular NMR</span></div><div class="casAuthors">Wishart, David S.; Bigam, Colin G.; Yao, Jian; Abildgaard, Frits; Dyson, H. Jane; Oldfield, Eric; Markley, John L.; Sykes, Brian D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-40</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">ESCOM</span>)
        </div><div class="casAbstract">A considerable degree of variability exists in the way that 1H, 13C and 15N chem. shifts are reported and referenced for biomols.  In this article we explore some of the reasons for this situation and propose guidelines for future chem. shift referencing and for conversion from many common 1H, 13C and 15N chem. shift stds., now used in biomol. NMR, to those proposed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFRqdN7SPVg7Vg90H21EOLACvtfcHk0lj4UUA9zxAqUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslWmtLk%253D&md5=536db79e0759864bf3ddb9961d985ba4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2FBF00211777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00211777%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DD.%2BS.%26aulast%3DBigam%26aufirst%3DC.%2BG.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DAbildgaard%26aufirst%3DF.%26aulast%3DDyson%26aufirst%3DH.%2BJ.%26aulast%3DOldfield%26aufirst%3DE.%26aulast%3DMarkley%26aufirst%3DJ.%2BL.%26aulast%3DSykes%26aufirst%3DB.%2BD.%26atitle%3D1H%252C%252013C%2520and%252015N%2520Chemical%2520Shift%2520Referencing%2520in%2520Biomolecular%2520NMR%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1995%26volume%3D6%26spage%3D135%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Breeman, W. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Optimizing Conditions for Radiolabeling of DOTA-Peptides with <sup>90</sup>Y, <sup>111</sup>In and <sup>177</sup>Lu at High Specific Activities</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">30</span> <span class="NLM_fpage">917</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm701056x&amp;key=10.1007%2Fs00259-003-1142-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm701056x&amp;key=12677301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvF2lsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=917-920&author=W.+A.+P.+Breemanauthor=M.+de+Jongauthor=T.+J.+Visserauthor=J.+L.+Erionauthor=E.+P.+Krenning&title=Optimizing+Conditions+for+Radiolabeling+of+DOTA-Peptides+with+90Y%2C+111In+and+177Lu+at+High+Specific+Activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing conditions for radiolabeling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities</span></div><div class="casAuthors">Breeman, Wouter A. P.; de Jong, Marion; Visser, Theo J.; Erion, Jack L.; Krenning, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">917-920</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">DOTA-conjugated peptides, such as [DOTA0,Tyr3]octreotide (DOTATOC) and [DOTA0,Tyr3]octreotate (DOTA-tate), can be labeled with radionuclides such as 90Y, 111In and 177Lu.  These radiolabeled somatostatin analogs are used for peptide receptor radionuclide therapy (PRRT).  Radioligands for PRRT require high specific activities.  However, although these radionuclides are produced without addn. of carrier, contaminants are introduced during prodn. and as decay products.  In this study, parameters influencing the kinetics of labeling of DOTA-peptides were investigated and conditions were optimized to obtain the highest achievable specific activity.  The effects of contaminants were systematically investigated, concn. dependently, in a test model mimicking conditions for labeling with minimal molar excess of DOTA-peptides over radionuclide.  Kinetics of labeling of DOTA-peptides were optimal at pH 4-4.5; pH <4 strongly slowed down the kinetics.  Above pH 5, reaction kinetics varied owing to the formation of radionuclide hydroxides.  Labeling with 90Y and 177Lu was completed after 20 min at 80°C, while labeling with 111In was completed after 30 min at 100°C.  The effects of contaminants were systematically categorized, e.g., Cd2+ is the target and decay product of 111In and it was found to be a strong competitor with 111In for incorporation in DOTA.  In contrast, Zr4+ and Hf4+, decay products of 90Y and 177Lu, resp., did not interfere with the incorporation of these radionuclides.  The following conclusions are drawn: (a) DOTA-peptides can be radiolabeled at high specific activity, (b) reaction kinetics differ for each radionuclide, and (c) reactions can be hampered by contaminants, such as target material and decay products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppyPxAqfM4yLVg90H21EOLACvtfcHk0lj4UUA9zxAqUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvF2lsb4%253D&md5=24bd1047a2ded6a7710b48608776551c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00259-003-1142-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-003-1142-0%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DOptimizing%2520Conditions%2520for%2520Radiolabeling%2520of%2520DOTA-Peptides%2520with%252090Y%252C%2520111In%2520and%2520177Lu%2520at%2520High%2520Specific%2520Activities%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2003%26volume%3D30%26spage%3D917%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Smith, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gali, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sieckman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higginbotham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkert, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Radiochemical Investigations of <sup>99m</sup>Tc-N<sub>3</sub>S-X-BBN[7–14]NH<sub>2</sub>: An in Vitro/in Vivo Structure-Activity Relationship Study Where <i>X</i> = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">93</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc020034r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm701056x&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFWmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=93-102&author=C.+J.+Smithauthor=H.+Galiauthor=G.+L.+Sieckmanauthor=C.+Higginbothamauthor=W.+A.+Volkertauthor=T.+J.+Hoffman&title=Radiochemical+Investigations+of+99mTc-N3S-X-BBN%5B7%E2%80%9314%5DNH2%3A+An+in+Vitro%2Fin+Vivo+Structure-Activity+Relationship+Study+Where+X+%3D+0-%2C+3-%2C+5-%2C+8-%2C+and+11-Carbon+Tethering+Moieties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Radiochemical Investigations of 99mTc-N3S-X-BBN[7-14]NH2: An in Vitro/in Vivo Structure-Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties</span></div><div class="casAuthors">Smith, C. Jeffrey; Gali, Hariprasad; Sieckman, Gary L.; Higginbotham, Chris; Volkert, Wynn A.; Hoffman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bombesin (BBN), a 14 amino acid peptide, is an analog of human gastrin releasing peptide (GRP) that binds to GRP receptors (GRPr) with high affinity and specificity.  The GRPr is overexpressed on a variety of human cancer cells, including prostate, breast, lung, and pancreatic cancers.  The specific aim of this study was to develop 99mTc-radiolabeled BBN analogs that maintain high specificity for the GRPr in vivo.  A preselected synthetic sequence via solid-phase peptide synthesis (SPPS) was designed to produce N3S-BBN (N3S = dimethylglycyl-L-seryl-L-cysteinylglycinamide) conjugates with the following general structure: DMG-S-C-G-X-Q-W-A-V-G-H-L-M-(NH2), where the spacer group, X = 0 (no spacer), ω-NH2(CH2)2COOH, ω-NH2(CH2)4COOH, ω-NH2(CH2)7COOH, or ω-NH2-(CH2)10COOH.  The new BBN constructs were purified by reversed phase-HPLC (RP-HPLC).  Electrospray mass spectrometry (ES-MS) was used to characterize the nonmetalated BBN conjugates.  Re(V)-BBN conjugates were prepd. by the reaction of Re(V)gluconate with N3S-X-BBN[7-14]NH2 (X = 0 carbons, β-Ala (β-alanine), 5-Ava (5-aminovaleric acid), 8-Aoc (8-aminooctanoic acid), and 11-Aun (11-aminoundecanoic acid)) with gentle heating. Re-N3S-5-Ava-BBN[7-14]NH2 was also prepd. by the reaction of [Re(V)dimethylglycyl-L-seryl-L-cysteinylglycinamide] with 5-Ava-BBN[7-14]NH2. ES-MS was used to det. the mol. constitution of the new Re(V) conjugates.  The 99mTc conjugates were prepd. at the tracer level by each the prelabeling, post-conjugation and pre-conjugation, postlabeling approaches from the reaction of Na[99mTcO4] with excess SnCl2, sodium gluconate, and corresponding ligand.  The 99mTc and Re(V) conjugates behaved similarly under identical RP-HPLC conditions.  In vitro and in vivo models demonstrated biol. integrity of the new conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3hpJybG-Tg7Vg90H21EOLACvtfcHk0lj4UUA9zxAqUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFWmtrY%253D&md5=18c07e13b6fbb5a2c20d4fe0a4ca724b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fbc020034r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc020034r%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26aulast%3DGali%26aufirst%3DH.%26aulast%3DSieckman%26aufirst%3DG.%2BL.%26aulast%3DHigginbotham%26aufirst%3DC.%26aulast%3DVolkert%26aufirst%3DW.%2BA.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26atitle%3DRadiochemical%2520Investigations%2520of%252099mTc-N3S-X-BBN%255B7%25E2%2580%259314%255DNH2%253A%2520An%2520in%2520Vitro%252Fin%2520Vivo%2520Structure-Activity%2520Relationship%2520Study%2520Where%2520X%2520%253D%25200-%252C%25203-%252C%25205-%252C%25208-%252C%2520and%252011-Carbon%2520Tethering%2520Moieties%26jtitle%3DBioconjugate%2520Chem.%26date%3D2003%26volume%3D14%26spage%3D93%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i18"><a href="/doi/suppl/10.1021/jm701056x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_76747"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H and <sup>13</sup>C NMR chemical shift tables (Tables S1−S6) for Re- and disulfide-cyclized Ac-Tyr<sup>3</sup>-octreotate, octreotide, and Tyr<sup>3</sup>-octreotate. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701056x/suppl_file/jm701056x-file003.pdf">jm701056x-file003.pdf (105.08 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm701056x&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm701056x%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm701056x" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                298KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996cd638373c04","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
